ANNUAL REPORT

FY2026 — Annual report

FY2026PDF · 92 pages14.4 MB
2026 Annual Report

-- 1 of 92 --

(1) Diluted net earnings per common share are calculated based on net earnings attributable to Procter & Gamble.
(2) Core EPS is a measure of the Company’s diluted net earnings per common share adjusted for certain items not viewed as part of our sustainable results.
Please see page 74 of the Annual Report for detail on the reconciling items.
(3) These results exclude net sales in Corporate.
(4) North America includes the United States, Canada and Puerto Rico.
VARIOUS STATEMENTS IN THIS ANNUAL REPORT, including estimates, projections, objectives and expected results, are “forward-looking statements” within
the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934
and are generally identified by the words “believe,” “expect,” “anticipate,” “intend,” “opportunity,” “plan,” “project,” “will,” “should,” “could,” “would,” “likely” and
similar expressions. Forward-looking statements are based on current assumptions that are subject to risks and uncertainties that may cause actual results to
differ materially from the forward-looking statements, including the risks and uncertainties discussed in Item 1A — Risk Factors of the Form 10-K included in
this Annual Report. Such forward-looking statements speak only as of the date they are made, and we undertake no obligation to update or revise publicly any
forward-looking statements, except as required by law.
Certain brand names referenced in this Annual Report are trademarks of The Procter & Gamble Company or one of its subsidiaries. All other brand names are
trademarks of their respective owners.
Fiscal Year 2026
by the Numbers
Adjusted Free
Cash Flow
Productivity	100%
Financial Highlights (Unaudited)
Amounts in billions, except per share amounts
HIGHLIGHT 	2026 	2025 2024 2023 2022
Net Sales 	$87.0 	$84.3 $84.0 $82.0 $80.2
Operating Income 	$19.7 	$20.5 	$18.5 	$18.1 	$17.8
Net Earnings
Attributable to P&G $16.0 	$16.0 	$14.9 	$14.7 	$14.7
Net Earnings Margin 	18.5% 	19.1% 	17.8% 18.0% 18.4%
Diluted Net Earnings
per Common Share 1 	$6.62 	$6.51 	$6.02 $5.90 	$5.81
Core Earnings
per Share 2 	$6.89 $6.83 $6.59 $5.90 	$5.81
Operating Cash Flow 	$19.6 	$17.8 	$19.8 	$16.8 	$16.7
Dividends per
Common Share $4.26 $4.08 $3.83 $3.68 $3.52
2026 Net Sales by Business Segment 3
Fabric & Home Care 	35%
Baby, Feminine
& Family Care 	24%
Beauty 	19%
Health Care 	14%
Grooming 	8%
2026 Net Sales by Geographic Region3
North America 4 	51%
Europe 	23%
Latin America 	7%
Greater China 	7%
Asia Pacific 	7%
India, Middle East
& Africa (IMEA) 	5%
Core EPS
Growth
Organic Sales
Growth	1% 1%

-- 2 of 92 --

Shailesh G. Jejurikar
Chairman of the Board, President
and Chief Executive Officer
We increased our dividend by 3% and returned
over $15 billion of value to shareowners through
over $10 billion in dividends and $5 billion in share
repurchase. This was our 70th consecutive annual
dividend increase, and the 136th consecutive year
P&G has paid a dividend.
In summary, fiscal 2026 was another year of sales
and earnings growth and strong cash return to
shareowners. Despite the volatile geopolitical,
macroeconomic and consumer dynamics we
faced — headwinds not anticipated at the start of
the fiscal year — we delivered within our going-in
guidance ranges across all key financial metrics.
There is much to build on in the year ahead with
broad-based growth across all regions and with
nine of 10 categories growing or holding organic
sales. We also finished the year holding global share,
with trends improving in the second semester.
However, there is clearly more work to be done to
sustain and accelerate the momentum underway.
We believe we are focused on the right strategic
choices and executional plans to deliver the sequential
progress we expect moving forward, and we are
committed to improving results semester by
semester and year by year.
P&G’s Integrated
Growth Strategy
Our integrated growth strategy provides a roadmap
for growth and value creation by consistently
delighting consumers.
Dear
Shareowners,
We met our core objectives for fiscal year 2026 despite
unexpected headwinds. We managed through a very
volatile environment to deliver another year of organic
sales and core earnings-per-share growth within our
initial guidance ranges. We built plans to return to
consistent growth across all categories and regions,
and we stabilized global market share. Importantly,
we continued our long-standing track record of
returning cash to you, our shareowners.
Organic sales grew more than 1%. Core earnings per
share grew 1%. On a currency neutral basis, core
earnings per share were in-line with the prior year.
Adjusted free cash flow productivity was 100%.
Over the course of the year, we sequentially improved
top-line results — moving from up one point in the
first half of the year to two points in the second half.
We also saw improvement in market share in the
second half despite some softening in underlying
market growth as inflation increased. Positive trends
to build on in the year ahead.
Growth was broad-based across categories
and regions.
Nine of 10 product categories held or grew organic
sales for the year. Hair Care and Skin & Personal Care
each grew mid-single digits. Personal Health Care,
Baby Care, Home Care, Fabric Care, Feminine Care,
Grooming and Oral Care were each in-line to up
low single digits. Family Care was down for the year.
All regions held or grew organic sales.
Focus market organic sales were up 1% for the year,
with North America and Europe Focus Markets each
up modestly. Greater China organic sales were up
4% for the year.
Enterprise markets were up 4%, led by Latin America
with 6% organic sales growth.
E-commerce sales increased 6%, now representing
20% of Company total sales.
Twenty-six of our top 50 category/country combinations
held or grew share for the fiscal year. Five of 10 product
categories held or grew share globally. In aggregate,
global value and volume share trends improved in the
back-half, exiting the year roughly flat.

-- 3 of 92 --

This strategy starts with
a portfolio of products
in categories where
performance matters to
consumers. These categories
include Fabric Care, Home
Care, Baby Care, Feminine Care,
Family Care, Hair Care, Skin &
Personal Care, Oral Care, Personal
Health Care and Grooming.
In each of these categories, we continue
to drive the superiority of our brand offerings
across product performance, packaging, brand
communication, retail execution and value.
When we do this well, we delight consumers and,
as a result, grow markets, household penetration,
sales, share and profit.
To fund investments in superiority and to offset cost
challenges, we focus relentlessly on productivity —
eliminating costs that do not lead to increased value
for consumers and removing internal work to free
capacity for consumer-facing activities. Each business
unit creates innovation and productivity plans that
provide multi-year visibility into savings opportunities
that can be reinvested to deliver stronger, holistic
brand experiences for consumers as well as financial
results at the levels we expect.
At the same time, we look for ways to constructively
disrupt ourselves to lead the changes that will shape
the future of P&G and our industry.
We deliver against these strategic pillars with an
organization that is fully engaged, enabled and excited
to serve consumers and win in the marketplace.
This strategy has enabled us to deliver significant
growth and value creation over the better part
of the past decade.
Our strategic choices
are the foundation
for balanced top- and
bottom-line growth. 	Superiority
to win with
consumers
Productivity
to fuel
investments
Organization
empowered, agile,
accountable
Constructive
Disruption
across our
business
Integrated
Growth Strategy
Portfolio
performance drives
brand choice
As we observe changes in the world around us,
we see many opportunities we want to pursue and
risks we will mitigate. There are three important
changes to highlight.
The first change is media fragmentation. In today’s
fragmented media landscape, it is much more difficult
to capture consumers’ attention and educate them
about the benefits of our brands. People have more
sources of information, more sources of influence
and more ways to engage — or disengage — than ever
before. This gives P&G an opportunity to lead another
evolution of brand communication — building
awareness, trust and preference through messages
that are more timely, more relevant and more directly
connected to the superior benefits our brands deliver.
The second change is in the retail landscape.
Consumers are shopping differently. Consider
new shopping methods such as agentic commerce,
quick commerce and social commerce. In the
U.S., channels like e-commerce, d-commerce and
club are growing exponentially, while traditional
formats are consolidating. Additionally, retailers are
becoming media platforms, and media platforms
are becoming retailers. We believe these shifts
ii • The Procter & Gamble Company

-- 4 of 92 --

We are making
four interventions to
strengthen how we
execute our strategy
to win with consumers
and accelerate growth.
Putting the
Consumer First
Transforming
Brand Building
Holistic Partnerships
with Retailers
Stronger Core
and Bigger More
create an opportunity to build stronger, more holistic
partnerships with our retail partners — grounded in
jointly aligned plans to win with shoppers.
The third change is inflation, which has grown
steadily over the last five years and is affecting energy,
food, healthcare and many other areas of household
spending. This has placed significant pressure on
consumers around the world. Even consumers with
higher disposable income are becoming more
disciplined and thoughtful about how they spend —
where they choose to trade up and what they expect
in return for every purchase. This is an opportunity
to better serve consumers with offerings at the right
sizes and price points, while continuing to deliver the
performance, quality and value consumers expect
from P&G brands across every value tier.
In summary, the consumer path to purchase is
changing daily, is non-linear and filled with millions
of possible distractions. To adjust for and benefit from
these shifts in the external landscape, we are making
four interventions to strengthen how we execute our
strategy to win with consumers and accelerate growth.
Putting the Consumer First
The first intervention is to have a deeper, more
complete connection with consumers. Nothing
matters more than putting the consumer first in
everything we do. “Consumer Is Boss” is not a slogan;
it is a belief that has shaped P&G for generations.
Our opportunity now is to apply this belief with
greater consistency and precision — end to end.
A consumer-first mindset means that each decision
we make — from product development to packaging
to communication to retail strategy — must be
meticulously crafted based on how it will be received
by the consumer. Our goal is to deliver a superior
consumer experience at every single touchpoint.
This requires having a profound, empathetic
understanding of the people we serve. It means
seeing the world through their eyes and viewing
them holistically and authentically — not merely
as consumers and shoppers completing a task,
but as people living full, rich lives.
To accomplish this, we spend countless hours with
consumers in their homes — observing, listening
and learning about their lives, daily routines and the
tensions we can help solve. This direct engagement
is more than good practice; it is essential for
understanding people’s needs and developing
superior offerings that address their problems.
In today’s world, having a deep understanding
of consumers matters more than ever to deliver
sustainable growth and value creation.
Transforming Brand Building
The next intervention is to transform brand building —
adapting how we build awareness of our brands and
benefits, drive consumer engagement and reduce
time and steps from awareness to purchase.
As always, brand building starts with clarity on who
we are talking to. However, today, how we reach
consumers is shaped by where they choose to engage
and how they spend their attention and precious time.
Each brand is developing a breadth of creative content
to show up in different ways across different channels,
so we can win in today’s algorithm-driven environment.
Each piece of content is designed to engage consumers
and increasingly includes a direct path to purchase.
This is powered by a modern content creation
engine that brings together in-house creatives,
agency partners, creators, brand fans and artificial
intelligence to produce hundreds of pieces of
content at any given time.
The Procter & Gamble Company • iii

-- 5 of 92 --

Superiority to Win with
Consumers and Grow Markets
Greater China Baby Care continues to lead the growth
of the premium and super premium-segments behind
consumer insight-driven innovation. Chinese parents
want “only the best” for their baby — softness, comfort
and dryness. The Greater China team translated that
insight into a diaper using silk materials to deliver
skin comfort and protection wrapped in a unique,
soft-feel package that conveys superiority at first
touch. The result is double-digit organic sales
growth in each of the past 6 quarters and nearly
5 points of value share over this period.
Authentic, personal conversations and trusted
recommendations from experts and social communities are
crucial to cutting through the fragmented media landscape.
Pantene in Germany transformed its communication to
support this insight. Pantene found new ways to create
relevance and earn consumer attention through connecting
with consumers via social media. The brand created
memorable consumer experiences by strengthening its
presence within influential beauty and lifestyle communities,
working with German opinion leaders and being present
at events where great hair styling matters. The result was a
four-fold increase in influencer-generated content and total
reach tripled. Pantene grew users resulting in value sales
growth of 14% and one-half point of value share growth
versus year ago.
Putting the
Consumer First
Transforming
Brand Building
iv • The Procter & Gamble Company	iv • The Procter & Gamble Company

-- 6 of 92 --

Tide made its biggest upgrade in over two decades on the
original Tide liquid detergent, significantly improving the
product for the same price. Tide original liquid has gone
from declining to high single-digit retail sales growth in the
months since launch — a powerful example of strengthening
the core. A great example of a “bigger more” is Tide evo.
Tide evo represents the biggest innovation in laundry,
crafted by concentrating active surfactant ingredients into a
mixture that is spun into individual fibers. This breakthrough
process ensures each functional fiber delivers the powerful
cleaning performance of Tide, while also enabling the
creation of the convenient Tide evo unit dose form with no
plastic bottles and no extra water. This new formulation and
assembly process is proprietary to P&G and protected by
over 50 granted patents, making it a truly unique technology
and strengthening Tide’s equity as the best clean.
P&G Mexico elevated its strategic partnerships with
retailers by transitioning from short-term tactical planning
to longer-term joint business planning. The team focused
on winning consumer propositions and aligning objectives
and priorities between P&G and each of the retailers,
creating shared accountability for winning the consumer.
As a result, P&G Mexico strengthened its position as a
preferred supplier to these customers, achieving record
levels of in-store visibility and support behind joint priority
growth initiatives. These efforts enabled P&G to drive
60% of category growth, approximately twice fair share.
P&G Mexico grew organic sales high single digits and
gained over one point of value share in fiscal 2026.
Stronger Core and
Bigger More Innovation
Holistic Partnerships
with Retailers
Winning with consumers
starts with insights that
lead to superiority across
these five vectors. 	Brand
Communication
Retail
Execution	Product 	Packaging
Consumer &
Customer Value
The Procter & Gamble Company • v

-- 7 of 92 --

These changes in how we build brands have
transformed creativity as well. Today, creativity is
far more dispersed across the brand’s voice, the
consumer’s voice and experts’ perspectives, all
powered by advanced digital tools. Together, these
voices and their creative ideas are reshaping brand
building into a faster, more dynamic ecosystem.
This evolution in how we approach brand building
is essential for truly putting the consumer first in
this fragmented media landscape.
Building Holistic Partnerships
with Retailers
The next intervention is to build holistic partnerships
with retailers across the entire value chain, not just
in their traditional role as merchants. This is critical
as the convergence of retail and media continues
to grow, especially in areas like digital commerce.
Additionally, sophisticated shopping agents and
AI-driven search capabilities are fundamentally
reshaping how consumers discover, choose and
purchase P&G brands.
Together with our retail partners, we are
establishing comprehensive, multi-year shared
ambitions. These integrate clear goals for sales,
profitability and household penetration across
our categories, underpinned by detailed plans
and time-bound checkpoints.
We are collaborating on integrating media, store
marketing and the customer experience directly
within their digital platforms. We are working together
to optimize costs across our entire combined supply
chains. We are seamlessly integrating P&G’s consumer
and shopper insights with their extensive customer
data in a respectful way that protects individuals’
privacy to improve the shopping experience.
This shared commitment we are developing in
our retail partnerships is essential to ensure that
the superior consumer experience we strive to
create extends flawlessly — from the moment
consumers learn about P&G brands and products,
to when they purchase them, to when they
experience them in their homes.
This strategic and holistic alignment is how we
collectively win in the evolving retail landscape,
leading to stronger results for P&G and our
partners and, most importantly, a better
experience for our consumers.
Innovating for a Stronger
Core and Bigger More
Finally, we need a stronger core and a bigger more.
One of P&G’s greatest strengths is our portfolio of
established brands — the core of our business. We need
to make sure this core is healthy and growing through
impactful innovations that elevate the superiority of the
brand and represent a good holistic value for consumers.
A ‘bigger more’ means that when we create a product
to address new consumer needs, it needs to be
big and innovative enough to justify the investment
needed to build awareness and distribution.
A stronger core and bigger more are critical in
today’s fragmented media landscape. They are also
vital in channels like Club stores, which have limited
assortment, or e-commerce platforms where consumers
typically only see the first two pages of results.
Accelerating Growth
By Growing Users
Ultimately, these interventions are aimed at improving
the vectors of superiority to win the consumer value
equation. We know we are winning the consumer value
equation when we are growing users of our brands.
The simplicity of linking superiority to user growth
in this way increases the urgency to adjust the vectors of
superiority as needed. When we get the equation right,
we accelerate growth — growing users, leading market
growth and growing market share, sales and profit.
vi • The Procter & Gamble Company

-- 8 of 92 --

Creating the
Consumer Packaged
Goods Company
of the Future
The same external landscape changes that
are affecting us in the short term — media
fragmentation, retail landscape, inflation —
also represent long-term opportunities to leap
ahead and invent the consumer packaged goods
company of the future.
The key to winning is to redefine what it takes to
build the strongest, most consumer-relevant, superior
brands in the industry, and P&G has the unique
strengths and capabilities to do just that — putting
the consumer first in everything we do.
We have some of the most well-known and iconic
brands in the world — brands with large consumer
bases. The equity of these brands is unmatched.
We know how to build brands rooted in deep
connections with consumers.
We have an enormous wealth of consumer data
and understanding. We transparently engage with
consumers across more touchpoints than anyone in
our industry — including product research, shopper
research, connected homes, ratings and reviews,
social media posts, brand fan clubs and many more.
We have a unique set of innovation capabilities in
our industry — substrate technologies, formulaic
chemistry, devices and biology. We have years of
experience integrating these capabilities to launch
new platform technologies and innovations, and
we see many more opportunities to combine these
technologies to bring new consumer-preferred
products to life. New technologies, like AI-enabled
molecular discovery, will drive faster acceleration
and more powerful integration of innovation
capabilities, leading to faster growth.
We’re leveraging P&G’s
unique strengths and
capabilities to create the
Consumer Packaged Goods
Company of the Future.
Uniq
u
e 
I
n
novation
C
a
p
a
b
i
l
i
t
i
e
s
S
u
p
p
l
y
C
h
a
i
n
I
n
d
u
s
t
r
y
-
l
e
a
d
i
n
g
D
a
t a
L
a k e & P l a t f o r m s
A
d v a n c e d
L
e
a
d
i
n
g
B
r
a
n
d
s
w
i
t
h
D
e
e
p
C
o
n
s
u
m
e
r
C
o
n
n
e
c
t
i
o
n
s
Superiority
Productivity
Organization
Constructive
Disruption
Portfolio
We have tremendous supply chain capabilities.
The upgrades we have made in P&G’s Supply Chain
are driving a more seamless system connection,
linking purchase signals back through inventory
management, production planning and material
ordering to help ensure consumers find the product
they want every time they shop. We know how to
automate, digitize and autonomize our operations,
and, more importantly, we have qualified a financial
framework to payout these investments.
Finally, we have built a structured data lake
stocked with petabytes of relevant data. We have
built data platforms, AI capabilities, programmatic
shelf tools, and media creation and evaluation
systems. We are now actively and successfully
scaling these technologies across our entire value
chain, further maximizing their impact across
all our categories.
We are now fully integrating all these strengths:
our leading brands, deep consumer understanding,
unique innovation expertise, industry-leading supply
chain, and advanced data lake and digital platforms.
As we close this loop, we believe this will create a
new S-curve for future growth and value creation,
centered around our consumers.

-- 9 of 92 --

Shailesh G. Jejurikar
Chairman of the Board, President
and Chief Executive Officer
Supporting the Virtuous Cycle
of Growth and Citizenship
At P&G, our Purpose as a company is to improve
people’s everyday lives with brands and products
of superior quality and value. This commitment
has been at the heart of everything we do for over
185 years. It focuses us squarely on consumers
and understanding how we can help make their
lives a little bit better.
This fundamental belief in putting the consumer
first means seeing the world through their lens.
It means recognizing them not merely as shoppers
or consumers fulfilling a task, but as individuals
within the fullness of their lives — as family members,
parents, caregivers, neighbors and valued members
of their communities. When we see people fully,
we connect more meaningfully — earning their
trust and increasing our ability to serve them well.
This holistic perspective creates a responsibility
to not only develop superior brands and products,
but to also mirror this broader view of the people
we serve by helping make communities stronger.
This is far more profound than just “doing good.”
It is an integrated commitment to corporate
citizenship that spans every facet of our operations.
Long ago, P&G’s founders recognized that business
success is inextricably linked to the well-being of
the broader community. This creates a virtuous cycle,
where a thriving society supports a thriving business.
This growth fuels our ability to invest in our talented
people, research and development programs, brand-
building activities and operations — enabling us to
deliver sustainable, profitable growth that creates
value for all our stakeholders: consumers, customers,
employees, society and shareowners.
Navigating a Dynamic World
Through a Consumer-First
Approach
Looking ahead, the external environment will remain
dynamic, ambiguous and certainly challenging.
Consumers around the world are dealing with change
at an ever-increasing pace. Economic conditions
continue to shift; technology is profoundly reshaping
how people discover, evaluate and purchase products;
media channels are fragmenting; retail formats are
evolving rapidly; and household budgets remain under
pressure. Undoubtedly, these realities create volatility.
At the same time, these uncertainties also create
opportunities. They challenge us to see consumers
and markets with fresh eyes and to sharpen every
aspect of our work from innovation to execution —
how we build brands, develop more holistic
partnerships with retailers, and increase the
superior performance and value of our brands
across all price tiers. This all starts with a more
deliberate focus on putting consumers first
in every decision we make.
I have every confidence in the ability of P&G people
to meet this moment by applying their deep expertise
and knowledge in consumer understanding; their
talent for developing game-changing innovations
and building consumer-preferred brands; and
their skill in operating with disciplined execution
in challenging environments. Most importantly,
P&G people are motivated by a shared commitment
to improving the daily lives of billions of people
around the world. This focus on putting consumers
first has guided our Company for generations,
and it will continue to guide us in the years ahead
as we build on our momentum and make the most
of the near- and long-term opportunities ahead.
viii • The Procter & Gamble Company

-- 10 of 92 --

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
(Mark one)
[x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRUE
For the Fiscal Year Ended June 30, 2026
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 False
For the transition period from to
Commission File No. 1-434
THE PROCTER & GAMBLE COMPANY
One Procter & Gamble Plaza, Cincinnati, Ohio 45202
Telephone (513) 983-1100
IRS Employer Identification No. 31-0411980
State of Incorporation: Ohio
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, without Par Value PG New York Stock Exchange
0.110% Notes due 2026 PG26D New York Stock Exchange
3.250% EUR Notes due 2026 PG26F New York Stock Exchange
4.875% EUR Notes due May 2027 PG27A New York Stock Exchange
1.200% Notes due 2028 PG28 New York Stock Exchange
3.150% EUR Notes due 2028 PG28B New York Stock Exchange
1.250% Notes due 2029 PG29B New York Stock Exchange
1.800% Notes due 2029 PG29A New York Stock Exchange
6.250% GBP Notes due January 2030 PG30 New York Stock Exchange
0.350% Notes due 2030 PG30C New York Stock Exchange
0.230% Notes due 2031 PG31A New York Stock Exchange
3.250% EUR Notes due 2031 PG31B New York Stock Exchange
5.250% GBP Notes due January 2033 PG33 New York Stock Exchange
2.900% Notes due 2033 PG33B New York Stock Exchange
3.200% EUR Notes due 2034 PG34C New York Stock Exchange
1.875% Notes due 2038 PG38 New York Stock Exchange
0.900% Notes due 2041 PG41 New York Stock Exchange
3.650% Notes due 2045 PG45 New York Stock Exchange
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes  No 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90
days. Yes  No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth
company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the
Exchange Act.
Large accelerated filer  Accelerated filer  Emerging growth company 
Non-accelerated filer  Smaller reporting company  FALSE FALS
E
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Yes  No  TRUE
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the
correction of an error to previously issued financial statements. 
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the
registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No  False
The aggregate market value of the voting stock held by non-affiliates amounted to $333 billion on December 31, 2025.
There were 2,324,433,060 shares of Common Stock outstanding as of July 31, 2026.
Documents Incorporated by Reference
Portions of the Proxy Statement for the 2026 Annual Meeting of Shareholders, which will be filed within one hundred and twenty days of the fiscal year ended June 30,
2026 (2026 Proxy Statement), are incorporated by reference into Part III of this report to the extent described herein.

-- 11 of 92 --

FORM 10-K TABLE OF CONTENTS Page
PART I Item 1. Business 1
Item 1A. Risk Factors 3
Item 1B. Unresolved Staff Comments 9
Item 1C. Cybersecurity 9
Item 2. Properties 10
Item 3. Legal Proceedings 10
Item 4. Mine Safety Disclosure 10
Information about our Executive Officers 11
PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities 12
Item 6. Intentionally Omitted 13
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 13
Item 7A. Quantitative and Qualitative Disclosures about Market Risk 32
Item 8. Financial Statements and Supplementary Data 33
Management's Report and Reports of Independent Registered Public Accounting Firm 33
Consolidated Statements of Earnings 37
Consolidated Statements of Comprehensive Income 37
Consolidated Balance Sheets 38
Consolidated Statements of Shareholders' Equity 39
Consolidated Statements of Cash Flows 40
Notes to Consolidated Financial Statements 41
Note 1: Summary of Significant Accounting Policies 41
Note 2: Segment Information 43
Note 3: Supplemental Financial Information 45
Note 4: Goodwill and Intangible Assets 47
Note 5: Income Taxes 49
Note 6: Earnings Per Share 51
Note 7: Share-based Compensation 52
Note 8: Postretirement Benefits and Employee Stock Ownership Plan 54
Note 9: Risk Management Activities and Fair Value Measurements 59
Note 10: Short-term and Long-term Debt 62
Note 11: Accumulated Other Comprehensive Income/(Loss) 64
Note 12: Leases 64
Note 13: Commitments and Contingencies 65
Note 14: Supplier Finance Programs 66
Note 15: Subsequent Event 67
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 67
Item 9A. Controls and Procedures 67
Item 9B. Other Information 67
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 67
PART III Item 10. Directors, Executive Officers and Corporate Governance 67
Item 11. Executive Compensation 67
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters 67
Item 13. Certain Relationships and Related Transactions and Director Independence 68
Item 14. Principal Accountant Fees and Services 68
PART IV Item 15. Exhibits and Financial Statement Schedules 68
Item 16. Form 10-K Summary 71
Signatures 72

-- 12 of 92 --

PART I
Item 1. Business.
The Procter & Gamble Company (the Company) is a world-leading multinational consumer goods company focused on
providing trusted, branded products of superior quality, performance and value to improve the lives of consumers around the
world - now and for generations to come. Our products are sold in about 180 countries and territories throughout the world. The
Company was incorporated in Ohio in 1905, having first been established as a New Jersey corporation in 1890, and was built
from a business founded in Cincinnati in 1837 by William Procter and James Gamble.
Additional information required by this item is incorporated herein by reference to Management's Discussion and Analysis
(MD&A); and Notes 1 and 2 to our Consolidated Financial Statements. Unless the context indicates otherwise, the terms
"Company," "P&G," "we," "our" or "us" as used herein refer to The Procter & Gamble Company (the registrant) and its
subsidiaries. Throughout this Form 10-K, we incorporate by reference information from other documents filed with the
Securities and Exchange Commission (SEC).
The Company's Annual Report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and
amendments thereto, are filed electronically with the SEC. The SEC maintains an internet site that contains these reports at:
www.sec.gov. Reports can also be accessed and downloaded through links from our website at: www.pginvestor.com. P&G
includes the website link solely as a textual reference and the information on our website is not incorporated by reference into
this report. Copies of these reports are also available, without charge, by contacting EQ Shareowner Services, 1100 Centre
Pointe Curve, Suite 101, Mendota, MN 55120-4100.
Financial Information about Segments
Information about our reportable segments can be found in the MD&A and Note 2 to our Consolidated Financial Statements.
Narrative Description of Business
Business Model. Our business model is focused on delivering sustainable value creation by driving balanced top- and bottom-
line growth. We create, manufacture, market and distribute a diversified portfolio of daily-use products to delight consumers
with irresistible superiority across five key vectors - product performance, packaging, brand communication, retail execution
and value. We invest in research and development and consumer insights to invent new categories or products and innovate our
existing products, ensuring they meet evolving consumer needs and preferences. We leverage marketing strategies including
advertising, promotions and endorsements to drive brand awareness and loyalty among consumers. The Company utilizes
various distribution channels, including retail stores, digital commerce platforms and direct-to-consumer platforms to deliver
our products. Our business model relies on continued productivity improvements to fuel investments in research and
development and marketing and deliver value creation. Our objective is to deliver sustainable and balanced top- and bottom-
line growth while serving the needs of all stakeholders — consumers, customers, employees, society and shareowners.
Key Product Categories. Information on key product categories can be found in the MD&A and Note 2 to our Consolidated
Financial Statements.
Key Customers. Our customers include mass merchandisers, digital commerce (including social commerce) channels, grocery
stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores (including
airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to
consumers. Sales to Walmart Inc. and its affiliates represent approximately 16% of our total sales in 2026, 2025 and 2024. No
other customer represents more than 10% of our total sales. Our top ten customers accounted for approximately 43% of our
total net sales in 2026 and 2025 and 42% in 2024.
Sources and Availability of Materials. Almost all of the raw and packaging materials used by the Company are purchased
from third parties, some of whom are single-source suppliers. We produce certain raw materials, primarily chemicals, for
further use in the manufacturing process. In addition, fuel, natural gas and derivative products are important commodities
consumed in our manufacturing processes and in the transportation of input materials and finished products. The prices we pay
for materials and other commodities are subject to fluctuation including new or increased tariffs. When prices for these items
change, we may or may not pass the change to our customers. The Company purchases a substantial variety of other raw and
packaging materials, none of which are material to our business taken as a whole.
Trademarks and Patents. We own or have rights to patents and trademarks, which are used in connection with our activity in
all businesses. Our patents cover a range of product features, including significant product formulation and processes used to
manufacture our products. The trademarks are important to the overall marketing and branding of our products. In part, our
success can be attributed to the existence and continued protection of these trademarks and patents.
Competitive Condition. The markets in which our products are sold are highly competitive. Our products compete against
similar products from a broad range of companies, both large and small, both established and new, including well-known global
competitors. In many of the markets and industry segments, we compete against other branded products as well as retailers'
private-label brands. In this highly competitive setting, we are well positioned in the industry segments and markets in which
we operate, often holding a leadership or significant market share position. Our integrated strategy and our focus on driving
superiority across product, packaging, brand communication, retail execution and value are key differentiators in the
marketplace.
The Procter & Gamble Company 1

-- 13 of 92 --

Government Regulation. Our Company is subject to a wide variety of laws and regulations across the countries in which we
do business. In the United States, many of our products and manufacturing operations are subject to one or more federal or state
regulatory agencies, including the U.S. Food and Drug Administration (FDA), the Environmental Protection Agency (EPA), the
Occupational Safety and Health Administration (OSHA), the Federal Trade Commission (FTC) and the Consumer Product
Safety Commission (CPSC). We are also subject to anti-corruption laws and regulations, such as the U.S. Foreign Corrupt
Practices Act, and antitrust and competition laws and regulations that govern our dealings with suppliers, customers,
competitors and government officials.
In addition, many foreign jurisdictions in which we do business have regulations and regulatory bodies that govern similar
aspects of our operations and products, in some cases to an even more significant degree. We are also subject to expanding laws
and regulations related to environmental protection and other sustainability-related matters, non-financial reporting and
diligence, labor and employment, trade, taxation and privacy and data protection, including the European Union’s General Data
Protection Regulation and similar regulations in states within the United States and in countries around the world.
The Company has in place compliance programs and internal and external experts to help guide our business in complying with
these and other existing laws and regulations that apply to us around the globe; and we have made, and plan to continue
making, necessary expenditures for compliance with these laws and regulations. We also expect that our many suppliers,
consultants and other third parties working on our behalf share our commitment to compliance, and we have policies and
procedures in place to manage these relationships, though they inherently involve a lesser degree of control over operations and
governance. We do not expect that the Company’s expenditures for compliance with current government regulations, including
current environmental regulations, will have a material effect on our total capital expenditures, earnings or competitive position
in fiscal year 2027 as compared to prior periods.
Human Capital. Our employees are a key source of competitive advantage. Their actions, guided by our Purpose, Values and
Principles (PVPs), are critical to the long-term success of our business. We aim to retain our talented employees by offering
competitive compensation and benefits, strong career development and a respectful and inclusive culture that provides equal
opportunity for all.
Our Board of Directors, through the Compensation and Leadership Development Committee (C&LD Committee), provides
oversight of the Company’s policies and strategy relating to talent, including equality and inclusion, as well as the Company’s
compensation principles and practices. The C&LD Committee also evaluates and approves the Company’s compensation plans,
policies and programs applicable to our senior executives.
Employees
As of June 30, 2026, the Company had approximately 104,000 employees, a decrease of 4% versus the prior year due to the
ongoing restructuring program. See Note 3 for further details on the restructuring program. The total number of employees is an
estimate of total Company employees excluding interns, co-ops, contractors and employees of joint ventures. 49% of our
employees are in manufacturing roles and 28% of our employees are located in the United States. 42% of our global employees
are women and 33% of our U.S. employees identify as multicultural.
Training and Development
We focus on attracting, developing and retaining the broadest pool of talent available, both from universities and the broader
market. We recruit from universities across markets in which we compete and are generally able to select from the top talent.
We focus on developing our employees by providing a variety of job experiences, training programs and skill development
opportunities. Given our develop-from-within model for staffing most of our senior leadership positions, it is particularly
important for us to ensure holistic growth and full engagement of our employees.
Equality and Inclusion
As a global consumer products company, P&G serves consumers around the world with operations in approximately 65
countries. We believe that it is good for business that our workforce is drawn from the best available talent from communities
worldwide, with insights about, connectivity to and understanding of all our consumers. Further, a foundational component of
P&G's strategy and success has been to foster an inclusive work environment, in which we develop and advance the very best
capabilities that all our people have to offer. Globally, we aspire to reflect the diversity of the consumers we serve in the
communities where we operate and are committed to creating a superior employee experience for all. Our aspiration is founded
on our longstanding values and principles for equal opportunity and compliance with the law.
Compensation and Benefits
Market-competitive compensation and reward programs are critical elements of our employee value equation to attract and
retain the best talent. Our total rewards programs are based on the principles of paying for performance, paying competitively
versus peer companies that we compete with for talent in the marketplace and focusing on long-term success through a
combination of short-term and long-term incentive programs. We also offer competitive benefit programs, including retirement
plans and health insurance, in line with local country practices, with flexibility to accommodate the needs of a diverse
workforce.
Sustainability. Environmental sustainability is integrated into our business strategy. We are focused on designing and
manufacturing irresistibly superior products that are more sustainable. We aim to reduce our own environmental footprint and
2 The Procter & Gamble Company

-- 14 of 92 --

enable our consumers to reduce their footprint without compromising on the performance of the products they use. We develop
and license technologies that can be used across industries to improve environmental sustainability at a broader scale.
Combined, this approach intends to positively impact the total environmental impact of the Company while driving market
growth and value creation.
In 2021, the Company announced a 2040 net zero ambition. Our Climate Transition Action Plan outlines the Company’s
ongoing efforts toward reducing greenhouse gas emissions across scopes 1 and 2 and elements of scope 3. The Company has
also declared ambitions towards purchasing renewable electricity for our operations, reducing intensity of virgin petroleum-
based plastic in packaging, designing more consumer packaging to be recyclable or reusable, responsible sourcing of key
forest-based commodities, improving efficiency of water usage in our operations and driving a global portfolio of water
restoration projects in key water basins. While we have met or exceeded some of the goals and are making significant progress
against others, scalable infrastructure and cost-effective solutions are not yet available to us to fully deliver against some of our
stated ambitions.
Sustainability related disclosures included in this Annual Report, our Proxy Statement and our sustainability reports are
informed by standards and guidelines such as the Global Reporting Initiative (GRI), the Task Force on Climate-related
Financial Disclosures (TCFD) and the Task Force on Nature-related Financial Disclosures (TNFD). The “materiality”
thresholds in those standards and guidelines may differ from the concept of “materiality” for purposes of the federal securities
laws and disclosures required by the SEC's rules in this Annual Report. References to our sustainability reports and website are
for informational purposes only and neither the sustainability reports nor the other information on our website is incorporated
by reference into this Annual Report on Form 10-K. Additional detailed information on our sustainability efforts can be found
on our website at https://pginvestor.com/esg.
Item 1A. Risk Factors.
We discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in
this Form 10-K, as well as in our quarterly and annual reports, current reports on Form 8-K, press releases and other written and
oral communications. All statements, except for historical and present factual information, are “forward-looking statements”
and are based on financial data and business plans available only as of the time the statements are made, which may become
outdated or incomplete. We assume no obligation to update any forward-looking statements as a result of new information,
future events or other factors, except to the extent required by law. Forward-looking statements are inherently uncertain, and
investors must recognize that events could significantly differ from our expectations.
The following discussion of “risk factors” identifies significant factors that may adversely affect our business, operations,
financial position or future financial performance. This information should be read in conjunction with Management's
Discussion and Analysis and the Consolidated Financial Statements and related Notes incorporated in this report. The following
discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when
evaluating our expectations. These and other factors could cause our future results to differ from those in the forward-looking
statements and from historical trends, perhaps materially.
MACROECONOMIC CONDITIONS AND RELATED FINANCIAL RISKS
Our business is subject to numerous risks as a result of having significant operations and sales in international markets,
including foreign currency fluctuations, currency exchange or pricing controls.
We are a global company, with operations in approximately 65 countries and products sold in about 180 countries and
territories around the world. We hold assets, incur liabilities, generate sales and pay expenses in a variety of currencies other
than the U.S. dollar, and our operations outside the U.S. generate more than 50% of our annual net sales. Fluctuations in
exchange rates for foreign currencies have and could reduce the U.S. dollar value of sales, earnings and cash flows we receive
from non-U.S. markets, increase our supply costs (as measured in U.S. dollars) in those markets, negatively impact our
competitiveness in those markets or otherwise adversely impact our business results or financial condition.
We have a significant amount of debt, including floating rate and foreign currency debt and derivatives, as part of our capital
markets activities. As we refinance debt or renew derivatives, we are exposed to movement in global interest rates and rate
differentials. The maturity cash outflows of foreign currency debt and derivative instruments could be adversely impacted by
significant appreciation of foreign currency exchange rates (particularly the Euro), which could impact our overall cash flows
and interest expense. Moreover, discriminatory or conflicting fiscal or trade policies in different countries, including changes to
tariffs and existing trade policies and agreements, have and could adversely affect our results. See also the Results of
Operations and Cash Flow, Financial Condition and Liquidity sections of the MD&A and the Consolidated Financial
Statements and related Notes.
We also have businesses and maintain local currency cash balances in a number of countries with currency exchange, import
authorization, pricing or other controls or restrictions. Our results of operations, financial condition and cash flows could be
adversely impacted if we are unable to successfully manage such controls and restrictions, continue existing business operations
and repatriate earnings from overseas, or if new or increased tariffs, quotas, exchange or price controls, trade barriers or similar
restrictions are imposed on our business.
The Procter & Gamble Company 3

-- 15 of 92 --

Uncertain economic or social conditions may adversely impact demand for our products or cause our customers and
other business partners to suffer financial hardship, which could adversely impact our business.
Our business could be negatively impacted by reduced demand for our products related to one or more significant local,
regional or global economic or social disruptions. These disruptions have included and may include: a slow-down, recession or
inflationary pressures in the general economy; reduced market growth rates; tighter credit markets for our suppliers, vendors or
customers; a significant shift in government policies; significant social unrest; the deterioration of economic relations between
countries or regions; potential negative consumer sentiment toward non-local products or sources; or the inability to conduct
day-to-day transactions through our financial intermediaries to pay funds to or collect funds from our customers, vendors and
suppliers. Additionally, these and other economic conditions may cause our suppliers, distributors, contractors or other third-
party partners to suffer financial or operational difficulties that they cannot overcome, resulting in their inability to provide us
with the materials and services we need, in which case our business and results of operations could be adversely affected.
Customers may also suffer financial hardships due to economic conditions such that their accounts become uncollectible or are
subject to longer collection cycles. In addition, if we are unable to generate sufficient sales, income and cash flow, it could
affect the Company’s ability to achieve expected share repurchase and dividend payments.
Changing political and geopolitical conditions could adversely impact our business and financial results.
Changes in the political conditions in markets in which we manufacture, sell or distribute our products, as well as changing
geopolitical conditions, may be difficult to predict and may adversely affect our business and financial results. Results of
elections, referendums, sanctions or other political processes and pressures in certain markets in which our products are
manufactured, sold or distributed have created and could create uncertainty regarding how existing governmental policies, laws
and regulations may change, including with respect to sanctions, taxes, tariffs, import and export controls and the general
movement of goods, materials, services, capital, data and people between countries. The potential implications of such
uncertainty, which include, among others, exchange rate fluctuations, variability and unpredictability in trade relations, new or
increased tariffs, trade barriers and market contraction, could adversely affect the Company’s results of operations and cash
flows.
The Company operates a global business with sales, manufacturing, distribution and research and development organizations
globally that contribute to our overall growth. If geopolitical tensions and trade controls continue to increase or disrupt our
business in markets where we have significant sales or operations, including disruptions due to governmental responses to such
conflicts (such as the imposition of sanctions, export controls, retaliatory tariffs, restrictions on cross-border data transfers,
increased business licensing requirements or limitations on profits), such disruptions could adversely impact our business,
financial condition, results of operations and cash flows.
Our business, operations or employees have been and could continue to be adversely affected (including by the need to de-
consolidate or even exit certain businesses in particular countries) by geopolitical conflicts, political volatility, trade controls,
labor market disruptions, epidemics or other crises or vulnerabilities in individual countries or regions. This could include
political instability, upheaval or acts of war and the related responses of governments or other entities (including, but not
limited to, boycotts in certain regions), broad economic instability or sovereign risk related to a default by or deterioration in the
creditworthiness of local governments, particularly in emerging markets.
For example, the ongoing war between Russia and Ukraine has negatively impacted, and the situation it generates may continue
to negatively impact, our operations. Future impacts to the Company are difficult to predict due to the high level of uncertainty
as to how the overall situation will continue to evolve. We may reduce further or discontinue our operations in Russia due to
significant and cumulative sanctions and export controls and counter-sanctions, monetary, currency or payment controls,
restrictions on data transfers or access to financial institutions and services, supply and transportation challenges or other
circumstances and considerations. In addition to operational disruptions, these factors could result in loss of assets or
impairments of our manufacturing plants and fixed assets or write-downs of other operating assets and working capital.
The conflict in the Middle East could also adversely impact our financial results and operations due to, for example, volatility in
global energy markets, supply chain disruptions, inflationary pressures or trade restrictions.
More broadly, there could be additional negative impacts to our net sales, earnings and cash flows should these situations
worsen or other geopolitical conflicts arise, including, among other potential impacts, economic recessions in certain
neighboring countries or globally due to inflationary pressures, energy and supply chain cost increases or the geographic
proximity of the conflicts relative to the rest of other markets.
Changes in geopolitical conditions could also amplify or affect the other risk factors set forth in this Part I, Item 1A, including,
but not limited to, foreign exchange volatility, disruptions to the financial and credit markets, energy supply and supply chain
disruptions, increased risks of an information security or operational technology incident, cost fluctuations and commodity cost
increases and increased costs to ensure compliance with global and local laws and regulations.
Disruptions in credit markets or to our banking partners or changes to our credit ratings may reduce our access to
credit or overall liquidity.
A disruption in the credit markets or a downgrade of our current credit rating could increase our future borrowing costs and
impair our ability to access capital and credit markets on terms commercially acceptable to us, which could adversely affect our
4 The Procter & Gamble Company

-- 16 of 92 --

liquidity and capital resources or significantly increase our cost of capital. In addition, we rely on top-tier banking partners in
key markets around the world, who themselves face economic, societal, reputational, political and other risks, for access to
credit and to facilitate collection, payment and supply chain finance programs. A disruption to one or more of these top-tier
partners could impact our ability to draw on existing credit facilities or otherwise adversely affect our cash flows or the cash
flows of our customers and vendors.
BUSINESS OPERATIONS RISKS
Our business results depend on our ability to manage disruptions in our global supply chain.
Our ability to meet our customers’ needs and achieve cost targets depends on our ability to maintain key manufacturing and
supply arrangements, including execution of supply chain optimizations and certain sole supplier or sole manufacturing plant
arrangements. The loss or disruption of such manufacturing and supply arrangements, including for issues such as labor
disputes or controversies, loss or impairment of key manufacturing sites, discontinuity or disruptions in our internal information
and data systems or those of our suppliers, cybersecurity incidents including but not limited to ransomware attacks, misuse of
artificial intelligence (AI) and machine learning technologies, inability to procure sufficient raw or input materials (including
water, recycled materials and materials that meet our labor standards), significant changes in trade policy, natural disasters,
increasing severity or frequency of extreme weather events due to climate change or otherwise, acts of war or terrorism, disease
outbreaks (including epidemics, pandemics or similar widespread public health concerns) or other external factors over which
we have no control, have at times interrupted and could interrupt product supply and, if not effectively managed and remedied,
have an adverse impact on our business, financial condition, results of operations or cash flows.
Our businesses face cost fluctuations and pressures that could affect our results.
Our costs are subject to fluctuations, particularly due to changes in the prices of commodities (including certain petroleum-
derived materials like resins and paper-based materials like pulp), raw and packaging materials and the costs of labor, tariffs,
transportation (including trucks and containers), energy, pensions and healthcare. Inflation pressures sometimes result in
increases in these input costs. Therefore, our business results depend, in part, on our continued ability to manage these
fluctuations through pricing actions, cost saving projects and sourcing decisions, while maintaining and improving margins and
market share. Failure to manage these fluctuations and to anticipate consumer reaction to our management of these fluctuations
could adversely impact our results of operations or cash flows.
The ability to achieve our business objectives depends on how well we can compete with our local and global
competitors in new and existing markets and channels.
The consumer products industry is highly competitive. Across all of our categories, we compete against a wide variety, and
increasing number, of global and local competitors. In addition, evolving sales channels and business models may continue to
affect customer and consumer preferences as well as market dynamics, which, for example, may be seen in the growing
consumer preference for shopping online, growth in digital tools, fragmentation of media, ease of competitive entry into certain
categories and growth in hard discounter channels. Failure to anticipate and successfully respond to competitive factors, retail
and consumer trends, new and growing sales channels and new business models, particularly digital commerce, at the pace in
which they are evolving could adversely affect our business results and operations.
A significant change in customer relationships or in customer demand for our products could have a significant impact
on our business.
We sell most of our products via retail customers, which include mass merchandisers, digital commerce (including social
commerce) channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty
beauty stores (including airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional
channels. Our success depends on our ability to successfully manage relationships with our retail customers, which includes our
ability to offer trade terms that are mutually acceptable and are aligned with our pricing and profitability targets in an
environment of changing customer practices driven by digital tools and investment in media platforms. In addition, continued
concentration among our retail customers, an increase in buying alliances or other changes in the negotiation strategies of our
customers could create significant cost and margin pressure on our business or business disruptions. If we cannot reach
agreement with a key customer on trade terms and principles, our business performance could suffer. Our business could also
be negatively impacted if a key customer were to significantly reduce the inventory level of or shelf space allocated to our
products as a result of increased offerings of other branded manufacturers, private label brands and generic non-branded
products or for other reasons, significantly tighten product delivery windows or experience a significant business disruption.
If the reputation of the Company or one or more of our brands erodes significantly, it could have a material impact on
our financial results.
The Company's reputation, and the reputation of our brands, form the foundation of our relationships with key stakeholders and
other constituencies, including consumers, customers and suppliers. The quality and safety of our products are critical to our
business. Many of our brands have worldwide recognition and our financial success directly depends on the success of our
brands. The success of our brands can suffer if our marketing plans or product initiatives do not have the desired impact on a
brand's image or its ability to attract consumers. Our results of operations or cash flows could also be negatively impacted if the
Company or one of our brands suffers substantial harm to its reputation due to a significant product recall, product-related
The Procter & Gamble Company 5

-- 17 of 92 --

litigation, defects or impurities in our products, product misuse, changing consumer perceptions of certain ingredients, negative
perceptions of packaging (such as plastics and other petroleum-based materials), lack of recyclability or other environmental
attributes, concerns about actual or alleged labor, equality and inclusion or social practices, cyber incidents, privacy failures or
data losses, implementation or deployment of a controversial technology, negative views of ongoing operations in certain
countries, allegations of product tampering, negative perceptions of or controversies related to employees or the distribution and
sale of counterfeit products. Additionally, negative or inaccurate postings or comments on social media or networking websites
about the Company or one of its brands could generate adverse publicity that could damage the reputation of our brands or the
Company. If we are unable to effectively manage real or perceived issues, including concerns about safety, quality, ingredients,
efficacy, environmental or social impacts or similar matters, sentiments toward the Company or our products could be
negatively impacted, and our results of operations or cash flows could suffer. Our Company also devotes time and resources to
citizenship efforts that are consistent with our corporate values and are designed to strengthen our business and protect and
preserve our reputation, including programs driving ethics and corporate responsibility, strong communities, equality and
inclusion and environmental sustainability. While the Company has many programs and initiatives to further these citizenship
efforts, we are impacted in part by the actions and efforts of third parties including local and other governmental authorities,
suppliers, vendors and customers. Consumer or broader stakeholder perceptions of these programs and initiatives widely vary
and could adversely affect our business. If these programs are changed, not fully achieved or suffer negative publicity, the
Company's reputation and results of operations or cash flows could be adversely impacted.
We rely on third parties in many aspects of our business, which creates additional risk.
Due to the scale and scope of our business, we must rely on relationships with third parties, including our suppliers, contract
manufacturers, distributors, contractors, commercial banks, joint venture partners and external business partners, for certain
functions. If we are unable to effectively manage our third-party relationships and the agreements under which our third-party
partners operate, our results of operations and cash flows could be adversely impacted. Failure of these third parties to meet
their obligations to the Company, including the transparency and accuracy of the disclosures of ingredients in materials or
processes, proper security of Company data and personal data, and the provision of information to timely address operational
disruptions or cyber incidents, or substantial disruptions in the relationships between the Company and these third parties could
adversely impact our operations and financial results. Additionally, while we have policies and procedures for managing these
relationships, they inherently involve a lesser degree of control over business operations, governance and compliance, thereby
potentially increasing our financial, legal, reputational and operational risk. In some situations, the actions or inactions of third
parties could be imputed to the Company or otherwise lead to inquiries, investigations, claims, proceedings or information
requests by government agencies or private parties.
A significant information security or operational technology incident, including a cybersecurity incident, or the failure
of one or more key information or operations technology systems, networks, hardware, processes and/or associated sites
involving the Company or one of its service providers could have a material adverse impact on our business or
reputation.
We rely extensively on information and operational technology (IT/OT) systems, networks and services, including internet and
intranet sites, data hosting and processing facilities and technologies, physical security systems and other hardware, AI,
software and technical applications and platforms. Many of these are managed, hosted, provided and/or used by third parties or
their vendors. The various uses of these IT/OT systems, networks and services include, but are not limited to, ordering and
managing materials from suppliers; converting materials to finished products; shipping, marketing and selling products;
collecting, transferring, storing and/or processing customer, consumer, employee, vendor, investor and other stakeholder
information and personal data; summarizing and reporting results of operations, including financial reporting; managing our
banking and other cash liquidity systems and platforms; hosting, processing and sharing, as appropriate, confidential and
proprietary research, trade secrets, business plans and financial information; collaborating via an online and efficient means of
global business communications; complying with regulatory, legal and tax requirements; providing data security; and handling
other processes necessary to manage our business.
Increasing and evolving information security threats, including advanced persistent cybersecurity threats and the use of AI to
autonomously find and exploit weaknesses, obtain information, craft social engineering content and execute large-scale attacks
with increased speed and minimal human effort, pose a risk to the security of our services, systems, networks and supply chain,
as well as the confidentiality, availability and integrity of our data and of our critical business operations. In addition, because
the techniques, tools and tactics used in cyber-attacks frequently change, continue to advance in sophistication and may be
difficult to detect for periods of time, we and our third-party providers may face difficulties in anticipating and implementing
adequate preventative measures, quickly evaluating the full impact of an attack or fully containing and mitigating harms after
such an attack.
Our IT/OT databases and systems and our third-party providers’ databases and systems have been, and will likely continue to
be, subject to advanced computer viruses or other malicious codes, ransomware, unauthorized access attempts, denial of service
attacks, phishing (including the use of adversarial AI techniques), social engineering, credential stuffing, automated
vulnerability discovery, data encryption or exfiltration, deep fakes, hacking, supply chain software compromise and other
cyber-attacks. Such attacks may originate from outside parties, hackers, criminal organizations or other threat actors, including
6 The Procter & Gamble Company

-- 18 of 92 --

nation states. In addition, operational errors and insider actors - malicious or otherwise - could cause technical disruptions and/
or data incidents. We cannot guarantee that our security efforts or the security efforts of our third-party providers will prevent
material breaches, operational outages or other breakdowns to our or our third-party providers’ IT/OT databases or systems.
A breach of our data security systems or digital customer products, such as connected devices, or failure of our IT/OT databases
and systems and those of our third-parties may have a material adverse impact on our business operations and financial results.
If the IT/OT systems, networks or service providers we rely upon fail to function properly or cause operational outages or
aberrations, or if we or one of our third-party providers suffer significant unavailability of key operations, or inadvertent
disclosure of, lack of integrity of, or loss of our sensitive business or stakeholder information, including personal information,
due to any number of causes, including catastrophic events, natural disasters, power outages, computer and telecommunications
failures, improper data handling, viruses, phishing attempts, cyber-attacks, malware and ransomware attacks, security incidents,
misuse or malicious use of AI or employee error or malfeasance, and our business continuity plans do not effectively address
these failures on a timely basis, we may suffer interruptions in our ability to manage operations and be exposed to reputational,
competitive, operational, financial and business harm as well as litigation and regulatory action. If our critical IT systems or
back-up systems or those of our third-party vendors are damaged or cease to function properly, we may have to make a
significant investment to repair or replace them.
In addition, if a ransomware attack, other cybersecurity incident or operational disruption occurs, either internally or at our
third-party providers, we could be prevented from accessing our data or systems, which may cause interruptions or delays in
our business operations, cause us to incur remediation costs, subject us to demands to pay a ransom or damage our reputation.
In addition, such events could result in unauthorized disclosure or loss of confidential information or stakeholder information,
including personal data from customers, consumers, employees, vendors, investors and other stakeholders, and we may suffer
financial and reputational damage as a result. Additionally, we could be exposed to potential liability, litigation, governmental
inquiries, reporting requirements, investigations or regulatory enforcement actions; and we could be subject to payment of fines
or other penalties, legal claims by our suppliers, customers or employees and significant remediation costs.
Periodically, we and/or our suppliers also upgrade IT/OT systems or adopt new technologies, including but not limited to AI, in
our operations. These technologies may have limitations, including biases, errors, insufficient or erroneous data. If a new
system or technology does not function properly, provides flawed or inaccurate outputs or exposes us to increased cybersecurity
incidents and failures, it could result in litigation or regulatory enforcement, affect our ability to order materials, make and ship
orders and process payments as well as cause other operational and information integrity and loss issues. The costs and
operational consequences of responding to the above items and implementing remediation measures could be significant and
could adversely impact our results of operations and cash flows and generate negative publicity affecting Company reputation
and relationships among consumers, customers and other business partners.
BUSINESS STRATEGY & ORGANIZATIONAL RISKS
Our ability to meet our growth targets depends on successful product, marketing and operations innovation and
successful responses to competitive innovation, evolving digital marketing and selling platforms and changing consumer
habits.
We are a consumer products company that relies on continued global demand for our brands and products, and consumer
expectations and purchasing habits are evolving at an accelerating pace. Achieving our business results depends, in part, on
successfully developing, introducing and marketing new products and on making significant improvements to our equipment
and manufacturing processes. The success of such innovation depends on our ability to correctly anticipate customer and
consumer acceptance and trends at the pace at which they are evolving, to obtain, maintain and enforce necessary intellectual
property protections and to avoid infringing upon the intellectual property rights of others and to continue to deliver efficient
and effective marketing across evolving and more fragmented media and mobile platforms with dynamic and increasingly more
restrictive privacy requirements. We must also successfully respond to technological advances made by, and intellectual
property rights granted to, competitors, customers and vendors. Failure to continually innovate, improve and respond to
competitive moves, changing consumer habits and platform evolution, including the timely, responsible and effective adoption
of emerging technologies such as AI, could compromise our competitive position and adversely impact our financial condition,
results of operations or cash flows.
We must successfully manage ongoing acquisition, joint venture and divestiture activities.
As a company that manages a portfolio of consumer brands, our ongoing business model includes a certain level of acquisition,
joint venture and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the
same time delivering against our business objectives. Specifically, our financial results have been and could be adversely
impacted by the dilutive impacts from the loss of earnings associated with divested brands or dissolution of joint ventures. Our
results of operations and cash flows have been and could be impacted by acquisitions or joint venture activities, if: 1) changes
in the cash flows or other market-based assumptions cause the value of acquired assets to fall below book value, or 2) we are
not able to deliver the expected cost and growth synergies associated with such acquisitions and joint ventures, including as a
result of integration and collaboration challenges, which could also result in an impairment of goodwill and intangible assets.
The Procter & Gamble Company 7

-- 19 of 92 --

Our business results depend on our ability to successfully manage productivity improvements and ongoing
organizational change, including attracting, developing and retaining key talent as part of our overall succession
planning.
Our financial projections assume certain new and ongoing productivity improvements and cost savings, including staffing
adjustments and employee departures. Failure to deliver these planned productivity improvements and cost savings, while
continuing to invest in business growth, could adversely impact our results of operations and cash flows. Additionally,
successfully executing organizational change, management transitions at leadership levels of the Company and motivation and
retention of key employees is critical to our business success. Factors that may affect our ability to attract and retain sufficient
numbers of qualified employees include: employee morale; our reputation; the impacts of political, social and geopolitical
polarization; competition from other employers and availability of qualified individuals. Our success depends on identifying,
developing and retaining key employees to provide uninterrupted leadership and direction for our business. This includes
developing and retaining organizational capabilities in key growth markets where the depth of skilled or experienced employees
may be limited and competition for these resources is intense as well as continuing the development and execution of robust
leadership succession plans. It also includes continuing to attract, develop and retain employees that adapt to new ways of
working and new technologies in a rapidly changing environment.
LEGAL & REGULATORY RISKS
We must successfully manage compliance with current and expanding laws and regulations, as well as manage new and
pending legal and regulatory matters in the U.S. and abroad.
Our business is subject to a wide variety of laws, regulations, policies and related interpretations across the countries in which
we do business, including those laws and regulations involving intellectual property, product liability, product composition or
formulation (including requirements related to ingredients or other substances present in products), manufacturing processes,
packaging content or corporate responsibility for packaging and product disposal (including plastics and other petroleum-based
materials), marketing, antitrust and competition, privacy, cybersecurity, data protection and data transfers, AI, environmental
(including increasing focus on the climate, nature, water and waste impacts of consumer packaged goods companies' operations
and products), employment, healthcare, anti-bribery and anti-corruption (including interactions with health care professionals
and government officials as well as corresponding internal controls and record-keeping requirements), trade (including tariffs,
sanctions and export controls), tax, accounting and financial reporting or other matters. In addition, governmental and societal
attention to environmental and social matters, including changing and disparate mandatory and voluntary reporting, diligence
and disclosure on topics such as climate change, waste production, water usage, nature impacts, human capital, respect for
human rights, labor and risk oversight, could continue to expand the nature, scope and complexity of matters that we are
required to control, assess and report. These and other rapidly changing laws, regulations, policies and related interpretations as
well as increased enforcement actions by various governmental and regulatory agencies, create challenges for the Company,
may alter the environment in which we do business, may increase the ongoing costs and complexities of compliance including
by requiring investments in technology or other compliance systems and may ultimately result in the need to cease
manufacturing, sales or other business activities in certain jurisdictions, which could adversely impact our results of operations
and cash flows. If we are unable to continue to meet these challenges and comply with all laws, regulations, policies and related
interpretations, it could negatively impact our reputation and our business results. Additionally, we are currently, and in the
future may be, subject to a number of inquiries, investigations, claims, proceedings and requests for information from
governmental agencies or private parties, the adverse outcomes of which could harm our business. Failure to successfully
manage these new or pending regulatory and legal matters and resolve such matters without significant liability or damage to
our reputation may materially adversely impact our financial condition, results of operations and cash flows. Furthermore, if
new or pending legal or regulatory matters result in fines or costs in excess of the amounts accrued to date, that may also
materially impact our results of operations and financial position.
Changes in applicable tax laws and regulations and resolutions of tax disputes could negatively affect our financial
results.
The Company is subject to taxation in the U.S. and numerous foreign jurisdictions. Changes in the various tax laws can and do
occur. For example, in July 2025, the U.S. government enacted the One Big Beautiful Bill Act (the 2025 U.S. Tax Act). The
2025 U.S. Tax Act extended or made permanent many of the corporate tax changes arising under the Tax Cuts and Jobs Act
passed in 2017 (the 2017 U.S. Tax Act). We do not anticipate the 2025 U.S. Tax Act to have a material impact to our financial
condition, results of operations, cash flows or effective tax rate.
In December 2021, the Organisation for Economic Co-operation and Development (OECD) issued “Pillar Two” model rules
which established a global minimum corporate tax rate of 15% for large multinational corporations. Many countries have
implemented or are in the process of implementing Pillar Two legislation into their respective domestic laws. The
implementation of the Pillar Two global minimum top-up tax did not have a material impact to our financial condition, results
of operations, cash flows or effective tax rate for the fiscal year ended 2026. Based on current legislation and available
guidance, including the January 5, 2026 Pillar Two "Side-by-Side Package", we do not anticipate the Pillar Two global
minimum top-up tax to have a material impact to our financial condition, results of operations, cash flows or effective tax rate
in future years. The Company continues to assess the overall impact of potential changes as developments occur, consistent
8 The Procter & Gamble Company

-- 20 of 92 --

with our practice to monitor all changes in tax laws. As the Pillar Two global minimum tax and other tax laws and related
regulations are revised, enacted and implemented, a material impact to our financial condition, results of operations, cash flows
or effective tax rate may occur.
Furthermore, we are subject to regular review and audit by both foreign and domestic tax authorities. While we believe our tax
positions will be sustained, the final outcome of tax audits and related litigation may differ materially from the tax amounts
recorded in our Consolidated Financial Statements, which could adversely impact our results of operations and cash flows.
Item 1B. Unresolved Staff Comments.
None.
Item 1C. Cybersecurity.
Risk Management and Strategy
The Company employs multiple tools and processes for assessing, identifying and managing material risks from cybersecurity
threats. A multi-functional enterprise security team reviews and assesses top cybersecurity risks. This assessment is shared with
members of senior management, including the Chief Information Officer (CIO) and Chief Information Security Officer (CISO),
and helps guide the Company's cybersecurity operational priorities and strategy. In addition, cybersecurity risks are integrated
into the Company’s broader Enterprise Risk Management program. When cybersecurity risks are identified through the
Enterprise Risk Management program or otherwise, they are reported to relevant business and governance leaders within the
Company for appropriate action.
To support the ongoing identification and management of cybersecurity issues, the Company provides information security
employee training, conducts global and targeted phishing simulation campaigns, conducts tabletop exercises and performs
penetration testing, vulnerability and maturity assessments. The Company also deploys a large library of security tools and
experts to help prevent, detect, contain, eradicate and recover from potential cybersecurity issues and cyber-attacks. Further, the
Company engages third-party consultants and services for cyber intelligence, insights, incident response support and
assessments of its cybersecurity risk posture and governance.
Cybersecurity reviews are embedded into the Company’s Third-Party Risk Management program. Generally under this
program, third parties that process personal data or high-risk business data on behalf of the Company complete privacy and
cybersecurity assessments on a risk basis, which may require such third parties to sign data processing agreements, comply with
particular security controls or complete an additional security and privacy assessment.
As a global company, we manage a variety of cybersecurity threats and cannot wholly eliminate the risk of adverse impacts
from such incidents. However, as of the date of this Form 10-K, we have not identified any cybersecurity threats that have
materially affected or are reasonably likely to materially affect our business strategy, results of our operations or financial
condition. For additional information on the risks from cybersecurity threats that we have faced in the past and expect to
continue to face in the future, please refer to the “Risk Factors” in Part I, Item 1A of this Form 10-K.
Governance
The Company’s Board of Directors oversees cybersecurity risks consistent with its general risk oversight responsibility. The
Audit Committee of the Board has specific responsibility for reviewing the status of the security of the Company’s electronic
data processing information systems and the general security, including cybersecurity, of the Company’s people, assets and
information systems. In support of this general oversight, the full Board reviews, at least annually, the most significant
enterprise risks facing the Company, including cybersecurity risks, as identified in the Company’s Enterprise Risk Management
program. This review, which includes key members of senior management, covers key risks from information security that have
been identified and corresponding action plans. The Audit Committee also receives regular updates from the Company’s CIO
and CISO about the Company’s information security and systems security programs and plans, including emerging trends and
progress on overall enterprise cybersecurity programs and priorities. These updates occur at least three times a year, with
interim updates as needed.
The Company’s management is responsible for implementing its strategic plans, including identifying, evaluating, managing
and mitigating the risks inherent in them, such as cybersecurity risks. Within management, the Company’s CISO has specific
responsibility for cybersecurity risk management, reporting to the CIO.
The Company’s CISO has over 20 years of experience at the Company with significant experience in supply chain operations,
risk management and governance and information security. The CISO's organization includes a dedicated team of centralized
information security experts and a network of security professionals embedded in each business unit and function.
The CISO also leads the design and development of the Company’s cybersecurity program, relying on functional experts within
the central Information Security organization as well as on information security experts within each of the Company’s
Organizational Units. These embedded experts are responsible for the execution of the Company’s overall information security
strategy and report security risks in their area of responsibility to their Organization Unit leader and to the CISO. Experts within
the Company’s central Information Security organization help develop the Company’s cybersecurity strategies, policies and
standards and similarly report security risks within the central enterprise to the CISO.
The Procter & Gamble Company 9

-- 21 of 92 --

A central team within the Company leads enterprise-wide incident investigations and response, assisting and consulting on
cybersecurity incidents impacting individual Organizational Units. Alerts of potential incidents can arise from security tool
alerts, employee reports, threat intelligence sources, threat hunting activities or external entities, among other sources. The
Company's Security Operations Center initially responds to incident alerts and notifies central experts to any potentially
significant cybersecurity incidents. Members of the Security Operations Center and relevant response teams work to contain
and eradicate potential and identified threats and support the system’s recovery efforts, advised as needed by the Legal
department and other Company experts. As a part of the incident response process, the severity of cybersecurity incidents are
assessed based on the nature, scope, timing and potential impact of the incident on the Company's business, operations and
financial condition. Incidents are communicated to the CISO and other members of management, including the Company’s
Ethics & Compliance Committee, as well as the Audit Committee of the Board, in accordance with documented escalation
criteria. The central enterprise team also regularly reviews incident reports to update the CISO.
As described above, both the CIO and CISO report information about the Company’s identification and management of
cybersecurity risks to the Audit Committee.
Item 2. Properties.
In the U.S., we own and operate 24 manufacturing sites located in 18 different states. In addition, we own and operate 72
manufacturing sites in 31 other countries. Many of the domestic and international sites manufacture products for multiple
businesses. Beauty products are manufactured at 20 of these locations; Grooming products at 17; Health Care products at 19;
Fabric & Home Care products at 34; and Baby, Feminine & Family Care products at 32. We own our Corporate headquarters in
Cincinnati, Ohio. We own or lease our principal regional general offices in Switzerland, Panama, Singapore, China and the
United Arab Emirates. We own or lease our principal regional shared service centers in Costa Rica, the United Kingdom and
the Philippines. Management believes that the Company's sites are adequate to support the business and that the properties and
equipment have been well maintained.
Item 3. Legal Proceedings.
The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a
wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues,
patent and trademark matters, labor and employment matters and tax. In addition, SEC regulations require that we disclose
certain environmental proceedings arising under federal, state or local law when a governmental authority is a party and such
proceeding involves potential monetary sanctions that the Company reasonably believes will exceed a certain threshold ($1
million or more).
On November 22, 2023, Procter & Gamble UK (“P&G UK”), a United Kingdom based wholly owned subsidiary of the
Company, received notification from the U.K. Environment Agency of its intent to assess an unspecified civil penalty for P&G
UK’s prior inadvertent failure to secure a required permit for its London-based manufacturing site under the European Union’s
and United Kingdom’s Emission Trading Systems. Among other requirements, these Emissions Trading Systems require
registration of the site and accounting of and payment for certain past greenhouse gas emissions. The site has been properly
registered since March 2021, and P&G UK proactively notified the U.K. Environment Agency after learning of the prior issue.
In July 2025, the U.K. Environment Agency notified P&G UK of its intent to impose a civil penalty of less than $2 million. The
matter is not yet resolved.
There are no other relevant matters to disclose under this Item for this period. See Note 13 to our Consolidated Financial
Statements for information on certain legal proceedings for which there are contingencies.
This item should be read in conjunction with the Company's Risk Factors in Part I, Item 1A for additional information.
Item 4. Mine Safety Disclosure.
Not applicable.
10 The Procter & Gamble Company

-- 22 of 92 --

INFORMATION ABOUT OUR EXECUTIVE OFFICERS
The names, ages and positions held by the Executive Officers of the Company on August 4, 2026, are:
Name Position Age First Elected to
Officer Position
Shailesh G. Jejurikar Chairman of the Board, President and Chief Executive
Officer 59 2018 (1)
Andre Schulten Chief Financial Officer 55 2021 (( )
Hesham Tohamy Abd El Hak Chief Executive Officer - Baby and Feminine Care 51 2026 (2)
Juliana Azevedo Chief Executive Officer - Grooming 50 2026 (3)
Freddy Bharucha Chief Executive Officer - Beauty 54 2025 (4)
Paul Gama Chief Executive Officer - Health Care 60 2026 (5)
Sundar G. Raman Chief Executive Officer - Fabric and Home Care and
Executive Sponsor for Corporate Sustainability 51 2021 (( )
Victor Aguilar Chief Research, Development and Innovation Officer 59 2020 (( )
Marc S. Pritchard Chief Brand Officer 66 2008 (( )
Balaji Purushothaman Chief Human Resources Officer 57 2023 (6)
Susan Street Whaley Chief Legal Officer and Secretary 52 2022 (7)
All the Executive Officers named above have been employed by the Company for more than the past five years.
(1) Mr. Jejurikar previously served as Chief Operating Officer (2021 - 2025) and Chief Executive Officer - Fabric and Home Care (2019 - 2021).
(2) Mr. Abd El Hak previously served as President - Baby Care (January 1, 2026 - June 1, 2026), President - Feminine Care (2022 - 2025) and Senior Vice
President, Feminine Care, North America Brand Franchise Leader (2018 - 2022).
(3) Ms. Azevedo previously served as President - Home Care and P&G Professional, Executive Sponsor, Gender Equality (2024 - 2026), President - Latin
America (2022 - 2024) and Senior Vice President, Brazil (2018 - 2022).
(4) Mr. Bharucha previously served as President - Personal Care and North America Beauty Ecosystem (2023 - 2025), Senior Vice President - Personal Care,
North America, Brand Franchise Leader, Old Spice and Global Commercial Leader, Antiperspirants and Deodorants (2018 - 2023).
(5) Mr. Gama previously served as President - Personal Health Care (2020 - 2026).
(6) Mr. Purushothaman previously served as Senior Vice President - Human Resources, Global Total Rewards, Employee and Labor Relations and Corporate
Services (2020 - 2022).
(7) Ms. Whaley previously served as Senior Vice President and General Counsel - North America, Practice Groups and Sector Business Units (2019 - 2022).
The Procter & Gamble Company 11

-- 23 of 92 --

PART II
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
ISSUER PURCHASES OF EQUITY SECURITIES
Period
Total Number of
Shares Purchased (1)
Average Price Paid
per Share (2)
Total Number of
Shares Purchased as
Part of Publicly Announced
Plans or Programs (3)
Approximate Dollar Value of
Shares that May Yet Be
Purchased Under Our Share
Repurchase Program
4/1/2026 - 4/30/2026 — — — (3)
5/1/2026 - 5/31/2026 3,116,914 $144.37 3,116,914 (3)
6/1/2026 - 6/30/2026 2,816,725 150.88 2,816,725 (3)
Total 5,933,639 $147.46 5,933,639 (3)
(1) All transactions are reported on a trade date basis and were made in the open market with large financial institutions. This table excludes
shares withheld from employees to satisfy tax withholding requirements on option exercises and other equity-based transactions. The
Company administers cashless exercises through an independent third party and does not repurchase stock in connection with cashless
exercises.
(2) Average price paid per share for open market transactions excludes commission.
(3) In accordance with the repurchase program announced on July 29, 2025, the Company reaffirmed in its earnings release on April 24,
2026, that it expected to reduce outstanding shares through direct share repurchases at a value of approximately $5 billion in fiscal year
2026, notwithstanding any purchases under the Company's compensation and benefit plans. The share repurchases were authorized
pursuant to a resolution issued by the Company's Board of Directors and were financed through a combination of operating cash flows
and issuance of debt. The total value of the shares purchased under the share repurchase plan was $5 billion. The share repurchase plan
ended on June 30, 2026.
Additional information required by this item can be found in Part III, Item 12 of this Form 10-K.
SHAREHOLDER RETURN PERFORMANCE GRAPHS
Market and Dividend Information
P&G has been paying a dividend for 136 consecutive years since its incorporation in 1890 and has increased its dividend for 70
consecutive years since 1956. Over the past ten years, the dividend has increased at an annual compound average rate of 5%.
Nevertheless, as in the past, further dividends will be considered after reviewing dividend yields, profitability and cash flow
expectations and financing needs and will be declared at the discretion of the Company's Board of Directors.
(in dollars; split-adjusted) 1956 1966 1976 1986 1996 2006 2016 2026
Dividends per share $ 0.01 $ 0.03 $ 0.06 $ 0.16 $ 0.40 $ 1.15 $ 2.66 $ 4.26
12 The Procter & Gamble Company

-- 24 of 92 --

Common Stock Information
P&G trades on the New York Stock Exchange under the stock symbol PG. As of June 30, 2026, there were approximately 6
million common stock shareowners, including shareowners of record, participants in P&G stock ownership plans and beneficial
owners with accounts at banks and brokerage firms.
Shareholder Return
The following graph compares the cumulative total return of P&G’s common stock for the five-year period ended June 30,
2026, against the cumulative total return of the S&P 500 Stock Index (broad market comparison) and the S&P 500 Consumer
Staples Index (line of business comparison). The graph and table assume $100 was invested on June 30, 2021, and that all
dividends were reinvested.
Cumulative Value of $100 Investment, through June 30
Company Name/Index 2021 2022 2023 2024 2025 2026
P&G $ 100 $ 109 $ 118 $ 132 $ 130 $ 123
S&P 500 100 89 107 133 153 188
S&P 500 Consumer Staples 100 107 114 123 138 145
Item 6. Intentionally Omitted.
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.
Forward-Looking Statements
Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to
our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are
“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear
throughout this report, including without limitation, in the following sections: “Management's Discussion and Analysis,” “Risk
Factors” and "Notes 4, 8 and 13 to the Consolidated Financial Statements." These forward-looking statements generally are
identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,”
“plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions. Forward-
looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may
cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no
obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or
otherwise, except to the extent required by law.
The Procter & Gamble Company 13

-- 25 of 92 --

Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to
successfully manage global financial risks, including foreign currency fluctuations, changes in global interest rates and rate
differentials, currency exchange or pricing controls and tariffs; (2) the ability to successfully manage local, regional or global
economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the
Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties
related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market
contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls; (4) the ability
to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key
manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole
manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our
control, such as natural disasters, conflicts or acts of war, terrorism or disease outbreaks; (6) the ability to successfully manage
cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy,
pensions and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels,
including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products;
(8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by
successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging
content, cyber incidents, supply chain practices, social or environmental practices or similar matters that may arise; (10) the
ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships,
such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on
and maintain key company and third-party information and operational technology systems, networks and services and maintain
the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to
successfully manage demand, supply and operational challenges; (13) the ability to stay on the leading edge of innovation,
obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving and more
fragmented digital marketing and selling platform requirements and technological advances attained by, and patents granted to,
competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each
case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base
business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing
organizational changes while successfully identifying, developing and retaining key employees, including in key growth
markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage
current and expanding regulatory and legal requirements and matters (including, without limitation, those laws, regulations,
policies and related interpretations involving product liability, product and packaging composition, manufacturing processes,
intellectual property, labor and employment, antitrust, privacy, cybersecurity, data protection and data transfers, artificial
intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and
pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the
ability to continue delivering progress towards our environmental sustainability ambitions. A detailed discussion of risks and
uncertainties that could cause actual results and events to differ materially from those projected herein is included in the section
titled "Economic Conditions and Uncertainties" and the section titled "Risk Factors" (Part I, Item 1A) of this Form 10-K.
Purpose, Approach and Non-GAAP Measures
The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's
financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The
MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and
accompanying Notes. The MD&A is organized in the following sections:
• Overview
• Summary of 2026 Results
• Economic Conditions and Uncertainties
• Results of Operations
• Segment Results
• Cash Flow, Financial Condition and Liquidity
• Critical Accounting Policies and Estimates
• Other Information
Throughout the MD&A we refer to measures used by management to evaluate performance, including unit volume growth, net
sales, net earnings, diluted net earnings per common share (diluted EPS) and operating cash flow. We also refer to a number of
financial measures that are not defined under U.S. GAAP, including organic sales growth, Core earnings per share (Core EPS),
adjusted free cash flow and adjusted free cash flow productivity. The explanation at the end of the MD&A provides the
definition of these non-GAAP measures, details on the use and the derivation of these measures, as well as reconciliations to the
most directly comparable U.S. GAAP measure.
14 The Procter & Gamble Company

-- 26 of 92 --

Management also uses certain market share and market consumption estimates to evaluate performance relative to competition
despite some limitations on the availability and comparability of share and consumption information. References to market
share and consumption in the MD&A are based on a combination of vendor-purchased traditional brick-and-mortar and online
data in key markets as well as internal estimates. All market share references represent the percentage of sales of our products
in dollar terms on a constant currency basis relative to all product sales in the category. The Company measures market shares
through the most recent period for which market share data is available, which typically reflects a lag time of one or two months
as compared to the end of the reporting period. Management also uses unit volume growth to evaluate drivers of changes in net
sales. Organic volume growth reflects year-over-year changes in unit volume excluding the impacts of acquisitions and
divestitures and certain one-time items, if applicable, and is used to explain changes in organic sales. In our presentation of data
in tables or other charts, certain columns and rows may not add due to rounding.
OVERVIEW
P&G is a global leader in the fast-moving consumer goods industry, focused on providing branded consumer packaged goods
of superior quality and value to our consumers around the world. Our products are sold in about 180 countries and territories
primarily through mass merchandisers, digital commerce (including social commerce) channels, grocery stores, membership
club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores (including airport duty-free stores),
high-frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to consumers. We have on-
the-ground operations in approximately 65 countries.
Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry
segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands.
Additionally, many of the product segments in which we compete are differentiated by price tiers (referred to as super-
premium, premium, mid-tier and value-tier products). We believe we are well positioned in the industry segments and markets
in which we operate, often holding a leadership or significant market share position.
Organizational Structure
Our organizational structure is comprised of Sector Business Units (SBUs), Enterprise Markets (EMs), Corporate Functions
(CF) and Global Business Services (GBS).
Sector Business Units
The Company's product categories are organized into five SBUs and five reportable segments (under U.S. GAAP): Beauty;
Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The SBUs are responsible for global brand
strategy, product upgrades and innovation, marketing plans and supply chain. They have direct profit responsibility for markets
(referred to as Focus Markets) representing the large majority of the Company's sales and earnings and are also responsible for
innovation plans, supply plans and operating frameworks to drive growth and value creation in the remaining markets (referred
to as Enterprise Markets). Throughout the MD&A, we reference business results by region, which are comprised of North
America, Europe, Greater China, Latin America, Asia Pacific and India, Middle East and Africa (IMEA).
The Procter & Gamble Company 15

-- 27 of 92 --

The following provides additional detail on our reportable segments and the product categories and brand composition within
each segment.
Reportable Segments % of
Net Sales (1) % of Net
Earnings (1) Product Categories (Sub-Categories) Major Brands
Beauty 19% 17%
Hair Care (Conditioners, Shampoos, Styling Aids,
Treatments) Head & Shoulders, Herbal
Essences, Pantene, Rejoice
Personal Care (Antiperspirants and Deodorants,
Personal Cleansing) Native, Old Spice,
Safeguard, Secret
Skin Care (Facial Moisturizers, Cleaners and
Treatments) Olay, SK-II
Grooming 8% 9% Grooming (Appliances, Female Blades & Razors,
Male Blades & Razors, Pre- and Post-Shave
Products, Other Grooming)
Braun, Gillette, Venus
Health Care 14% 15%
Oral Care (Toothbrushes, Toothpastes, Other Oral
Care) Crest, Oral-B
Personal Health Care (Gastrointestinal, Pain Relief,
Rapid Diagnostics, Respiratory, Vitamins/Minerals/
Supplements, Other Personal Health Care)
Metamucil, Neurobion,
Pepto-Bismol, Vicks
Fabric & Home
Care 35% 35%
Fabric Care (Fabric Enhancers, Laundry Additives,
Laundry Detergents) Ariel, Downy, Gain, Tide
Home Care (Air Care, Dish Care, P&G Professional,
Surface Care) Cascade, Dawn, Fairy,
Febreze, Mr. Clean, Swiffer
Baby, Feminine
& Family Care 24% 24%
Baby Care (Baby Wipes, Taped Diapers and Pants) Luvs, Pampers
Feminine Care (Adult Incontinence, Menstrual Care) Always, Always Discreet,
Tampax
Family Care (Paper Towels, Tissues, Toilet Paper) Bounty, Charmin, Puffs
(1) Percent of Net sales and Net earnings for the fiscal year ended June 30, 2026 (excluding results held in Corporate).
Organization Design:
Sector Business Units
Beauty: The beauty categories in which we compete are hair care, personal care and skin care. We are a global market leader in
the retail hair care market with about 20% global market share primarily behind our Head & Shoulders and Pantene brands. In
personal care, we have the number two market share position with about 20% global market share, primarily behind our Old
Spice, Native, Secret and Safeguard brands. In skin care, the Olay brand is one of the top facial skin care brands in the world
with about 5% global market share.
Grooming: We are the global market leader in the grooming market, where we hold more than 50% share. Our global blades
and razors market share is more than 60%, primarily behind our Gillette and Venus brands. Our appliances, such as electric
shavers and intense pulse light devices, are sold primarily under the Braun brand. We hold nearly 30% of the male electric
shavers market.
Health Care: We compete in oral care and personal health care. In oral care, we are a leader with a nearly 30% global market
share behind our Crest and Oral-B brands. In personal health care, we are a global market leader among the categories in which
we compete, including respiratory treatments, digestive wellness, sleep aids, vitamins and analgesics behind our Vicks,
Metamucil, Pepto-Bismol and Neurobion brands.
Fabric & Home Care: This segment is comprised of a variety of fabric care products, including laundry detergents, additives
and fabric enhancers; and home care products, including dishwashing liquids and detergents, surface cleaners and air
fresheners. In fabric care, we generally have the number one or number two market share position and are the global market
leader with over 35% market share in the markets in which we compete, primarily behind our Tide, Ariel and Downy brands.
Our global home care market share is more than 30% across the categories in which we compete, primarily behind our Cascade,
Dawn, Febreze and Swiffer brands.
Baby, Feminine & Family Care: In baby care, we are a global market leader and compete mainly in taped diapers, pants and
baby wipes, with more than 30% global market share. We generally have the number one or number two market share position
in the markets in which we compete, primarily behind our Pampers brand. We are the global market leader in the feminine care
category with nearly 30% global market share. We compete in the menstrual care sub-category primarily behind our Always
and Tampax brands with nearly 35% global market share. We also compete in the adult incontinence sub-category behind
Always Discreet, with over 15% market share in the markets in which we compete. Our family care business is predominantly a
16 The Procter & Gamble Company

-- 28 of 92 --

North American business comprised primarily of the Bounty paper towel and Charmin toilet paper brands. North America
market shares are nearly 40% for Bounty and over 25% for Charmin.
Enterprise Markets
Enterprise Markets are responsible for sales and profit delivery in specific countries, supported by SBU-agreed innovation and
supply chain plans, along with scaled services like planning, distribution and customer management.
Corporate Functions
Corporate Functions provides company-level strategy and portfolio analysis, corporate accounting, treasury, tax, external
relations, governance, human resources, information technology and legal services.
Global Business Services
Global Business Services provides scaled services in technology, process and data tools to enable the SBUs, the EMs and CF to
better serve consumers and customers. The GBS organization is responsible for providing world-class services and solutions
that drive value for P&G.
Strategic Focus
Procter & Gamble aspires to serve the world’s consumers better than our best competitors in every category and in every
country in which we compete and, as a result, deliver total shareholder return in the top one-third of our peer group. Delivering
and sustaining leadership levels of shareholder value creation requires balanced top- and bottom-line growth and strong cash
generation.
Our strategy is to deliver and sustain value creation through five integrated choices: a portfolio of daily-use products where
performance drives brand choice; superiority across product, package, brand communication, retail execution and value;
productivity; constructive disruption of the entire value chain; and a highly efficient and effective organization structure.
The Company competes in daily-use product categories where performance plays a significant role in the consumer's choice of
brands, and therefore, plays to P&G's strengths. Our focused portfolio of businesses consists of product categories where P&G
has strong brands and consumer-meaningful product technologies with typically leadership market positions.
Within these categories, our strategic choices are focused on delighting and winning with consumers. Our consumers are at the
center of everything we do. We win with consumers by delivering irresistible superiority across five key vectors - product
performance, packaging, brand communication, retail execution and value. Winning with consumers around the world and
against our best competitors requires superior innovation. Innovation has always been, and continues to be, P&G’s lifeblood.
Superior products delivered with superior execution drive market growth, value creation for retailers and build share growth for
P&G.
Ongoing productivity improvement is strategic and crucial to delivering our balanced top- and bottom-line growth, cash
generation and value creation objectives. Productivity improvement enables investments to strengthen the superiority of our
brands via product and packaging innovation, more efficient and effective supply chains, equity and awareness-building brand
advertising and other programs and expansion of sales coverage and research and development programs. Productivity
improvements also enable us to mitigate and manage through periods of challenging cost environments (including periods of
increasing commodity, inflation and negative foreign exchange impacts). Our objective is to drive productivity improvements
across all elements of the statement of earnings and balance sheet, including cost of goods sold, marketing and promotional
spending, overhead costs and capital spending.
We act with agility and are constructively disrupting our highly competitive industry and the way we do business, including
how we innovate, communicate and leverage new technologies, to create more value.
We are improving operational effectiveness and organizational culture through enhanced clarity of roles and responsibilities,
accountability and incentive compensation programs.
The Company’s strategic framework has been delivering strong results over an extended period of time. As we observe changes
in the markets in which we operate, we will adapt the execution of our core strategy. These market changes include evolving
ways in which consumers are engaging with our brands across social media platforms, streaming services or AI based search.
We observe changes in retail landscapes around the world, where retailers are selling across multiple platforms (digital and
physical outlets) and building their own media platforms. Consumers are changing how they perceive value across their basket
of goods as cumulative inflation impacts their shopping behavior. Lastly, technologies, including AI, offer new capabilities to
innovate, produce and market our products and brands. We are embracing these changes, and to benefit from them, the
Company can and will adjust the execution of its strategy.
Beyond the short-term interventions, the Company expects the delivery of the following long-term growth algorithm will result
in total shareholder returns in the top third of the competitive, fast-moving consumer goods peer group:
• Organic sales growth above market growth rates in the categories and geographies in which we compete;
• Core EPS growth of mid-to-high single digits; and
• Adjusted free cash flow productivity of 90% or greater.
The Procter & Gamble Company 17

-- 29 of 92 --

While periods of significant macroeconomic pressures may cause short-term results to deviate from the long-term growth
algorithm, we intend to maintain a disciplined approach to investing in our business.
RECENT DEVELOPMENTS
Limited Market Portfolio Restructuring
In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations,
primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal
conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring
with the substantial liquidation of its operations in Argentina and recorded incremental restructuring charges of $801 million
after tax, comprised primarily of non-cash charges for accumulated foreign currency translation losses previously included in
Accumulated other comprehensive income/(loss). The total incremental restructuring charges incurred under the program
beginning in the three-month period ended December 31, 2023, through the three-month period ended September 30, 2024,
were $1.2 billion after tax. For more details on the restructuring program, refer to Note 3 to the Consolidated Financial
Statements.
Intangible Asset Impairment
During the fiscal year ended June 30, 2024, the Company recorded a $1.3 billion before tax ($1.0 billion after tax) non-cash
impairment charge on an indefinite-lived intangible asset acquired as part of the Company’s 2005 acquisition of The Gillette
Company. The impairment charge arose from a reduction in the estimated fair value of the Gillette indefinite-lived intangible
asset due to a higher discount rate, weakening of several currencies relative to the U.S. dollar and the impact of the non-core
restructuring program described above. This impairment charge adjusted the carrying value of the Gillette indefinite-lived
intangible asset to fair value. For a more detailed discussion of the Gillette impairment, refer to Note 4 to the Consolidated
Financial Statements.
Focused Portfolio, Supply Chain and Productivity Plan
In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve
its cost structure and invest in growth. The Company expects to incur approximately $1.5 to $2.0 billion in before-tax
restructuring costs over a two-year period, including costs incurred as part of this plan and the ongoing plan. The Company
incurred over half of the costs under this plan in fiscal 2026, with the remainder expected in fiscal 2027.
The restructuring activities are being executed across the Sector Business Units as well as the Enterprise Markets, Corporate
Functions and Global Business Services. These restructuring activities include a plan for a reduction of up to 7,000 non-
manufacturing overhead personnel by the end of fiscal 2027. Consistent with our historical policies for ongoing restructuring-
type activities, resulting charges are funded by and included within Corporate for segment reporting. Restructuring charges
above the normal ongoing level of restructuring costs are reported as non-core charges. For more details on the restructuring
program, refer to Note 3 to the Consolidated Financial Statements.
Glad Joint Venture Agreement
In January 2026, the Glad joint venture agreement between the Company and The Clorox Company (Clorox) expired. Under
the terms of the agreement, Clorox purchased the Company’s minority interest in the venture at fair market value for $476
million. This transaction was accounted for as a dissolution of the Glad joint venture business and the Company recorded an
after-tax gain of $261 million.
U.S. Tariffs
On February 20, 2026, the U.S. Supreme Court ruled that the tariffs imposed under the International Emergency Economic
Powers Act (IEEPA) were invalid. The Company previously paid approximately $200 million in IEEPA tariffs that may be
recoverable. During the three-month period ended June 30, 2026, the Company recognized recovery of half of this amount in its
Consolidated Financial Statements.
Thorne Acquisition
On August 4, 2026, the Company entered into an agreement to acquire Thorne, a premium wellness and supplement brand in
the vitamins, minerals and supplements category for $3.8 billion. We anticipate the transaction to close in the second quarter of
fiscal year 2027, with the timing subject to regulatory approval and customary closing conditions.
18 The Procter & Gamble Company

-- 30 of 92 --

SUMMARY OF 2026 RESULTS
Amounts in millions, except per share amounts 2026 2025 Change vs. Prior
Year
Net sales $ 87,032 $ 84,284 3 %
Operating income 19,748 20,451 (3)%
Net earnings 16,144 16,065 — %
Net earnings attributable to Procter & Gamble 16,046 15,974 — %
Diluted net earnings per common share 6.62 6.51 2 %
Core earnings per share 6.89 6.83 1 %
Cash flow from operating activities 19,556 17,817 10 %
• Net sales increased 3% to $87.0 billion versus the prior year. Net sales increased high single digits in Beauty, mid-single
digits in Grooming and Health Care and low single digits in Fabric & Home Care and Baby, Feminine & Family Care.
Organic sales, which exclude the impact of acquisitions and divestitures and foreign exchange, increased 1%. Organic sales
increased mid-single digits in Beauty and low single digits in Health Care, Grooming and Fabric & Home Care. Organic
sales declined low single digits in Baby, Feminine & Family Care.
• Operating income decreased $703 million, or 3%, to $19.7 billion as the net sales increase was more than offset by a
decrease in operating margin.
• Net earnings increased $79 million to $16.1 billion as the decrease in operating income was offset by higher non-operating
restructuring charges in the prior year, primarily driven by the non-cash charge for accumulated foreign currency
translation losses due to the substantial liquidation of operations in Argentina.
• Net earnings attributable to Procter & Gamble increased $72 million to $16.0 billion.
• Diluted EPS increased 2% to $6.62 due to an increase in net earnings and a reduction in shares outstanding. Core EPS,
which excludes the gain from the dissolution of the Glad joint venture business and incremental restructuring charges,
increased 1% to $6.89.
• Cash flow from operating activities was $19.6 billion.
◦ Adjusted free cash flow, which is defined as operating cash flow less capital expenditures and excluding payments for
the transitional tax resulting from the 2017 U.S. Tax Act, was $15.8 billion.
◦ Adjusted free cash flow productivity, which is defined as adjusted free cash flow as a percentage of net earnings
excluding the gain from the dissolution of the Glad joint venture business, was 100%.
ECONOMIC CONDITIONS AND UNCERTAINTIES
Global Economic Conditions. Our products are sold in numerous countries worldwide, with more than half our sales
generated outside the United States. Our largest international markets are Greater China, the United Kingdom, Canada, Japan
and Germany and collectively comprised approximately 21% of our net sales in fiscal 2026. As a result, we are exposed to
global macroeconomic factors, geopolitical tensions and government policies. We are exposed to various risks due to economic,
political and social instabilities, market volatility, natural disasters, debt and credit issues, currency controls, new or increased
tariffs, foreign exchange, the availability and cost of materials and interest rate changes. These risks can negatively impact our
net sales, net earnings and cash flows. For example, we are exposed to risks due to the conflict in the Middle East and the
ongoing war between Russia and Ukraine. Our Russia business accounted for 1% of consolidated net sales, net earnings and net
assets as of June 30, 2026.
Foreign Exchange. We have significant exposure to exchange rate fluctuations, both due to translation and transaction
exposures. Translation exposures arise from measuring income statements of foreign subsidiaries with functional currencies
other than the U.S. dollar. Transaction exposures involve impacts from 1) input costs that are denominated in currencies other
than the local reporting currency and 2) revaluation of working capital balances denominated in currencies other than the
functional currency. We have experienced significant foreign exchange impacts in the past due to the weakening of certain
foreign currencies versus the U.S. dollar, which have negatively impacted net sales, net earnings and cash flows. In response to
the devaluation of foreign currencies (including those deemed highly inflationary), any lags or inability (due to government
restrictions) to implement price increases or the negative impacts of such actions on product consumption may lead to a decline
in our net sales, net earnings and cash flows.
Commodities and Supply Chain. Our costs are subject to fluctuations due to changes in commodity and input material prices,
transportation costs, inflationary impacts and productivity efforts. We have significant exposures to certain commodities and
input materials, in particular certain oil-derived materials like resins and paper-based materials like pulp. Volatility in the
market price of commodities and input materials directly affects our costs. Disruptions in manufacturing, supply and
distribution operations can lead to increased costs. Legal or regulatory requirements and sustainability initiatives may result in
increased costs. We strive to implement, achieve and sustain cost improvement plans, including supply chain optimization and
general overhead and workforce optimization. Increased pricing in response to certain inflationary or cost increases may also
The Procter & Gamble Company 19

-- 31 of 92 --

offset portions of the cost impacts; however, such price increases may negatively impact product consumption. If we are unable
to manage cost impacts through pricing actions and consistent productivity improvements, it may negatively impact our net
sales, net earnings and cash flows.
Government Policies. We are exposed to changes in U.S. and foreign government legislative, regulatory or enforcement
policies that can have a negative impact on net sales, net earnings and cash flows. These include tax policy changes (both U.S.
and foreign), including those resulting from the current work being led by the OECD/G20 Inclusive Framework focused on
"Addressing the Challenges of the Digitalization of the Economy”. Government controls such as currency exchanges, pricing
and import authorizations as well as government policies related to environmental and climate change matters and changes to
international trade agreements can also impact our financial performance.
For additional information on risk factors that could impact our business results, please refer to Risk Factors in Part I, Item 1A
of the Company's Form 10-K for the fiscal year ended June 30, 2026.
RESULTS OF OPERATIONS
The key metrics included in the discussion of our consolidated results of operations include net sales, gross margin, selling,
general and administrative expense (SG&A), operating margin, other non-operating items, income taxes and net earnings. The
primary factors driving year-over-year changes in net sales include overall market growth in the categories in which we
compete, product initiatives, competitive activities (the level of initiatives, pricing and other activities by competitors),
marketing spending, retail executions (both in-store and online) and acquisition and divestiture activity, all of which drive
changes in our underlying unit volume, as well as our pricing actions (which can also impact volume), changes in product and
geographic mix and foreign exchange impacts on sales outside the U.S.
Our cost of products sold and SG&A are variable in nature to some extent. Accordingly, our discussion of these operating costs
focuses primarily on relative margins rather than the absolute year-over-year changes in total costs. The primary drivers of
changes in gross margin are input costs (energy and other commodities), pricing impacts, geographic mix (for example, gross
margins in North America are generally higher than the Company average for similar products), product mix (for example, the
Beauty segment has higher gross margins than the Company average), foreign exchange rate fluctuations (in situations where
certain input costs may be tied to a different functional currency than the underlying sales), the impacts of manufacturing
savings projects and reinvestments (for example, product or package improvements) and, to a lesser extent, scale impacts (for
costs that are fixed or less variable in nature). The primary components of SG&A are marketing-related costs and non-
manufacturing overhead costs. Marketing-related costs are primarily variable in nature, although we may achieve some level of
scale benefit over time due to overall growth and other marketing efficiencies. While overhead costs are variable to some
extent, we generally experience more scale-related impacts for these costs due to our ability to leverage our organization and
systems' infrastructures to support business growth. The main drivers of changes in SG&A as a percentage of net sales are
overhead and marketing cost savings, reinvestments (for example, increased advertising), inflation, foreign exchange
fluctuations and scale impacts.
For a detailed discussion of the fiscal 2025 year-over-year changes, please refer to the MD&A in Part II, Item 7 of the
Company's Form 10-K for the fiscal year ended June 30, 2025.
Net Sales
Net sales increased 3% to $87.0 billion in fiscal 2026 driven by favorable foreign exchange of 2% and pricing of 1%. Unit
volume and mix were unchanged versus the prior year.
Net sales increased high single digits in Beauty, mid-single digits in Grooming and Health Care and low single digits in Fabric
& Home Care and Baby, Feminine & Family Care. Organic sales, which exclude the impact of acquisitions and divestitures and
foreign exchange, increased 1%. Organic sales increased mid-single digits in Beauty and low single digits in Health Care,
Grooming and Fabric & Home Care. Organic sales declined low single digits in Baby, Feminine & Family Care.
Operating Costs
Comparisons as a percentage of net sales; fiscal years ended June 30 2026 2025 Basis Point Change
Gross margin 50.2 % 51.2 % (100) bps
Selling, general and administrative expense 27.5 % 26.9 % 60 bps
Operating margin 22.7 % 24.3 % (160) bps
Earnings before income taxes 23.4 % 23.9 % (50) bps
Net earnings 18.5 % 19.1 % (60) bps
Net earnings attributable to Procter & Gamble 18.4 % 19.0 % (60) bps
Gross margin decreased 100 basis points to 50.2% of net sales. The decrease in gross margin was due to:
• 120 basis points of decline from unfavorable product mix,
• 70 basis points of product and packaging investments,
• 60 basis points of higher restructuring costs,
20 The Procter & Gamble Company

-- 32 of 92 --

• 30 basis points of net tariff impact from higher costs and recognized recoveries,
• 20 basis points of higher commodity costs,
• 10 basis points of unfavorable foreign exchange impacts and
• 10 basis points of other items and rounding.
These decreases were partially offset by:
• 180 basis points of manufacturing productivity savings,
• 40 basis points of increase due to higher pricing.
Total SG&A increased 6% to $23.9 billion and increased 60 basis points to 27.5% as a percentage of net sales due primarily to
an increase in marketing spending as a percentage of net sales.
• Marketing spending as a percentage of net sales increased 80 basis points due to an increase in marketing spending,
partially offset by productivity savings.
• Overhead costs as a percentage of net sales were unchanged as wage inflation headwinds and restructuring spending were
offset by productivity savings.
• Other operating expenses as a percentage of net sales were unchanged.
Productivity-driven cost savings delivered 160 basis points of benefit to SG&A as a percentage of net sales.
Operating income decreased $703 million, or 3%, to $19.7 billion as the increase in net sales was more than offset by the
decrease in gross margin and increase in SG&A spending. The operating margin decreased 160 basis points to 22.7% due
primarily to the decrease in gross margin and increase in marketing spending.
Non-Operating Items
• Interest expense was $877 million, a decrease of $30 million versus the prior year.
• Interest income was $430 million, a decrease of $39 million versus the prior year.
• Other non-operating income/(expense), net increased $922 million to $1.1 billion primarily driven by the non-cash charge
for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina in the prior
year and the gain from the dissolution of the Glad joint venture business in the current year period.
Income Taxes
The effective income tax rate for fiscal year ended June 30, 2026, was 20.8%, compared to 20.3% for the fiscal year ended
June 30, 2025. The increase in the effective tax rate was primarily driven by lower excess tax benefits of share-based
compensation in the current year and unfavorable geographic mix impacts, partially offset by a decrease from discrete impacts
related to uncertain tax positions and the prior year charge for accumulated foreign currency translation losses due to the
substantial liquidation of operations in Argentina.
Net Earnings
Earnings before income taxes increased $210 million, or 1%, to $20.4 billion as the increase in other non-operating income/
(expense), net, the components of which are described above, were partially offset by the decrease in operating income. Net
earnings increased $79 million to $16.1 billion as the increase in earnings before income taxes was partially offset by the
effective income tax rate increase discussed above.
Foreign exchange impacts increased net earnings by approximately $224 million due to a strengthening of certain currencies
against the U.S. dollar. This impact includes both transactional charges and translational impacts from converting earnings from
foreign subsidiaries to U.S. dollars.
Net earnings attributable to Procter & Gamble increased $72 million to $16.0 billion.
Diluted EPS increased $0.11, or 2%, to $6.62 due to an increase in net earnings and a reduction in shares outstanding.
SEGMENT RESULTS
Segment results reflect information on the same basis we use for internal management reporting and performance evaluation.
The results of these reportable segments do not include certain non-business unit specific costs which are reported in Corporate
and are included as part of the Corporate discussion. Additionally, we apply blended statutory tax rates in the segments.
Eliminations to adjust segment results to arrive at our consolidated effective tax rate are included in Corporate. See Note 2 to
the Consolidated Financial Statements for additional information on items included in Corporate.
The Procter & Gamble Company 21

-- 33 of 92 --

Net Sales Change Drivers 2026 vs. 2025 (1)
Volume with
Acquisitions &
Divestitures
Volume
Excluding
Acquisitions &
Divestitures Foreign
Exchange Price Mix Other (2) Net Sales
Growth
Beauty 4 % 4 % 2 % 1 % — % — % 7 %
Grooming (1) % (1) % 3 % 2 % — % — % 4 %
Health Care (2) % (2) % 3 % 2 % 1 % — % 4 %
Fabric & Home Care — % — % 1 % 1 % — % — % 2 %
Baby, Feminine & Family Care (1) % (1) % 2 % — % — % — % 1 %
TOTAL COMPANY — % — % 2 % 1 % — % — % 3 %
(1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2) Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.
BEAUTY
($ millions) 2026 2025 Change vs. 2025
Volume N/A N/A 4%
Net sales $16,023 $14,964 7%
Net earnings $2,672 $2,715 (2)%
% of net sales 16.7% 18.1% (140) bps
Beauty net sales increased 7% to $16.0 billion, driven by a unit volume increase of 4%, favorable foreign exchange of 2% and
positive impact of higher pricing of 1%. Excluding the impact of acquisitions and divestitures and foreign exchange, organic
sales increased 5%. Global market share of the Beauty segment decreased 0.3 points.
• Hair Care net sales increased high single digits driven by positive impacts of a unit volume increase, favorable foreign
exchange and innovation-based pricing (primarily in North America and Latin America), partially offset by unfavorable
geographic mix. The increase in unit volume was driven by growth in Latin America, Europe and Asia Pacific (all due to
innovation), partially offset by a decline in North America (due to competitive activity). Organic sales increased mid-single
digits driven by double-digit growth in Latin America, high single-digit growth in Europe and Asia Pacific, partially offset
by a low single-digit decline in North America. Global market share of the hair care category decreased 0.5 points.
• Personal Care net sales increased high single digits driven by positive impacts of a unit volume increase, favorable foreign
exchange and higher pricing (primarily in North America), partially offset by unfavorable geographic mix. The volume
increase was across all regions, led by growth in Greater China, North America and Europe (all due to innovation). Organic
sales also increased high single digits led by high-teens growth in Europe and mid-single-digit growth in Greater China and
North America. Global market share of the personal care category increased 0.2 points.
• Skin Care net sales increased mid-single digits driven by positive impacts of favorable product mix (due primarily to the
increase of the super-premium SK-II brand, which has higher than category-average selling prices) and favorable foreign
exchange, partially offset by a unit volume decrease. The volume decrease was driven by Greater China (due to
competitive activity). Organic sales increased low single digits due to a double-digit growth in Asia Pacific and a mid-
single-digit growth in Greater China, partially offset by a low single-digit decline in North America. Global market share of
the skin care category decreased 0.6 points.
Net earnings decreased 2% to $2.7 billion due to a 140 basis-point decline in net earnings margin, partially offset by an increase
in net sales. Net earnings margin decreased due to a decrease in gross margin and an increase in SG&A as a percentage of net
sales. The gross margin decline of 100 basis points was driven by unfavorable product mix and higher commodity costs,
partially offset by productivity savings. SG&A as a percentage of net sales increased due to an increase in marketing spending,
partially offset by a decrease in overhead spending.
GROOMING
($ millions) 2026 2025 Change vs. 2025
Volume N/A N/A (1)%
Net sales $6,918 $6,662 4%
Net earnings $1,529 $1,577 (3)%
% of net sales 22.1% 23.7% (160) bps
Grooming net sales increased 4% to $6.9 billion driven by the positive impacts of favorable foreign exchange of 3% and higher
pricing (primarily in North America and Europe) of 2%, partially offset by a 1% decrease in unit volume. The unit volume
decrease was driven by declines in IMEA (due to distribution loss) and North America (due to market contraction), partially
22 The Procter & Gamble Company

-- 34 of 92 --

offset by a unit volume increase in Latin America (due to increased distribution). Excluding the impact of acquisitions and
divestitures and foreign exchange, organic sales increased 1% driven by low single-digit growth in Europe and North America,
partially offset by a high single-digit decline in Asia Pacific. Global market share of the Grooming segment decreased 0.4
points.
Net earnings decreased 3% to $1.5 billion due to a 160 basis-point decline in net earnings margin, partially offset by an increase
in net sales. Net earnings margin decreased due to a decrease in gross margin and an increase in the effective tax rate, partially
offset by an decrease in SG&A as a percentage of net sales. The gross margin decrease of 90 basis points was driven by
unfavorable product mix, partially offset by higher pricing and productivity savings. SG&A as a percentage of net sales
decreased due to a decrease in overhead spending, partially offset by an increase in marketing spending. The higher effective
tax rate was driven by unfavorable geographic mix.
HEALTH CARE
($ millions) 2026 2025 Change vs. 2025
Volume N/A N/A (2)%
Net sales $12,456 $11,998 4%
Net earnings $2,404 $2,440 (1)%
% of net sales 19.3% 20.3% (100) bps
Health Care net sales increased 4% to $12.5 billion driven by favorable foreign exchange of 3%, higher pricing of 2% and
favorable product mix of 1%, partially offset by a 2% decrease in unit volume. Excluding the impact of foreign exchange and
acquisitions and divestitures, organic sales increased 1%. Global market share of the Health Care segment increased 0.4 points.
• Oral Care net sales increased low single digits due to the positive impacts of favorable foreign exchange and favorable
product mix (due to growth of premium paste and power brushes, which have higher than category-average selling prices),
partially offset by a unit volume decrease. The unit volume decrease was due to a decline in Greater China (due to market
contraction and competitive activity) and North America (due to competitive activity), partially offset by an increase in
IMEA (due to market growth). Organic sales were unchanged as a low single-digit increase in Europe was offset by a mid-
teens decrease in Greater China. Global market share of the oral care category was unchanged.
• Personal Health Care net sales increased mid-single digits due to the positive impacts of higher pricing (driven by North
America) and favorable foreign exchange, partially offset by a decrease in unit volume. The unit volume decrease was
driven by a decline in North America (due to lower average incidence of cough and cold), partially offset by an increase in
IMEA (due to innovation). Organic sales increased low single digits due to high single-digit growth in IMEA and Latin
America, partially offset by low single-digit growth in North America and Europe. Global market share of the personal
health care category increased 0.5 points.
Net earnings decreased 1% to $2.4 billion due to a 100 basis-point decline in net earnings margin, partially offset by an increase
in net sales. Net earnings margin decreased due to a decrease in gross margin and an increase in SG&A as a percentage of net
sales. The gross margin decrease of 30 basis points was driven by unfavorable product mix, partially offset by productivity
savings and higher pricing. SG&A as a percentage of net sales increased due to increased marketing spending, partially offset
by decreased overhead spending.
FABRIC & HOME CARE
($ millions) 2026 2025 Change vs. 2025
Volume N/A N/A —%
Net sales $30,314 $29,617 2%
Net earnings $5,632 $5,848 (4)%
% of net sales 18.6% 19.7% (110) bps
Fabric & Home Care net sales increased 2% to $30.3 billion driven by favorable foreign exchange of 1% and higher pricing of
1%. Unit volume was unchanged. Excluding the impact of foreign exchange and acquisitions and divestitures, organic sales
increased 1%. Global market share of the Fabric & Home Care segment was unchanged.
• Fabric Care net sales increased low single digits driven by favorable foreign exchange and favorable product mix. Unit
volume was unchanged as the volume increase in North America (due to innovation) and Latin America (due to market
growth) was offset by the volume decrease in Europe (due to competitive activity). Organic sales were unchanged as a mid-
single-digit increase in Latin America and a low single-digit increase in North America were offset by a low single-digit
decrease in Europe. Global market share of the fabric care category decreased 0.4 points.
• Home Care net sales increased low single digits driven by higher pricing (primarily in North America) and favorable
foreign exchange. Unit volume was unchanged as increases in Latin America and Asia Pacific (both due to innovation)
were offset by a decline in North America (due to competitive activity). Organic sales also increased low single digits as a
The Procter & Gamble Company 23

-- 35 of 92 --

high single-digit growth in Latin America was partially offset by low single-digit growth in Europe and North America.
Global market share of the home care category increased 0.3 points.
Net earnings decreased 4% to $5.6 billion due to a 110 basis-point decline in net earnings margin, partially offset by an increase
in net sales. Net earnings margin decreased due to a decrease in gross margin, partially offset by a decrease in SG&A as a
percentage of net sales. The gross margin decrease of 140 basis points was driven by unfavorable product mix and higher
commodity costs, partially offset by productivity savings. SG&A as a percentage of net sales decreased due primarily to a
decrease in overhead spending as a percentage of net sales and lower foreign exchange transactional charges, partially offset by
an increase in marketing spending.
BABY, FEMININE & FAMILY CARE
($ millions) 2026 2025 Change vs. 2025
Volume N/A N/A (1)%
Net sales $20,401 $20,248 1%
Net earnings $3,930 $4,013 (2)%
% of net sales 19.3% 19.8% (50) bps
Baby, Feminine & Family Care net sales increased 1% to $20.4 billion driven by favorable foreign exchange of 2%, partially
offset by a unit volume decrease of 1%. Excluding the impact of foreign exchange and acquisitions and divestitures, organic
sales decreased 1%. Global market share of the Baby, Feminine & Family Care segment decreased 0.2 points.
• Baby Care net sales increased low single digits driven by favorable foreign exchange and a unit volume increase. The unit
volume increase was driven by increases in Greater China (due to innovation) and IMEA (due to market growth), partially
offset by a decrease in North America (due to competitive activity). Organic sales also increased low single digits as a 20%
increase in Greater China and a mid-single-digit increase in IMEA were partially offset by a low single-digit decrease in
North America. Global market share of the baby care category increased 0.3 points.
• Feminine Care net sales increased low single digits driven by positive impacts of favorable foreign exchange, favorable
geographic mix and higher pricing (primarily in North America), partially offset by a decrease in unit volume. The unit
volume decrease was driven by IMEA and Europe (both due to competitive activity) and Greater China (due to market
contraction). Organic sales were unchanged as low single-digit growth in North America was offset by a high single-digit
decline in IMEA and a low single-digit decline in Europe. Market share of the feminine care category decreased 0.2 points.
• Net sales in Family Care, which is predominantly a North American business, decreased low single digits driven by lower
pricing (due to merchandising investments) and a unit volume decrease (due to competitive activity). Organic sales also
decreased low single digits. North America's share of the family care category decreased 0.7 points.
Net earnings decreased 2% to $3.9 billion due to a 50 basis-point decline in net earnings margin, partially offset by an increase
in net sales. Net earnings margin decreased due to a decrease in gross margin and an increase in SG&A as a percentage of net
sales. Gross margin decreased 40 basis points due to unfavorable category mix, partially offset by lower commodity costs and
productivity savings. SG&A as a percentage of net sales increased due to an increase in marketing spending, partially offset by
a reduction in overhead spending.
CORPORATE
($ millions) 2026 2025 Change vs. 2025
Net sales $919 $794 16%
Net earnings/(loss) $(23) $(527) N/A
Corporate includes certain operating and non-operating activities not allocated to specific business segments. These include but
are not limited to incidental businesses managed at the corporate level, gains and losses related to certain divested brands or
businesses, impacts from various financing and investing activities, certain impacts related to employee benefits, asset
impairments and restructuring activities including manufacturing and workforce optimization. Corporate also includes
reconciling items to adjust the accounting policies used within the reportable segments to U.S. GAAP. The most notable
ongoing reconciling item is income taxes, which adjusts the blended statutory rates that are reflected in the reportable segments
to the overall Company effective tax rate.
Corporate net sales increased 16% to $919 million due to an increase in net sales of incidental businesses managed at the
corporate level. Corporate net earnings increased $504 million to a loss of $23 million due to restructuring charges related to
the substantial liquidation of operations in certain Enterprise Markets, including Argentina, in the prior year period and the
dissolution of the Glad joint venture business in the current year period, partially offset by current year restructuring charges.
Restructuring Program to Deliver Productivity and Cost Savings
The Company has historically had an ongoing restructuring program with annual spending in the range of $250 to $500 million
before tax. In fiscal 2024, the Company announced an incremental limited market portfolio restructuring of its business
operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, and during the period ended September
24 The Procter & Gamble Company

-- 36 of 92 --

30, 2024, the Company completed the limited market portfolio restructuring. The total incremental restructuring charges
incurred under the program were $1.2 billion after tax.
In June 2025, the Company announced a two-year portfolio and productivity plan to streamline its portfolio and organization to
improve its cost structure and competitiveness. In fiscal 2026, the Company incurred incremental restructuring charges of $903
million after tax under the program. Restructuring accruals of $336 million as of June 30, 2026, are classified as current
liabilities. Approximately 67% of the before tax restructuring charges incurred in fiscal 2026 either have been or will be settled
with cash. Consistent with our policies for restructuring-type activities, the resulting charges are funded by and included within
Corporate for segment reporting.
Savings generated from the Company's restructuring program are difficult to estimate, given the nature of the activities, the
timing of the execution and the degree of reinvestment. In addition to our restructuring programs, we have additional ongoing
savings efforts in our supply chain, marketing and overhead areas that yield additional benefits to our operating margins. Refer
to Note 3 to the Consolidated Financial Statements for more details on the restructuring program.
CASH FLOW, FINANCIAL CONDITION AND LIQUIDITY
We believe our financial condition continues to be of high quality, as evidenced by our ability to generate substantial cash from
operations and to readily access capital markets at competitive rates.
Operating cash flow provides the primary source of cash to fund operating needs and capital expenditures. Excess operating
cash is used first to fund shareholder dividends. Other discretionary uses include share repurchases and acquisitions to
complement our portfolio of businesses, brands and geographies. As necessary, we may supplement operating cash flow with
debt to fund these activities. The overall cash position of the Company reflects our strong business results and a global cash
management strategy that takes into account liquidity management, economic factors and tax considerations.
Cash Flow Analysis
($ millions) 2026 2025
Net cash provided by operating activities $ 19,556 $ 17,817
Net cash used in investing activities (4,624) (3,818)
Net cash used in financing activities (14,460) (14,036)
Adjusted Free Cash Flow 15,835 14,606
Adjusted Free Cash Flow Productivity 100 % 87 %
Operating Cash Flow
Operating cash flow was $19.6 billion in 2026, a 10% increase versus the prior year. Net earnings, adjusted for certain non-cash
items (depreciation and amortization, share-based compensation expense, deferred income taxes and (gain)/loss on sale of
assets) generated approximately $19.5 billion of operating cash flow. Working capital and other impacts generated $29 million
of cash in the period. Accounts receivable decreased, resulting in $84 million of cash flow help. Days sales outstanding
decreased by one day. Total inventories increased, consuming $641 million of cash, driven primarily by increased safety stock
levels and new product initiatives. Days inventory on hand increased by two days. Accounts payable increased, generating $919
million of cash, driven primarily by increased supply chain activity in line with the increase in inventory and increased
marketing support activity. Other impacts reduced cash by $333 million primarily driven by the final payment of the
transitional tax related to the 2017 U.S. Tax Act and a reduction in postretirement benefit accruals, partially offset by tax
accruals in excess of estimated payments and accrued marketing expense.
Adjusted Free Cash Flow. We view adjusted free cash flow as an important non-GAAP measure because it is a factor
impacting the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments. It is
defined as operating cash flow less capital expenditures and excluding payments for the transitional tax resulting from the 2017
U.S. Tax Act. Adjusted free cash flow is one of the measures used to evaluate senior management and determine their at-risk
compensation.
Adjusted free cash flow was $15.8 billion in 2026, an increase of 8% versus the prior year. The increase was primarily driven
by the increase in operating cash flows as discussed above. Adjusted free cash flow productivity, defined as the ratio of adjusted
free cash flow to net earnings excluding the gain from the dissolution of the Glad joint venture business, was 100% in 2026.
Investing Cash Flow
Net investing activities used $4.6 billion of cash in 2026, primarily due to capital expenditures and the settlement of net
investment hedges, partially offset by proceeds from the dissolution of the Glad joint venture business.
Financing Cash Flow
Net financing activities used $14.5 billion of cash in 2026, mainly due to dividends to shareholders and treasury stock
purchases, partially offset by the impact of stock options and other.
The Procter & Gamble Company 25

-- 37 of 92 --

Liquidity
At June 30, 2026, our current liabilities exceeded current assets by $12.5 billion, largely due to accounts payable, short-term
borrowings and debt due within one year. We anticipate being able to support our short-term liquidity and operating needs
largely through cash generated from operations. The Company regularly assesses its cash needs and the available sources to
fund these needs. As of June 30, 2026, the Company had $8.9 billion of cash and cash equivalents related to foreign
subsidiaries, primarily in various European and Asian countries. We did not have material cash and cash equivalents related to
any country subject to exchange controls that significantly restrict our ability to access or repatriate the funds. Under current
law, we do not expect restrictions or taxes on repatriation of cash held outside of the U.S. to have a material effect on our
overall liquidity, financial condition or the results of operations for the foreseeable future.
We utilize short- and long-term debt to fund discretionary items, such as acquisitions and share repurchases. We have strong
short- and long-term debt ratings, that have enabled and should continue to enable us to refinance our debt as it becomes due in
commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if
needed, should provide sufficient funding to meet short-term financing requirements.
On June 30, 2026, our short-term credit ratings were P-1 (Moody's) and A-1+ (Standard & Poor's), while our long-term credit
ratings were Aa3 (Moody's) and AA- (Standard & Poor's), all with a stable outlook.
We maintain bank credit facilities to support our ongoing commercial paper program. The current facility is an $8.0 billion
facility split between a $3.2 billion five-year facility and a $4.8 billion 364-day facility, which expire in October 2030 and
October 2026, respectively. Both facilities can be extended for certain periods of time as specified in the terms of the credit
agreement. These facilities are currently undrawn and we anticipate that they will remain undrawn. These credit facilities do not
have cross-default or ratings triggers, nor do they have material adverse events clauses, except at the time of signing. In addition
to these credit facilities, we have an automatically effective registration statement on Form S-3 filed with the SEC that is
available for registered offerings of short- or long-term debt securities. For additional details on debt, see Note 10 to the
Consolidated Financial Statements.
Guarantees and Other Off-Balance Sheet Arrangements
We do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, which we
believe could have a material impact on our financial condition or liquidity.
Contractual Commitments
The following table provides information on the amount and payable date of our contractual commitments as of June 30, 2026.
($ millions) Total Less Than 1 Year 1-3 Years 3-5 Years After 5 Years
RECORDED LIABILITIES
Total debt $ 34,490 $ 11,357 $ 4,173 $ 6,306 $ 12,654
Leases 1,028 246 376 208 198
OTHER
Interest payments relating to long-term debt 6,102 884 1,365 1,075 2,777
Minimum pension funding (1) 573 186 387 — —
Purchase obligations (2) 3,651 1,155 1,366 636 494
TOTAL CONTRACTUAL COMMITMENTS $ 45,843 $ 13,828 $ 7,667 $ 8,225 $ 16,123
(1) Represents future pension payments to comply with local funding requirements. These future pension payments assume the Company
continues to meet its future statutory funding requirements. Considering the current economic environment in which the Company
operates, the Company believes its cash flows are adequate to meet the future statutory funding requirements. The projected payments
beyond fiscal year 2029 are not currently determinable.
(2) Primarily reflects future contractual payments under various take-or-pay arrangements entered into as part of the normal course of
business. Commitments made under take-or-pay obligations represent minimum commitments with suppliers and are in line with
expected usage. This includes service contracts for information technology, human resources management and facilities management
activities that have been outsourced. While the amounts listed represent contractual obligations, we do not believe it is likely that the full
contractual amount would be paid if the underlying contracts were canceled prior to maturity. In such cases, we generally are able to
negotiate new contracts or cancellation penalties, resulting in a reduced payment. The amounts do not include other contractual purchase
obligations that are not take-or-pay arrangements. Such contractual purchase obligations are primarily purchase orders at fair value that
are part of normal operations and are reflected in historical operating cash flow trends. We do not believe such purchase obligations will
adversely affect our liquidity position.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
In preparing our financial statements in accordance with U.S. GAAP, there are certain accounting policies that may require a
choice between acceptable accounting methods or may require substantial judgment or estimation in their application. These
include revenue recognition, income taxes, certain employee benefits and goodwill and intangible assets. We believe these
26 The Procter & Gamble Company

-- 38 of 92 --

accounting policies, and others set forth in Note 1 to the Consolidated Financial Statements, should be reviewed as they are
integral to understanding the results of operations and financial condition of the Company.
The Company has discussed the selection of critical accounting policies and the effect of estimates with the Audit Committee of
the Company's Board of Directors.
Revenue Recognition
Our revenue is primarily generated from the sale of finished product to customers. Those sales predominantly contain a single
performance obligation and revenue is recognized at a single point in time when ownership, risks and rewards transfer, which
can be on the date of shipment or the date of receipt by the customer. Trade promotions, consisting primarily of customer
pricing allowances, in-store merchandising funds, advertising and other promotional activities and consumer coupons, are
offered through various programs to customers and consumers. Sales are recorded net of trade promotion spending, which is
recognized as incurred at the time of the sale. Amounts accrued for trade promotions at the end of a period require estimation,
based on contractual terms, sales volumes and historical utilization and redemption rates. The actual amounts paid may be
different from such estimates. These differences, which have historically not been significant, are recognized as a change in
management estimate in a subsequent period.
Income Taxes
Our annual tax rate is determined based on our income, statutory tax rates and the tax impacts of items treated differently for tax
purposes than for financial reporting purposes. Also inherent in determining our annual tax rate are judgments and assumptions
regarding the recoverability of certain deferred tax balances, primarily net operating loss and other carryforwards, and our
ability to uphold certain tax positions.
Realization of net operating losses and other carryforwards is dependent upon generating sufficient taxable income in the
appropriate jurisdiction prior to the expiration of the carryforward periods, which involves business plans, planning
opportunities and expectations about future outcomes. Although realization is not assured, management believes it is more
likely than not that our deferred tax assets, net of valuation allowances, will be realized.
We operate in multiple jurisdictions with complex tax policy and regulatory environments. In certain of these jurisdictions, we
may take tax positions that management believes are supportable but are potentially subject to successful challenge by the
applicable taxing authority. These interpretational differences with the respective governmental taxing authorities can be
impacted by the local economic and fiscal environment.
A core operating principle is that our tax structure is based on our business operating model, such that profits are earned in line
with the business substance and functions of the various legal entities in the jurisdictions where those functions are performed.
However, because of the complexity of transfer pricing concepts, we may have income tax uncertainty related to the
determination of intercompany transfer prices for our various cross-border transactions. We have obtained and continue to
prioritize the strategy of seeking advance rulings with tax authorities to reduce this uncertainty. We estimate that our current
portfolio of advance rulings reduces this uncertainty with respect to over 70% of our global earnings. We evaluate our tax
positions and establish liabilities in accordance with the applicable accounting guidance on uncertainty in income taxes. We
review these tax uncertainties considering changing facts and circumstances, such as the progress of tax audits, and adjust them
accordingly. We have several audits in process in various jurisdictions. Although the resolution of these tax positions is
uncertain, based on currently available information, we believe that the ultimate outcomes will not have a material adverse
effect on our financial position, results of operations or cash flows.
Because there are several estimates and assumptions inherent in calculating the various components of our tax provision, certain
future events such as changes in tax legislation, geographic mix of earnings, completion of tax audits or earnings repatriation
plans could have an impact on those estimates and our effective tax rate. See Note 5 to the Consolidated Financial Statements
for additional details on the Company's income taxes.
Employee Benefits
We sponsor various postretirement benefits throughout the world. These include pension plans, both defined contribution plans
and defined benefit plans, and other postretirement benefit (OPRB) plans consisting primarily of health care and life insurance
for retirees. For accounting purposes, the defined benefit pension and OPRB plans require assumptions to estimate the net
projected and accumulated benefit obligations, including the following variables: discount rate; expected salary increases;
certain employee-related factors, such as turnover, retirement age and mortality; expected return on assets; and health care cost
trend rates. These and other assumptions affect the annual expense and net obligations recognized for the underlying plans. Our
assumptions reflect our historical experiences and management's best judgment regarding future expectations. As permitted by
U.S. GAAP, the net amount by which actual results differ from our assumptions is deferred. If this net deferred amount exceeds
10% of the greater of plan assets or liabilities, a portion of the deferred amount is included in expense for the following year.
The cost or benefit of plan changes, such as increasing or decreasing benefits for prior employee service (prior service cost), is
deferred and included in expense on a straight-line basis over the average remaining service period of the employees expected
to receive benefits.
The expected return on plan assets assumption impacts our defined benefit expense since many of our defined benefit pension
plans and our primary OPRB plan are partially funded. The process for setting the expected rates of return is described in Note
The Procter & Gamble Company 27

-- 39 of 92 --

8 to the Consolidated Financial Statements. For 2026, the average return on assets assumptions for pension plan assets and
OPRB assets was 6.0% and 8.5%, respectively. A change in the rate of return of 100 basis points for both pension and OPRB
assets would impact annual after-tax benefit/expense by approximately $160 million.
Since pension and OPRB liabilities are measured on a discounted basis, the discount rate impacts our plan obligations and
expenses. Discount rates used for our U.S. defined benefit pension and OPRB plans are based on a yield curve constructed from
a portfolio of high-quality bonds for which the timing and amount of cash outflows approximate the estimated payouts of the
plan. For our international plans, the discount rates are set by benchmarking against investment grade corporate bonds rated AA
or better. The average discount rate on the defined benefit pension plans of 4.6% represents a weighted average of local rates in
countries where such plans exist. A 100 basis-point change in the discount rate would impact annual after-tax benefit expense
by approximately $35 million. The average discount rate on the OPRB plan of 6.0% reflects the higher interest rates generally
applicable in the U.S., which is where most of the plan participants receive benefits. A 100 basis-point change in the discount
rate would impact annual after-tax OPRB expense by approximately $20 million. See Note 8 to the Consolidated Financial
Statements for additional details on our defined benefit pension and OPRB plans.
Goodwill and Intangible Assets
Significant judgment is required to estimate the fair value of our goodwill reporting units and intangible assets. Accordingly, we
typically obtain the assistance of third-party valuation specialists for those goodwill reporting units and intangible assets that do
not have fair values that significantly exceed their underlying carrying values. Determining the useful life of an intangible asset
also requires judgment. Certain brand intangible assets are expected to have indefinite lives based on their history and our plans
to continue to support and build the acquired brands. Other acquired intangible assets (e.g., certain brands, customer
relationships, patents and technologies) are expected to have determinable useful lives. Our assessment as to brands that have
an indefinite life and those that have a determinable life is based on a number of factors including competitive environment,
market share, brand history, underlying product life cycles, operating plans and the macroeconomic environment of the
countries in which the brands are sold. Determinable-lived intangible assets are amortized to expense over their estimated lives.
An impairment assessment for determinable-lived intangibles is only required when an event or change in circumstances
indicates that the carrying amount of the asset may not be recoverable.
Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment. Our annual
impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31.
Other than our Gillette indefinite-lived intangible asset, our goodwill reporting units and our indefinite-lived intangible assets
have fair values that significantly exceed their underlying carrying values.
As previously disclosed, we recorded a non-cash impairment charge related to the Gillette indefinite-lived intangible asset
during the fiscal year ended June 30, 2024. For additional information regarding the impairment charge and related accounting,
see Note 4 to the Consolidated Financial Statements.
Based on our impairment testing performed during the three months ended December 31, 2025, the Gillette indefinite-lived
intangible asset's fair value exceeds its carrying value by greater than 10%. As of June 30, 2026, the carrying value of the
Gillette indefinite-lived intangible asset was $12.8 billion. While we have concluded that no triggering event has occurred since
our annual impairment test, the Gillette indefinite-lived intangible asset is susceptible to impairment risk. Adverse changes in
the business or in the macroeconomic environment including foreign currency devaluation, increasing global inflation or market
contraction from an economic recession or geopolitical conflicts, could reduce the underlying cash flows used to estimate the
fair value of the Gillette indefinite-lived intangible asset and result in a future impairment charge.
The most significant assumptions utilized in the determination of the estimated fair value of the Gillette indefinite-lived
intangible asset are the net sales growth rates (including residual growth rate), discount rate and royalty rate.
Net sales growth rates could be negatively impacted by reductions or changes in demand for our Gillette products, which may
be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or
more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global
and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries’ currencies
relative to the U.S. dollar. The residual growth rate represents the expected rate at which the Gillette brand is expected to grow
beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with
the brand operating plans and approximates expected long-term category market growth rates. The residual growth rate depends
on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities
that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in
category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive
environment.
The discount rate is based on a weighted average cost of capital that is likely to be expected by a market participant, including
consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse
changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as
further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair
value estimates for cash flows outside the U.S.
28 The Procter & Gamble Company

-- 40 of 92 --

The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical
and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse
changes in long-term operating margins.
We performed a sensitivity analysis for the Gillette indefinite-lived intangible asset as part of our annual impairment testing
during the three months ended December 31, 2025, utilizing reasonably possible changes in the assumptions for the discount
rate, the short-term and residual growth rates and the royalty rate to demonstrate the potential impacts to estimated fair values.
The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a
25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.
Approximate Percent Change in Estimated Fair Value
+25 bps
Discount Rate -25 bps
Growth Rate -50 bps
Royalty Rate
Gillette indefinite-lived intangible asset (5)% (5)% (4)%
See Note 4 to the Consolidated Financial Statements for additional information on goodwill and intangible assets, including the
recorded impairment charge discussed above.
New Accounting Pronouncements
Refer to Note 1 to the Consolidated Financial Statements for recently adopted accounting pronouncements and recently issued
accounting pronouncements not yet adopted as of June 30, 2026.
OTHER INFORMATION
Hedging and Derivative Financial Instruments
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates,
currency exchange rates and commodity prices. We evaluate exposures on a centralized basis to take advantage of natural
exposure correlation and netting. We leverage the Company's diversified portfolio of exposures as a natural hedge and prioritize
these operational hedging activities over financial market instruments. To the extent we choose to further manage volatility
within our financing operations, as discussed below, we enter into various financial transactions which we account for using the
applicable accounting guidance for derivative instruments and hedging activities. These financial transactions are governed by
our policies covering acceptable counterparty exposure, instrument types and other hedging practices. See Note 9 to the
Consolidated Financial Statements for a discussion of our accounting policies for derivative instruments.
Derivative positions are monitored using techniques including market valuation, sensitivity analysis and value-at-risk modeling.
The tests for interest rate, currency rate and commodity derivative positions discussed below are based on the RiskManager™
value-at-risk model using a one-year horizon and a 95% confidence level. The model incorporates the impact of correlation (the
degree to which exposures move together over time) and diversification (from holding multiple currency, commodity and
interest rate instruments) and assumes that financial returns are normally distributed. Estimates of volatility and correlations of
market factors are drawn from the RiskMetrics™ dataset as of June 30, 2026. In cases where data is unavailable in
RiskMetrics™, a reasonable proxy is included.
Our market risk exposures relative to interest rates, currency rates and commodity prices, as discussed below, have not changed
materially versus the previous reporting period. In addition, we are not aware of any facts or circumstances that would
significantly impact such exposures in the near term.
Interest Rate Exposure. We are exposed to interest rate movements due to our long and short-term borrowing program. Interest
rate swaps are used to manage exposures to interest rates on underlying debt obligations. Certain interest rate swaps
denominated in foreign currencies are designated to hedge exposures to currency exchange rate movements on our investments
in foreign operations. These currency interest rate swaps are designated as hedges of the Company's foreign net investments.
Based on our interest rate exposure as of and during the fiscal year ended June 30, 2026, including derivative and other
instruments sensitive to interest rates, we believe a near-term change in interest rates, at a 95% confidence level based on
historical interest rate movements, would not materially affect our financial statements.
Currency Rate Exposure. Because we manufacture and sell products and finance operations in a number of countries
throughout the world, we are exposed to movements in currency exchange rates. We leverage the Company’s diversified
portfolio of exposures as a natural hedge. Corporate policy prescribes the range of allowable hedging activity. To manage the
exchange rate risk associated with the financing of our operations, we primarily use forward contracts and currency swaps with
maturities of less than 18 months.
Based on our currency rate exposure on derivative and other instruments as of and during the fiscal year ended June 30, 2026,
we believe, at a 95% confidence level based on historical currency rate movements, the impact on such instruments of a near-
term change in currency rates would not materially affect our financial statements.
Commodity Price Exposure. We use raw materials that are subject to price volatility caused by weather, supply conditions,
political and economic variables and other unpredictable factors. We may use futures, options and swap contracts to manage the
volatility related to the above exposures. During the fiscal years ended June 30, 2026 and 2025, we did not have any financial
commodity hedging activity.
The Procter & Gamble Company 29

-- 41 of 92 --

Measures Not Defined By U.S. GAAP
In accordance with the SEC's Regulation S-K Item 10(e), the following provides definitions of non-GAAP measures and a
reconciliation to the most closely related GAAP measure. We believe that these measures provide useful perspective on
underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental
measure of year-on-year results. The non-GAAP measures described below are used by management in making operating
decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors, as they
provide supplemental information about business performance and provide investors with a view of our business results through
the eyes of management. These measures are also used to evaluate senior management and are a factor in determining their at-
risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP
measures but rather as supplemental information to our business results. These non-GAAP measures may not be the same as
similar measures used by other companies due to possible differences in method and in the items or events being adjusted.
Organic Sales Growth. Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions,
divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a
supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is used in
assessing the achievement of management goals for at-risk compensation.
The following tables provide a numerical reconciliation of net sales growth to organic sales growth:
Fiscal year ended June 30, 2026 Net Sales Growth Foreign Exchange
Impact
Acquisition &
Divestiture
Impact/Other (1) Organic Sales
Growth
Beauty 7 % (2) % — % 5 %
Grooming 4 % (3) % — % 1 %
Health Care 4 % (3) % — % 1 %
Fabric & Home Care 2 % (1) % — % 1 %
Baby, Feminine & Family Care 1 % (2) % — % (1) %
TOTAL COMPANY 3 % (2)% — % 1 %
(1) Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts
necessary to reconcile net sales to organic sales.
Adjusted Free Cash Flow. Adjusted free cash flow is defined as operating cash flow less capital spending and excluding
payments for the transitional tax resulting from the 2017 U.S. Tax Act. Adjusted free cash flow represents the cash that the
Company is able to generate after taking into account planned maintenance and asset expansion. We view adjusted free cash
flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share
repurchases, acquisitions and other discretionary investments.
The following table provides a numerical reconciliation of adjusted free cash flow ($ millions):
Operating Cash Flow Capital Spending 2017 U.S. Tax Act
Payments Adjusted Free Cash Flow
2026 $ 19,556 $ (4,409) $ 688 $ 15,835
2025 $ 17,817 $ (3,773) $ 562 $ 14,606
Adjusted Free Cash Flow Productivity. Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow
to net earnings excluding the gain from the dissolution of the Glad joint venture business in fiscal 2026 and the non-cash charge
for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina in fiscal 2025.
We view adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash.
Adjusted free cash flow productivity is used by management in making operating decisions, in allocating financial resources
and for budget planning purposes. This measure is used in assessing the achievement of management goals for at-risk
compensation.
The following table provides a numerical reconciliation of adjusted free cash flow productivity ($ millions):
Adjusted Free
Cash Flow Net Earnings Adjustments to Net
Earnings (1) Net Earnings as Adjusted Adjusted Free
Cash Flow Productivity
2026 $ 15,835 $ 16,144 $ (261) $ 15,883 100 %
2025 $ 14,606 $ 16,065 $ 752 $ 16,817 87 %
(1) Adjustments to Net Earnings relate to the gain from the dissolution of the Glad joint venture business in fiscal 2026 and the non-cash
charge for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina in fiscal 2025.
Core EPS. Core EPS is a measure of the Company's diluted EPS excluding items that are not judged by management to be part
of the Company's sustainable results or trends. Management views this non-GAAP measure as a useful supplemental measure
30 The Procter & Gamble Company

-- 42 of 92 --

of Company performance over time. This measure is also used in assessing the achievement of management goals for at-risk
compensation. The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP
measures adjusted as applicable for the following items:
• Incremental restructuring: The Company has historically had an ongoing level of restructuring activities of
approximately $250 - $500 million before tax. As discussed in Note 3 to the Consolidated Financial Statements, during
the period ended September 30, 2024, the Company completed its limited market portfolio restructuring with the
substantial liquidation of its operations in Argentina. In June 2025, the Company announced a portfolio and
productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. The
Company incurred over half of the costs under this plan in fiscal 2026, with the remainder expected to be incurred in
fiscal 2027. The adjustments to Core earnings include the restructuring charges that exceed the normal, recurring level
of restructuring charges.
• Glad joint venture agreement: In January 2026, the Glad joint venture agreement between the Company and Clorox
expired. Under the terms of the agreement, Clorox purchased the Company’s minority interest in the venture at fair
market value for $476 million. This transaction was accounted for as a dissolution of the Glad joint venture business
and the Company recorded an after-tax gain of $261 million.
We do not view the above items to be part of our sustainable results, and their exclusion from Core earnings measures provides
a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in
determining their at-risk compensation.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Fiscal Year Ended June 30, 2026
Amounts in millions except per share amounts
As Reported
(GAAP) Incremental
Restructuring Glad Joint Venture
Agreement Core
(Non-GAAP)
Cost of products sold $ 43,362 $ (436) $ — $ 42,927
Selling, general and administrative expense 23,922 (313) — 23,608
Operating income 19,748 749 — 20,497
Other non-operating income/(expense), net 1,076 161 (343) 894
Income taxes 4,233 6 (81) 4,158
Net earnings 16,144 904 (261) 16,786
Less: Net earnings attributable to noncontrolling
interests 98 1 — 98
Net earnings attributable to P&G 16,046 903 (261) 16,688
Core EPS
Diluted net earnings per common share (1) $ 6.62 $ 0.37 $ (0.11) $ 6.89
(1) Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
CHANGE VERSUS YEAR AGO
Diluted net earnings per common share 2 %
Core EPS 1 %
The Procter & Gamble Company 31

-- 43 of 92 --

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Fiscal Year Ended June 30, 2025
Amounts in millions except per share amounts As Reported (GAAP) Incremental
Restructuring Core
(Non-GAAP)
Cost of products sold $ 41,164 $ 20 $ 41,184
Selling, general and administrative expense 22,669 (25) 22,643
Operating income 20,451 5 20,456
Other non-operating income/(expense), net 154 789 943
Income taxes 4,102 (7) 4,094
Net earnings attributable to P&G 15,974 801 16,775
Core EPS
Diluted net earnings per common share (1) $ 6.51 $ 0.33 $ 6.83
(1) Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
The information required by this item is incorporated by reference to the section entitled Other Information in the MD&A and
Note 9 to the Consolidated Financial Statements.
32 The Procter & Gamble Company

-- 44 of 92 --

Item 8. Financial Statements and Supplementary Data.
MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Management is responsible for establishing and maintaining adequate internal control over financial reporting of The Procter &
Gamble Company (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended). Our internal control
over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the
United States of America.
Strong internal controls is an objective that is reinforced through our Worldwide Business Conduct Manual, which sets forth our
commitment to conduct business with integrity, and within both the letter and the spirit of the law. Our people are deeply
committed to our Purpose, Values and Principles, which unite us in doing what’s right. Our system of internal controls includes
written policies and procedures, segregation of duties and the careful selection and development of employees. Additional key
elements of our internal control structure include our Global Leadership Council, which is actively involved in oversight of the
business strategies, initiatives, results and controls, our Disclosure Committee, which is responsible for evaluating disclosure
implications of significant business activities and events, our Board of Directors, which provides strong and effective corporate
governance, and our Audit Committee, which reviews critical accounting policies and estimates, financial reporting and internal
control matters.
Global Internal Audit performs audits of internal controls over financial reporting as well as broader financial, operational and
compliance audits around the world, provides training and continually improves our internal control processes. The Company’s
internal control over financial reporting also includes a robust Control Self-Assessment Program that is conducted annually on
critical financial reporting areas of the Company. Management takes the appropriate action to correct any identified control
deficiencies.
Because of its inherent limitations, any system of internal control over financial reporting, no matter how well designed, may
not prevent or detect misstatements due to the possibility that a control can be circumvented or overridden or that misstatements
due to error or fraud may occur that are not detected. Also, because of changes in conditions, internal control effectiveness may
vary over time.
Management assessed the effectiveness of the Company's internal control over financial reporting as of June 30, 2026, using
criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of
the Treadway Commission (COSO) and concluded that the Company maintained effective internal control over financial
reporting as of June 30, 2026, based on these criteria.
Deloitte & Touche LLP, an independent registered public accounting firm, has audited the effectiveness of the Company's
internal control over financial reporting as of June 30, 2026, as stated in their report which is included herein.
/s/ Shailesh Jejurikar
(Shailesh Jejurikar)
Chairman of the Board, President and Chief Executive Officer
/s/ Andre Schulten
(Andre Schulten)
Chief Financial Officer
August 4, 2026
The Procter & Gamble Company 33

-- 45 of 92 --

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the shareholders and the Board of Directors of The Procter & Gamble Company
Opinion on the Financial Statements
We have audited the accompanying Consolidated Balance Sheets of The Procter & Gamble Company and subsidiaries (the
"Company") as of June 30, 2026 and 2025, the related Consolidated Statements of Earnings, Comprehensive Income,
Shareholders' Equity, and Cash Flows, for each of the three years in the period ended June 30, 2026, and the related notes
(collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material
respects, the financial position of the Company as of June 30, 2026 and 2025, and the results of its operations and its cash flows
for each of the three years in the period ended June 30, 2026, in conformity with accounting principles generally accepted in the
United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the Company's internal control over financial reporting as of June 30, 2026, based on criteria established in Internal
Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission
and our report dated August 4, 2026, expressed an unqualified opinion on the Company's internal control over financial
reporting.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on
the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to
error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial
statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included
examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall
presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that
was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that
are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The
communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and
we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the
accounts or disclosures to which it relates.
Intangible Assets — Gillette Indefinite-Lived Intangible Asset — Refer to Notes 1 and 4 to the financial statements
Critical Audit Matter Description
The Company’s evaluation of the Gillette indefinite-lived intangible asset (the “Gillette Brand”) for impairment involves the
comparison of the fair value to its carrying value. The Company estimates fair value using the income method, which is based
on the present value of estimated future cash flows attributable to the respective asset. This requires management to make
significant estimates and assumptions related to the forecast of future net sales, including the growth rate beyond a 10-year time
period, royalty rate and discount rate. Changes in the assumptions could have a significant impact on either the fair value, the
amount of any impairment charge, or both. The Company performed their annual impairment assessment of the Gillette Brand
as of October 1, 2025. Because the estimated fair value exceeded the carrying value, no impairment was recorded. As of June
30, 2026, the carrying value of the Gillette Brand was $12.8 billion.
We identified the Company’s impairment evaluation of the Gillette Brand as a critical audit matter because of the significant
judgments made by management to estimate the fair value of the indefinite-lived intangible asset. A high degree of auditor
judgment and an increased extent of effort was required when performing audit procedures to evaluate the reasonableness of
management’s estimates and assumptions related to the forecast of future net sales as well as the selection of royalty rate and
discount rate, including the need to involve our fair value specialists.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to the forecast of future net sales and the selection of the royalty rate and discount rate for the
Gillette Brand included the following, among others:
• We tested the effectiveness of controls over the Gillette Brand, including those over the determination of fair value, such as
controls related to management’s development of the forecast of future net sales, and the selection of the royalty rate and
discount rate.
34 The Procter & Gamble Company

-- 46 of 92 --

• We evaluated management's ability to accurately forecast net sales by comparing actual results to
management's historical forecasts.
• We evaluated the reasonableness of management’s forecast of net sales by comparing the forecast to:
• Historical net sales.
• Underlying analysis detailing business strategies and growth plans.
• Internal communications to management and the Board of Directors.
• Forecasted information included in analyst and industry reports for the Company and certain of its peer companies.
• With the assistance of our fair value specialists, we evaluated the net sales growth rate, royalty rate, and discount rate by:
• Testing the source information underlying the determination of the net sales growth rate, royalty rate, and discount rate
and the mathematical accuracy of the calculations.
• Developing a range of independent estimates for the discount rate and comparing the discount rate selected by
management to that range.
/s/ Deloitte & Touche LLP
Cincinnati, Ohio
August 4, 2026
We have served as the Company’s auditor since 1890.
The Procter & Gamble Company 35

-- 47 of 92 --

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the shareholders and the Board of Directors of The Procter & Gamble Company
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of The Procter & Gamble Company and subsidiaries (the
"Company") as of June 30, 2026, based on criteria established in Internal Control — Integrated Framework (2013) issued by the
Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all
material respects, effective internal control over financial reporting as of June 30, 2026, based on criteria established in Internal
Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the consolidated financial statements as of and for the year ended June 30, 2026, of the Company and our report
dated August 4, 2026, expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company's management is responsible for maintaining effective internal control over financial reporting and for its
assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report
on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control
over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be
independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all
material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the
assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit
provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures
that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and directors of the
company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Deloitte & Touche LLP
Cincinnati, Ohio
August 4, 2026
36 The Procter & Gamble Company

-- 48 of 92 --

Consolidated Statements of Earnings
Amounts in millions except per share amounts; fiscal years ended June 30 2026 2025 2024
NET SALES $ 87,032 $ 84,284 $ 84,039
Cost of products sold 43,362 41,164 40,848
Selling, general and administrative expense 23,922 22,669 23,305
Indefinite-lived intangible asset impairment charge — — 1,341
OPERATING INCOME 19,748 20,451 18,545
Interest expense (877) (907) (925)
Interest income 430 469 473
Other non-operating income/(expense), net 1,076 154 668
EARNINGS BEFORE INCOME TAXES 20,377 20,167 18,761
Income taxes 4,233 4,102 3,787
NET EARNINGS 16,144 16,065 14,974
Less: Net earnings attributable to noncontrolling interests 98 91 95
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 16,046 $ 15,974 $ 14,879
NET EARNINGS PER COMMON SHARE (1)
Basic $ 6.75 $ 6.67 $ 6.18
Diluted $ 6.62 $ 6.51 $ 6.02
(1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter &
Gamble.
Consolidated Statements of Comprehensive Income
Amounts in millions; fiscal years ended June 30 2026 2025 2024
NET EARNINGS $ 16,144 $ 16,065 $ 14,974
OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
Foreign currency translation
(net of tax (benefit)/expense of $129, $(442) and $66, respectively) 96 1,143 (226)
Unrealized gains/(losses) on investment securities
(net of tax (benefit)/expense of $1, $(1) and $(1), respectively) 1 — (3)
Unrealized gains/(losses) on defined benefit postretirement plans
(net of tax (benefit)/expense of $(81), $(407) and $230, respectively) (440) (1,390) 546
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX (343) (248) 317
COMPREHENSIVE INCOME 15,801 15,817 15,291
Less: Comprehensive income attributable to noncontrolling interests 77 87 92
COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER &
GAMBLE $ 15,724 $ 15,730 $ 15,199
The Procter & Gamble Company 37
See accompanying Notes to Consolidated Financial Statements.

-- 49 of 92 --

Consolidated Balance Sheets
Amounts in millions except stated values; as of June 30 2026 2025
Assets
CURRENT ASSETS
Cash and cash equivalents $ 9,942 $ 9,556
Accounts receivable 6,056 6,185
INVENTORIES
Materials and supplies 2,143 2,022
Work in process 1,105 1,012
Finished goods 4,922 4,516
Total inventories 8,170 7,551
Prepaid expenses and other current assets 2,040 2,100
TOTAL CURRENT ASSETS 26,208 25,392
PROPERTY, PLANT AND EQUIPMENT, NET 25,360 23,897
GOODWILL 41,276 41,650
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET 21,444 21,910
OTHER NONCURRENT ASSETS 12,231 12,381
TOTAL ASSETS $ 126,521 $ 125,231
Liabilities and Shareholders' Equity
CURRENT LIABILITIES
Accounts payable $ 16,306 $ 15,227
Accrued and other liabilities 11,091 11,318
Debt due within one year 11,296 9,513
TOTAL CURRENT LIABILITIES 38,694 36,058
LONG-TERM DEBT 22,842 24,995
DEFERRED INCOME TAXES 5,760 5,774
OTHER NONCURRENT LIABILITIES 4,914 6,120
TOTAL LIABILITIES 72,210 72,946
SHAREHOLDERS' EQUITY
Convertible Class A preferred stock, stated value $1 per share (600 shares authorized) 756 777
Non-Voting Class B preferred stock, stated value $1 per share (200 shares authorized) — —
Common stock, stated value $1 per share (10,000 shares authorized; shares issued: 2026 -
4,009.2, 2025 - 4,009.2) 4,009 4,009
Additional paid-in capital 69,533 68,770
Reserve for ESOP debt retirement (596) (672)
Accumulated other comprehensive loss (12,465) (12,143)
Treasury stock (shares held: 2026 -1,685.4; 2025 - 1,667.3) (143,008) (138,702)
Retained earnings 135,852 129,973
Noncontrolling interest 230 272
TOTAL SHAREHOLDERS' EQUITY 54,311 52,284
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 126,521 $ 125,231
38 The Procter & Gamble Company
See accompanying Notes to Consolidated Financial Statements.

-- 50 of 92 --

Consolidated Statements of Shareholders' Equity
Amounts in millions except
per share amounts;
shares in thousands
Common Stock Preferred
Stock
Additional
Paid-In
Capital
Reserve
for ESOP
Debt
Retirement
Accumulated
Other
Comprehens
ive
Income/
(Loss) Treasury
Stock Retained
Earnings
Noncont
rolling
Interest
Total
Sharehol
ders'
Equity	Shares Amount
BALANCE JUNE 30, 2023 2,362,120 $4,009 $819 $66,556 ($821) ($12,220) ($129,736) $118,170 $288 $47,065
Net earnings 14,879 95 14,974
Other comprehensive
income/(loss) 320 (3) 317
Dividends and dividend
equivalents ($3.8286 per
share):
Common (9,053) (9,053)
Preferred (284) (284)
Treasury stock purchases (31,877) (5,014) (5,014)
Employee stock plans 24,095 1,125 1,353 2,478
Preferred stock conversions 2,713 (21) 3 18 —
ESOP debt impacts 85 99 184
Noncontrolling interest, net — (108) (108)
BALANCE JUNE 30, 2024 2,357,051 $4,009 $798 $67,684 ($737) ($11,900) ($133,379) $123,811 $272 $50,559
Net earnings 15,974 91 16,065
Other comprehensive
income/(loss) (243) (4) (248)
Dividends and dividend
equivalents ($4.0763 per
share):
Common (9,606) (9,606)
Preferred (291) (291)
Treasury stock purchases (38,552) (6,517) (6,517)
Employee stock plans 20,940 1,084 1,175 2,259
Preferred stock conversions 2,555 (20) 3 18 —
ESOP debt impacts 64 86 150
Noncontrolling interest, net — (87) (87)
BALANCE JUNE 30, 2025 2,341,994 $4,009 $777 $68,770 ($672) ($12,143) ($138,702) $129,973 $272 $52,284
Net earnings 16,046 98 16,144
Other comprehensive
income/(loss) (322) (21) (343)
Dividends and dividend
equivalents ($4.2589 per
share):
Common (9,966) (9,966)
Preferred (292) (292)
Treasury stock purchases (33,437) (5,029) (5,029)
Employee stock plans 12,566 764 705 1,470
Preferred stock conversions 2,735 (22) 3 19 —
ESOP debt impacts 76 91 168
Noncontrolling interest, net (5) (119) (125)
BALANCE JUNE 30, 2026 2,323,859 $4,009 $756 $69,533 ($596) ($12,465) ($143,008) $135,852 $230 $54,311
The Procter & Gamble Company 39
See accompanying Notes to Consolidated Financial Statements.

-- 51 of 92 --

Consolidated Statements of Cash Flows
Amounts in millions; fiscal years ended June 30 2026 2025 2024
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF YEAR $ 9,556 $ 9,482 $ 8,246
OPERATING ACTIVITIES (1)
Net earnings 16,144 16,065 14,974
Depreciation and amortization 3,160 2,847 2,896
Share-based compensation expense 524 476 562
Deferred income taxes 51 149 (244)
(Gain)/loss on sale of assets (351) 755 (215)
Indefinite-lived intangible asset impairment charge — — 1,341
Change in accounts receivable 84 45 (766)
Change in inventories (641) (324) (70)
Change in accounts payable 919 (542) 878
Other (333) (1,653) 491
TOTAL OPERATING ACTIVITIES 19,556 17,817 19,846
INVESTING ACTIVITIES
Capital expenditures (4,409) (3,773) (3,322)
Proceeds from asset sales 508 107 346
Acquisitions, net of cash acquired (85) (11) (21)
Other investing activity (638) (141) (507)
TOTAL INVESTING ACTIVITIES (4,624) (3,818) (3,504)
FINANCING ACTIVITIES
Dividends to shareholders (10,232) (9,872) (9,312)
Additions to short-term debt with original maturities of more than three months 7,941 8,020 3,528
Reductions in short-term debt with original maturities of more than three months (9,984) (6,512) (7,689)
Net additions/(reductions) to other short-term debt 2,674 (1,138) 857
Additions to long-term debt 2,652 2,237 3,197
Reductions in long-term debt (3,390) (1,977) (2,335)
Treasury stock purchases (5,028) (6,500) (5,006)
Impact of stock options and other 907 1,707 1,905
TOTAL FINANCING ACTIVITIES (14,460) (14,036) (14,855)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS
AND RESTRICTED CASH (86) 112 (251)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 386 75 1,235
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF YEAR $ 9,942 $ 9,556 $ 9,482
SUPPLEMENTAL DISCLOSURE
Cash payments for interest $ 866 $ 896 $ 878
(1) Certain prior period amounts within Operating Activities have been reclassified for consistency with the current period presentation.
These reclassifications had no effect on the previously reported Total Operating Activities.
40 The Procter & Gamble Company
See accompanying Notes to Consolidated Financial Statements.

-- 52 of 92 --

Notes to Consolidated Financial Statements
NOTE 1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations
The Procter & Gamble Company's (the "Company," "Procter & Gamble," "we" or "us") business is focused on providing
branded consumer packaged goods of superior quality and value. Our products are sold in about 180 countries and territories
primarily through mass merchandisers, digital commerce (including social commerce) channels, grocery stores, membership
club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores (including airport duty-free stores),
high-frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to consumers. We have on-
the-ground operations in approximately 65 countries.
Basis of Presentation
The Consolidated Financial Statements include the Company and its controlled subsidiaries. Intercompany transactions are
eliminated.
Use of Estimates
Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America
(U.S. GAAP) requires management to make estimates and assumptions that affect the amounts reported in the Consolidated
Financial Statements and accompanying disclosures. These estimates are based on management's best knowledge of current
events and actions the Company may undertake in the future. Estimates are used in accounting for, among other items,
consumer and trade promotion accruals, restructuring reserves, pensions, postretirement benefits, stock options, valuation of
acquired intangible assets, useful lives for depreciation and amortization of long-lived assets, future cash flows associated with
impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets, deferred tax assets and liabilities,
uncertain income tax positions and contingencies. Actual results may ultimately differ from estimates, although management
does not generally believe such differences would materially affect the financial statements in any individual year. However,
regarding ongoing impairment testing of goodwill and indefinite-lived intangible assets, significant deterioration in future cash
flow projections or other assumptions used in estimating fair values versus those anticipated at the time of the initial valuations,
could result in impairment charges that materially affect the financial statements in a given year.
Revenue Recognition
Our revenue is primarily generated from the sale of finished product to customers. Those sales predominantly contain a single
performance obligation and revenue is recognized at a single point in time when ownership, risks and rewards transfer, which
can be on the date of shipment or the date of receipt by the customer. A provision for payment discounts and product return
allowances is recorded as a reduction of sales in the same period the revenue is recognized. The revenue recorded is presented
net of sales and other taxes we collect on behalf of governmental authorities. The revenue includes shipping and handling costs,
which generally are included in the list price to the customer.
Trade promotions, consisting primarily of customer pricing allowances, merchandising funds and consumer coupons, are
offered through various programs to customers and consumers. Sales are recorded net of trade promotion spending, which is
recognized as incurred at the time of the sale. Most of these arrangements have terms of approximately one year. Accruals for
expected payouts under these programs are included as Accrued marketing and promotion in the Accrued and other liabilities
line item in the Consolidated Balance Sheets.
Cost of Products Sold
Cost of products sold is primarily comprised of direct materials and supplies consumed in the manufacturing of product, as well
as manufacturing labor, depreciation expense and direct overhead expenses necessary to acquire and convert the purchased
materials and supplies into finished products. Cost of products sold also includes the cost to distribute products to customers,
inbound freight costs, customs and duties, internal transfer costs, warehousing costs and other shipping and handling activity.
Selling, General and Administrative Expense
Selling, general and administrative expense (SG&A) is primarily comprised of marketing expenses, selling expenses, research
and development costs, administrative and other indirect overhead costs, depreciation and amortization expense on non-
manufacturing assets and other miscellaneous operating items. Research and development costs are charged to expense as
incurred and were $2.1 billion in 2026 and 2025 and $2.0 billion in 2024. Advertising costs, charged to expense as incurred,
include television, print, radio, digital and in-store advertising expenses and were $10.2 billion in 2026, $9.2 billion in 2025 and
$9.6 billion in 2024. Non-advertising related components of the Company's total marketing spending reported in SG&A include
costs associated with consumer promotions, product sampling and sales aids.
Other Non-Operating Income/(Expense), Net
Other non-operating income/(expense), net primarily includes divestiture gains/(losses), net non-service impacts related to
postretirement benefit plans, investment income, accumulated foreign currency translation losses recognized upon the
substantial liquidation of foreign operations and other non-operating items.
The Procter & Gamble Company 41
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 53 of 92 --

Currency Translation
Financial statements of operating subsidiaries outside the U.S. generally are measured using the local currency as the functional
currency. Adjustments to translate those statements into U.S. dollars are recorded in Other comprehensive income (OCI). For
subsidiaries operating in highly inflationary economies, the U.S. dollar is the functional currency. Re-measurement adjustments
for financial statements in highly inflationary economies and other transactional exchange gains and losses are reflected in
earnings.
Cash Flow Presentation
The Consolidated Statements of Cash Flows are prepared using the indirect method, which reconciles net earnings to cash flows
from operating activities. Cash flows from foreign currency transactions and operations are translated at monthly exchange rates
for each period. Cash flows from hedging activities are included in the same category as the items being hedged. Cash flows
from derivative instruments designated as net investment hedges are classified as investing activities. Realized gains and losses
from non-qualifying derivative instruments used to hedge currency exposures resulting from intercompany financing
transactions are classified as financing activities. Cash flows from other derivative instruments used to manage interest rates,
commodity or other currency exposures are classified as operating activities. Cash payments related to income taxes are
classified as operating activities.
Investments
The Company holds minor equity investments in certain companies over which we exert significant influence, but do not
control the financial and operating decisions. These are accounted for as equity method investments. Other equity investments
that are not controlled, over which we do not have the ability to exercise significant influence, and for which there is a readily
determinable market value, are recorded at fair value, with gains and losses recorded through net earnings. Equity investments
without readily determinable fair values are measured at cost, less impairments, plus or minus observable price changes. Equity
investments are included as Other noncurrent assets in the Consolidated Balance Sheets.
The Company also holds highly liquid investments, primarily money market funds and time deposits. Such investments are
considered cash equivalents and are included within Cash and cash equivalents in the Consolidated Balance Sheets.
Inventory Valuation
Inventories are valued at the lower of cost or net realizable value. Product-related inventories are maintained on the first-in,
first-out method. The cost of spare part inventories is maintained using the average-cost method.
Property, Plant and Equipment
Property, plant and equipment is recorded at cost reduced by accumulated depreciation. Depreciation expense is recognized
over the assets' estimated useful lives using the straight-line method. Machinery and equipment includes office furniture and
fixtures (15-year life), computer equipment and capitalized software (3- to 5-year lives) and manufacturing equipment
(primarily 3- to 20-year lives). Buildings are depreciated over an estimated useful life of 40 years. Estimated useful lives are
periodically reviewed and, when appropriate, changes are made prospectively. When certain events or changes in operating
conditions occur, asset lives may be adjusted and an impairment assessment may be performed on the recoverability of the
carrying amounts.
Goodwill and Other Intangible Assets
Goodwill and indefinite-lived intangible assets are not amortized but are evaluated for impairment annually or more often if
indicators of a potential impairment are present. Our annual impairment testing of goodwill is performed separately from our
impairment testing of indefinite-lived intangible assets.
We have acquired brands that have been determined to have indefinite lives. We evaluate several factors to determine whether
an indefinite life is appropriate, including the competitive environment, market share, brand history, underlying product life
cycles, operating plans and the macroeconomic environment of the countries in which the brands are sold. In addition, when
certain events or changes in operating conditions occur, an additional impairment assessment is performed and indefinite-lived
assets may be adjusted to a determinable life.
The cost of intangible assets with determinable useful lives is amortized to reflect the pattern of economic benefits consumed,
either on a straight-line or accelerated basis over the estimated periods benefited. Patents, technology and other intangible assets
with contractual terms are generally amortized over their respective legal or contractual lives. Customer relationships, brands
and other non-contractual intangible assets with determinable lives are amortized over periods generally ranging from 5 to 30
years. When certain events or changes in operating conditions occur, an impairment assessment is performed and remaining
lives of intangible assets with determinable lives may be adjusted.
For additional details on goodwill and intangible assets see Note 4.
Fair Values of Financial Instruments
Certain financial instruments are required to be recorded at fair value. Changes in assumptions or estimation methods could
affect the fair value estimates; however, we do not believe any such changes would have a material impact on our financial
condition, results of operations or cash flows. Other financial instruments, including cash equivalents, certain investments and
42 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 54 of 92 --

certain short-term debt, are recorded at cost, which approximates fair value. The fair values of long-term debt and financial
instruments are disclosed in Note 9.
New Accounting Pronouncements and Policies
On July 1, 2025, we adopted the Accounting Standards Update (ASU) No. 2023-09, “Income Taxes: Improvements to Income
Tax Disclosures". This guidance requires consistent categories and greater disaggregation of information in the rate
reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ended June
30, 2026. This standard was applied retrospectively to all periods presented in the financial statements and resulted in additional
disclosures (see Note 5).
In November 2024, the Financial Accounting Standards Board (FASB) issued ASU No. 2024-03, “Income Statement—
Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”.
This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases,
employee compensation, depreciation, amortization and selling expenses. This amendment is effective for our fiscal year
ending June 30, 2028, and our interim periods within the fiscal year ending June 30, 2029. This guidance will require additional
disclosure of income statement expenses but will not have a material impact on our Consolidated Financial Statements.
In September 2025, the FASB issued ASU No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software: Targeted
Improvements to the Accounting for Internal-Use Software”. This guidance amends the accounting for and disclosure of
internal-use software costs. This amendment is effective for our fiscal year ending June 30, 2029, and the interim periods within
that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.
In December 2025, the FASB issued ASU No. 2025-10, “Accounting for Government Grants Received by Business Entities”.
This amendment provides guidance on the recognition, measurement and presentation of government grants. This amendment
is effective for our fiscal year ending June 30, 2030, and the interim periods within that fiscal year. We are currently assessing
the impact of this guidance on our Consolidated Financial Statements.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact
on our Consolidated Financial Statements.
NOTE 2
SEGMENT INFORMATION
Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health
Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of:
• Beauty: Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Personal Care (Antiperspirants and Deodorants,
Personal Cleansing); Skin Care (Facial Moisturizers, Cleaners and Treatments);
• Grooming: Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other
Grooming);
• Health Care: Oral Care (Toothbrushes, Toothpastes, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief,
Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care);
• Fabric & Home Care: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care,
Dish Care, P&G Professional, Surface Care); and
• Baby, Feminine & Family Care: Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence,
Menstrual Care); Family Care (Paper Towels, Tissues, Toilet Paper).
While none of our reportable segments are highly seasonal, components within certain reportable segments, such as Appliances
(Grooming) and Personal Health Care (Health Care), are seasonal.
The accounting policies of the segments are generally the same as those described in Note 1. Differences between these policies
and U.S. GAAP primarily reflect income taxes, which are reflected in the segments using applicable blended statutory rates.
Adjustments to arrive at our effective tax rate are included in Corporate. In addition, capital expenditures in the segments are on
an accrual basis consistent with the balance sheet. Adjustments to move from an accrual to cash basis, for purposes of the cash
flow statement, are reflected in Corporate.
Corporate includes certain operating and non-operating activities that are not reflected in the operating results used internally to
measure and evaluate the businesses, as well as items to adjust management reporting principles to U.S. GAAP. Operating
activities in Corporate include the results of incidental businesses managed at the corporate level. Operating elements also
include certain employee benefit costs, the costs of certain restructuring-type activities to maintain a competitive cost structure,
including manufacturing and workforce optimization, asset impairment charges and other general Corporate items. The non-
operating elements in Corporate primarily include interest expense, certain pension and other postretirement benefit costs,
certain acquisition and divestiture gains/(losses), interest and investing income and other financing costs.
The Company’s Chief Operating Decision Maker (CODM) is the Chief Executive Officer. As the Company allocates taxes to
individual segments, the CODM uses Earnings before income taxes and Net earnings to assess segment performance and
The Procter & Gamble Company 43
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 55 of 92 --

allocate resources in the budgeting and forecasting process. The CODM does not use assets by segment to evaluate
performance or allocate resources. Therefore, we do not disclose assets by segment.
Our operating segments are comprised of similar product categories. Operating segments as a percentage of consolidated net
sales (excluding sales recorded in Corporate) are as follows:
Fiscal years ended June 30 2026 2025 2024
Fabric Care 23% 23% 24%
Home Care 12% 13% 12%
Baby Care 9% 9% 9%
Hair Care 9% 9% 9%
Family Care 8% 9% 9%
Grooming 8% 8% 8%
Oral Care 8% 8% 8%
Feminine Care 7% 6% 6%
Personal Health Care 6% 6% 6%
Personal Care (1) 6% 6% 5%
Skin Care (1) 4% 3% 4%
TOTAL 100% 100% 100%
(1) Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments,
Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans,
financial targets, budgets and management reporting.
Net sales and long-lived assets in the United States and internationally were as follows (in billions):
Fiscal years ended June 30 2026 2025 2024
NET SALES
United States $ 41.7 $ 41.6 $ 40.5
International $ 45.3 $ 42.7 $ 43.5
LONG-LIVED ASSETS (1)
United States $ 13.9 $ 12.6 $ 12.0
International $ 11.5 $ 11.3 $ 10.2
(1) Long-lived assets consists of property, plant and equipment.
No country, other than the United States, exceeds 10% of the Company's consolidated net sales or long-lived assets.
Our largest customer, Walmart Inc. and its affiliates, accounted for consolidated net sales of approximately 16% in 2026, 2025
and 2024. No other customer represents more than 10% of our consolidated net sales.
Fiscal Year Ended June 30, 2026
Beauty Grooming Health Care Fabric &
Home Care
Baby,
Feminine &
Family
Care Corporate Total
Company
Net sales $ 16,023 $ 6,918 $ 12,456 $ 30,314 $ 20,401 $ 919 $ 87,032
Cost of products sold (6,397) (2,845) (5,208) (16,428) (11,089) (1,395) (43,362)
Selling, general and administrative
expense (6,152) (2,111) (4,087) (6,597) (4,167) (808) (23,922)
Other segment items (1) — 3 2 — — 623 629
Earnings/(loss) before income taxes 3,473 1,966 3,163 7,290 5,145 (660) 20,377
Net earnings/(loss) $ 2,672 $ 1,529 $ 2,404 $ 5,632 $ 3,930 $ (23) $ 16,144
Other segment information
Depreciation and amortization $ 410 $ 320 $ 439 $ 756 $ 835 $ 400 $ 3,160
Capital expenditures $ 415 $ 540 $ 592 $ 1,250 $ 1,520 $ 93 $ 4,409
(1) Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/
(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture
business.
44 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 56 of 92 --

Fiscal Year Ended June 30, 2025
Beauty Grooming Health Care Fabric &
Home Care
Baby,
Feminine &
Family
Care Corporate Total
Company
Net sales $ 14,964 $ 6,662 $ 11,998 $ 29,617 $ 20,248 $ 794 $ 84,284
Cost of products sold (5,822) (2,675) (4,974) (15,650) (10,926) (1,118) (41,164)
Selling, general and administrative
expense (5,687) (2,036) (3,886) (6,509) (4,108) (443) (22,669)
Other segment items (1) (1) — 10 1 — (294) (284)
Earnings/(loss) before income taxes 3,454 1,952 3,149 7,459 5,214 (1,061) 20,167
Net earnings/(loss) $ 2,715 $ 1,577 $ 2,440 $ 5,848 $ 4,013 $ (527) $ 16,065
Other segment information
Depreciation and amortization $ 399 $ 313 $ 397 $ 723 $ 814 $ 200 $ 2,847
Capital expenditures $ 328 $ 451 $ 526 $ 1,208 $ 1,080 $ 180 $ 3,773
(1) Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/
(expense). Corporate includes non-operating losses comprised primarily of a non-cash charge of $752 for accumulated foreign currency
translation losses due to the substantial liquidation of operations in Argentina. See Note 3 for more information on the limited market
portfolio restructuring program.
Fiscal Year Ended June 30, 2024
Beauty Grooming Health Care Fabric &
Home Care
Baby,
Feminine &
Family
Care Corporate Total
Company
Net sales $ 15,220 $ 6,654 $ 11,793 $ 29,495 $ 20,277 $ 601 $ 84,039
Cost of products sold (5,722) (2,711) (4,967) (15,535) (10,831) (1,082) (40,848)
Selling, general and administrative
expense (5,700) (2,105) (3,886) (6,631) (4,198) (784) (23,305)
Other segment items (1) 8 7 1 10 6 (1,156) (1,125)
Earnings/(loss) before income taxes 3,805 1,845 2,941 7,339 5,253 (2,422) 18,761
Net earnings/(loss) $ 2,963 $ 1,477 $ 2,258 $ 5,687 $ 4,020 $ (1,430) $ 14,974
Other segment information
Depreciation and amortization $ 399 $ 335 $ 381 $ 710 $ 824 $ 247 $ 2,896
Capital expenditures $ 280 $ 337 $ 524 $ 1,076 $ 979 $ 126 $ 3,322
(1) Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/
(expense). The non-cash impairment charge of $1.3 billion on the Gillette intangible asset was included in Other segment items within
Corporate and is discussed further in Note 4.
NOTE 3
SUPPLEMENTAL FINANCIAL INFORMATION
The components of property, plant and equipment were as follows:
As of June 30 2026 2025
PROPERTY, PLANT AND EQUIPMENT
Machinery and equipment $ 42,001 $ 40,077
Buildings 9,760 9,190
Construction in progress 4,448 3,935
Land 963 979
TOTAL PROPERTY, PLANT AND EQUIPMENT 57,172 54,181
Accumulated depreciation (31,811) (30,284)
PROPERTY, PLANT AND EQUIPMENT, NET $ 25,360 $ 23,897
The Procter & Gamble Company 45
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 57 of 92 --

Selected components of current and noncurrent liabilities were as follows:
As of June 30 2026 2025
ACCRUED AND OTHER LIABILITIES - CURRENT
Accrued marketing and promotion $ 4,141 $ 3,851
Accrued compensation 2,043 2,007
Taxes payable 778 1,177
Restructuring reserves 336 189
Accrued interest 301 293
Lease liabilities 246 255
Derivative liabilities 206 627
Other 3,040 2,920
TOTAL $ 11,091 $ 11,318
OTHER NONCURRENT LIABILITIES
Pension benefit obligations $ 2,204 $ 3,026
Other retiree benefit obligations 736 691
Uncertain tax positions 654 701
Lease liabilities 641 701
Derivative liabilities 195 435
Other 484 566
TOTAL $ 4,914 $ 6,120
RESTRUCTURING PROGRAM
The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost
structure, including manufacturing and workforce optimization. Before tax costs incurred under the ongoing program have
generally ranged from $250 to $500 annually.
In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations,
primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal
conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring
with the substantial liquidation of its operations in Argentina and recorded $801 after tax of incremental charges, comprised
primarily of non-cash charges for accumulated foreign currency translation losses previously included in Accumulated other
comprehensive income/(loss). The total incremental restructuring charges incurred under the program beginning in the three-
month period ended December 31, 2023, through the three-month period ended September 30, 2024, were $1.2 billion after tax.
In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve
its cost structure and competitiveness. The Company expects to incur approximately $1.5 to $2.0 billion in before-tax
restructuring costs over two years. The Company incurred over half of the costs under this plan in fiscal 2026, with the
remainder expected to be incurred in fiscal 2027. The restructuring activities will be executed across the Sector Business Units
as well as the Enterprise Markets, Corporate Functions and Global Business Services. These restructuring activities include a
plan for a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027. In addition, the plan
includes brand and market exits as well as the optimization of the supply chain and other manufacturing processes. Costs
incurred under the plan will consist primarily of costs to separate employees and asset-related costs to exit facilities. The
Company will also incur other types of costs outlined below as a direct result of the plan.
The Company incurred total before tax restructuring charges of $1.2 billion and $1.1 billion for the fiscal years ended June 30,
2026 and 2025, respectively. Of the charges incurred in fiscal year 2026, $606 were recorded in Costs of products sold, $460 in
SG&A and $165 in Other non-operating income/(expense), net. Of the charges incurred in fiscal year 2025, $150 were recorded
in Costs of products sold, $171 in SG&A and $793 in Other non-operating income/(expense), net.
46 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 58 of 92 --

The following table presents restructuring activity for the fiscal years ended June 30, 2026 and 2025:
Separation
Costs Asset-Related
Costs Other Costs Total
RESERVE JUNE 30, 2024 $ 133 $ — $ 32 $ 166
Cost incurred 145 55 914 1,114
Cost paid/settled (158) (55) (877) (1,090)
RESERVE JUNE 30, 2025 120 — 69 189
Cost incurred 608 231 391 1,230
Cost paid/settled (500) (231) (353) (1,084)
RESERVE JUNE 30, 2026 $ 229 $ — $ 107 $ 336
Separation Costs
Employee separation costs relate to severance packages that are primarily voluntary and the amounts calculated are based on
salary levels and past service periods.
Asset-Related Costs
Asset-related costs consist of both asset write-downs and accelerated depreciation for manufacturing and office consolidations.
Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or for disposal. These assets are
written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal
costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their
normal service period.
Other Costs
Other restructuring-type charges are incurred as a direct result of the restructuring plan. Such charges include accumulated
foreign currency translation losses, asset removal and termination of contracts. In the period ended September 30, 2024, the
Company substantially liquidated its operations in Argentina and recorded a non-cash charge of $752 for accumulated foreign
currency translation losses previously included in Accumulated other comprehensive income/(loss). In the period ended June
30, 2026, the Company substantially liquidated its operations in Pakistan and recorded a non-cash charge of $131 for
accumulated foreign currency translation losses previously included in Accumulated other comprehensive income/(loss).
Consistent with our historical policies for ongoing restructuring-type activities, the restructuring charges are funded by and
included within Corporate for management and segment reporting. However, for information purposes, the following table
summarizes the total before tax restructuring costs related to our reportable segments:
Fiscal years ended June 30 2026 2025 2024
Beauty $ 76 $ 43 $ 43
Grooming 47 32 76
Health Care 132 30 33
Fabric & Home Care 220 24 84
Baby, Feminine & Family Care 201 40 50
Corporate (1) 556 945 371
TOTAL $ 1,230 $ 1,114 $ 659
(1) Corporate includes costs related to allocated overheads, including charges related to our Enterprise Markets, Global Business Services
and Corporate Functions activities.
The Procter & Gamble Company 47
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 59 of 92 --

NOTE 4
GOODWILL AND INTANGIBLE ASSETS
The change in the net carrying amount of goodwill by reportable segment was as follows:
Beauty Grooming Health Care
Fabric &
Home Care
Baby,
Feminine &
Family Care TOTAL
BALANCE AT JUNE 30, 2024 - NET (1) $ 13,723 $ 12,633 $ 7,638 $ 1,810 $ 4,499 $ 40,303
Acquisitions and divestitures — — — — — —
Translation and other 507 360 303 38 141 1,348
BALANCE AT JUNE 30, 2025 - NET (1) 14,229 12,993 7,941 1,848 4,640 41,650
Acquisitions and divestitures — — 40 — — 40
Translation and other (157) (105) (96) (10) (45) (414)
BALANCE AT JUNE 30, 2026 - NET (1) $ 14,073 $ 12,887 $ 7,884 $ 1,838 $ 4,595 $ 41,276
(1) Grooming goodwill balance is net of $7.9 billion accumulated impairment losses.
Goodwill decreased during fiscal 2026 primarily due to currency translation across all reportable segments, partially offset by a
minor acquisition within Health Care. Goodwill increased during fiscal 2025 primarily due to currency translation across all
reportable segments.
Goodwill and indefinite-lived intangibles are tested for impairment at least annually by comparing the estimated fair values of
our reporting units and indefinite-lived intangible assets to their respective carrying values. We use the income method to
estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the
respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings
multiples, is weighted with the income approach to estimate fair value. Significant estimates and assumptions inherent in the
valuations reflect a consideration of other marketplace participants and include the amount and timing of future cash flows
(including expected growth rates and profitability). Significant judgment by management is required to estimate the impact of
macroeconomic and other factors on future cash flows. Estimates utilized in the projected cash flows include consideration of
macroeconomic conditions, overall category growth rates, competitive activities, cost containment and margin expansion,
Company business plans, the underlying product or technology life cycles, economic barriers to entry, a brand's relative market
position and the discount rate applied to the cash flows. Unanticipated market or macroeconomic events and circumstances may
occur, which could affect the accuracy or validity of the estimates and assumptions.
We believe the estimates and assumptions utilized in our impairment testing are reasonable and are comparable to those that
would be used by other marketplace participants. However, actual events and results could differ substantially from those used
in our valuations. To the extent such factors result in a failure to achieve the level of projected cash flows initially used to
estimate fair value for purposes of establishing or subsequently impairing the carrying amount of goodwill and related
intangible assets, we may need to record additional non-cash impairment charges in the future.
As previously disclosed, we recorded a non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette
indefinite-lived intangible asset during the fiscal year ended June 30, 2024. The impairment charge arose due to a higher
discount rate, weakening of several currencies relative to the U.S. dollar and the impact of a new restructuring program focused
primarily in certain Enterprise Markets, including Argentina and Nigeria. Following the impairment charge, the carrying value
of the Gillette indefinite-lived intangible asset was equivalent to the estimated fair value as of December 31, 2023.
48 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 60 of 92 --

Identifiable intangible assets were comprised of:
2026 2025
As of June 30 Gross Carrying
Amount Accumulated
Amortization Gross Carrying
Amount Accumulated
Amortization
INTANGIBLE ASSETS WITH DETERMINABLE LIVES
Brands $ 4,421 $ (3,181) $ 4,449 $ (3,019)
Patents and technology 2,795 (2,739) 2,803 (2,722)
Customer relationships 1,866 (1,300) 1,879 (1,236)
Other 82 (35) 73 (31)
TOTAL $ 9,164 $ (7,255) $ 9,204 $ (7,008)
INTANGIBLE ASSETS WITH INDEFINITE LIVES
Brands 19,535 — 19,714 —
TOTAL INTANGIBLE ASSETS $ 28,699 $ (7,255) $ 28,918 $ (7,008)
Amortization expense of intangible assets was as follows:
Fiscal years ended June 30 2026 2025 2024
Intangible asset amortization $ 308 $ 320 $ 338
Estimated amortization expense over the next five fiscal years is as follows:
Fiscal years ending June 30 2027 2028 2029 2030 2031
Estimated amortization expense $ 297 $ 256 $ 206 $ 181 $ 166
NOTE 5
INCOME TAXES
Income taxes are recognized for the amount of taxes payable for the current year and for the impact of deferred tax assets and
liabilities, which represent future tax consequences of events that have been recognized differently in the financial statements
than for tax purposes. Deferred tax assets and liabilities are established using the enacted statutory tax rates and are adjusted for
any changes in such rates in the period of change.
We have elected to account for the tax effects of Global Intangible Low-Taxed Income (GILTI) as a current period expense
when incurred.
Earnings before income taxes consisted of the following:
Fiscal years ended June 30 2026 2025 2024
United States $ 13,728 $ 13,911 $ 12,246
International 6,649 6,256 6,515
TOTAL $ 20,377 $ 20,167 $ 18,761
Income taxes consisted of the following:
Fiscal years ended June 30 2026 2025 2024
CURRENT TAX EXPENSE
U.S. federal $ 2,105 $ 2,215 $ 1,954
International 1,700 1,330 1,708
U.S. state and local 378 407 368
TOTAL 4,182 3,953 4,031
DEFERRED TAX EXPENSE/(BENEFIT)
U.S. federal (27) 9 (133)
International 98 146 (85)
U.S. state and local (21) (5) (26)
TOTAL 51 149 (244)
TOTAL TAX EXPENSE $ 4,233 $ 4,102 $ 3,787
The Procter & Gamble Company 49
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 61 of 92 --

Cash payments for income taxes, net of refunds, consisted of the following:
Fiscal years ended June 30 2026 2025 2024
U.S. federal $ 3,057 $ 2,993 $ 2,554
International 1,257 1,187 1,408
U.S. state and local 365 373 402
TOTAL $ 4,678 $ 4,554 $ 4,363
A reconciliation of the U.S. federal statutory income tax rate to our actual effective income tax rate is provided below:
Fiscal years ended June 30 2026 2025 2024
U.S. federal statutory income tax rate $ 4,279 21.0 % $ 4,235 21.0 % $ 3,940 21.0 %
Effect of cross-border tax laws, net of foreign tax credits
Foreign-derived intangible income (235) (1.2)% (163) (0.8)% (201) (1.1)%
Other 41 0.2 % (2) — % 64 0.3 %
Tax credits
Foreign tax credits from foreign withholding taxes (222) (1.1)% (180) (0.9)% (240) (1.3)%
Other (42) (0.2)% (36) (0.2)% (42) (0.2)%
Non-taxable or non-deductible items
Excess tax benefits from the exercise of stock options (82) (0.4)% (189) (0.9)% (186) (1.0)%
Domestic state and local income taxes, net of federal
effect (1) 277 1.4 % 334 1.7 % 333 1.8 %
Foreign tax effects 344 1.7 % 137 0.7 % 91 0.5 %
Worldwide changes in unrecognized tax benefits (2) (50) (0.2)% 87 0.4 % 189 1.0 %
Other (76) (0.4)% (121) (0.6)% (160) (0.9)%
TOTAL $ 4,233 20.8 % $ 4,102 20.3 % $ 3,787 20.2 %
(1) State taxes in California, Illinois, New York, and New Jersey made up the majority of the tax effect in this category.
(2) The company has elected to present this category on a global aggregated basis and includes the effect of current year increases into
unrecognized tax benefits.
Prior to the passage of the 2017 U.S. Tax Act, the Company asserted that substantially all of the undistributed earnings of its
foreign subsidiaries were considered indefinitely invested and, accordingly, no deferred taxes were provided. Pursuant to the
provisions of the 2017 U.S. Tax Act, these earnings were subjected to a one-time transition tax. This charge included taxes for
all U.S. income taxes and for the related foreign withholding taxes for the portion of those earnings which are no longer
considered indefinitely invested. We have not provided deferred taxes on undistributed foreign earnings which are considered
indefinitely reinvested.
A reconciliation of the beginning and ending liability for uncertain tax positions is as follows:
Fiscal years ended June 30 2026 2025 2024
BEGINNING OF YEAR $ 634 $ 582 $ 515
Increases in tax positions for prior years 59 240 157
Decreases in tax positions for prior years (96) (181) (133)
Increases in tax positions for current year 40 57 160
Settlements with taxing authorities (73) (65) (100)
Lapse in statute of limitations (13) (6) (9)
Currency translation (4) 7 (8)
END OF YEAR $ 547 $ 634 $ 582
Included in the total liability for uncertain tax positions at June 30, 2026, is $438 that, depending on the ultimate resolution,
could impact the effective tax rate in future periods.
The Company is present in approximately 65 countries and 140 taxable jurisdictions and, at any point in time, has 30-40
jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for
uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the
underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted for
50 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 62 of 92 --

changing facts and circumstances, including progress of tax audits, developments in case law and the closing of statutes of
limitation. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2013 and
forward. We are generally not able to reliably estimate the timing and ultimate settlement amounts until the close of an audit.
We recognize the additional accrual of any possible related interest and penalties relating to the underlying uncertain tax
position in income tax expense. As of June 30, 2026 and 2025, we had accrued interest of $142 and $141 and accrued penalties
of $48 and $45, respectively, which are not included in the above table.
Deferred income tax assets and liabilities were comprised of the following:
As of June 30 2026 2025
DEFERRED TAX ASSETS
Capitalized research & development $ 1,439 $ 1,251
Loss and other carryforwards 769 857
Accrued marketing and promotion 548 497
Stock-based compensation 466 445
Pension and other retiree benefits 388 601
Fixed assets 266 230
Advance payments 206 —
Lease liabilities 198 212
Unrealized loss on financial and foreign exchange transactions 144 358
Other 832 758
Valuation allowances (330) (293)
TOTAL $ 4,927 $ 4,915
DEFERRED TAX LIABILITIES
Goodwill and other intangible assets $ 5,443 $ 5,475
Fixed assets 1,606 1,547
Other retiree benefits 888 1,102
Lease right-of-use assets 194 209
Unrealized gain on financial and foreign exchange transactions 187 96
Foreign withholding tax on earnings to be repatriated 158 131
Other 630 492
TOTAL $ 9,106 $ 9,052
Net operating loss carryforwards were $1.6 billion at June 30, 2026, and $2.0 billion at June 30, 2025. If unused, approximately
$100 will expire between 2026 and 2046. The remainder, totaling $1.5 billion at June 30, 2026, may be carried forward
indefinitely.
NOTE 6
EARNINGS PER SHARE
Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred
dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common
share are calculated by dividing Net earnings attributable to Procter & Gamble by the diluted weighted average number of
common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other unvested
stock-based awards based on the treasury stock method (see Note 7) and the assumed conversion of preferred stock (see Note
8).
The Procter & Gamble Company 51
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 63 of 92 --

Net earnings per common share were calculated as follows:
Fiscal years ended June 30 2026 2025 2024
CONSOLIDATED AMOUNTS
Net earnings attributable to P&G (Diluted) $ 16,046 $ 15,974 $ 14,879
Less: Preferred dividends 292 291 284
Net earnings attributable to P&G available to common shareholders
(Basic) $ 15,754 $ 15,682 $ 14,595
SHARES IN MILLIONS
Basic weighted average common shares outstanding 2,333.7 2,350.1 2,360.1
Add effect of dilutive securities:
Stock options and other unvested equity awards (1) 20.5 33.3 38.3
Convertible preferred shares (2) 68.3 71.0 73.6
Diluted weighted average common shares outstanding 2,422.5 2,454.4 2,471.9
NET EARNINGS PER COMMON SHARE
Basic $ 6.75 $ 6.67 $ 6.18
Diluted $ 6.62 $ 6.51 $ 6.02
(1) For the years ended June 30, 2026, 2025 and 2024, the weighted average of stock options that were antidilutive and not included in the
diluted net earnings per share calculation were 20 million, 6 million and 4 million, respectively.
(2) An overview of preferred shares can be found in Note 8.
NOTE 7
SHARE-BASED COMPENSATION
The Company has two primary share-based compensation programs under which we annually grant stock option, restricted
stock unit (RSU) and performance stock unit (PSU) awards to certain managers and directors.
In our main long-term incentive program, managers can elect to receive stock options or RSUs. All options vest after three
years and have a 10-year life. Exercise prices on options are set equal to the market price of the underlying shares on the date of
the grant. RSUs vest and settle in shares of common stock three years from the grant date.
Senior-level executives participate in an additional long-term incentive program that awards PSUs, which are paid in shares
after the end of a three-year performance period subject to pre-established performance goals. The program includes a Relative
Total Shareholder Return (R-TSR) modifier under which the number of shares ultimately granted is also impacted by the
Company's actual shareholder return relative to our consumer products competitive peer set.
In addition to these long-term incentive programs, we award RSUs to the Company's non-employee directors and make other
minor stock option and RSU grants to employees for which the terms are not substantially different from our long-term
incentive awards.
The Company's share-based compensation plan was approved by shareholders in 2025. Under the 2025 plan, a maximum of
175 million shares of common stock was authorized for issuance. Additionally, the number of shares available for award under
the 2025 plan includes 38 million shares previously authorized but not awarded under the shareholders approved plan in 2019
plus any shares of Common Stock subject to outstanding awards under the 2019 Plan that are forfeited, cancelled or otherwise
terminated without the issuance of shares of Common Stock as set forth in the 2025 Plan. A total of 213 million shares remain
available for grant.
The Company recognizes share-based compensation expense based on the fair value of the awards at the date of grant. The
expense is recognized on a straight-line basis over the requisite service period. Awards to employees eligible for retirement
prior to the award becoming fully vested are recognized as compensation expense ratably from the grant date through the date
the employee first becomes eligible to retire and/or is no longer required to provide services to earn the award. Share-based
compensation expense is included as part of Cost of products sold and SG&A in the Consolidated Statements of Earnings and
includes an estimate of forfeitures, which is based on historical data.
52 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 64 of 92 --

Total expense and related recognized tax benefit were as follows:
Fiscal years ended June 30 2026 2025 2024
Stock options $ 264 $ 219 $ 270
RSUs and PSUs 260 257 292
Total share-based expense $ 524 $ 476 $ 562
Income tax benefit $ 92 $ 85 $ 103
We utilize an industry standard lattice-based valuation model to calculate the fair value for stock options granted. Assumptions
utilized in the model, which are evaluated and revised to reflect market conditions and experience, were as follows:
Fiscal years ended June 30 2026 2025 2024
Interest rate 3.6 - 4.2 % 3.5 - 4.4 % 4.6 - 5.5 %
Weighted average interest rate 4.1 % 3.7 % 4.6 %
Dividend yield 2.7 % 2.4 % 2.5 %
Expected volatility 19 % 18 % 18 %
Expected life in years 8.8 8.9 8.8
Lattice-based option valuation models incorporate ranges of assumptions for inputs and those ranges are disclosed in the
preceding table. Expected volatilities are based on a combination of historical volatility of our stock and implied volatilities of
call options on our stock. We use historical data to estimate option exercise and employee termination patterns within the
valuation model. The expected life of options granted is derived from the output of the option valuation model and represents
the average period of time that options granted are expected to be outstanding. The interest rate for periods within the
contractual life of the options is based on the U.S. Treasury yield curve in effect at the time of grant.
We utilize a Monte-Carlo simulation model to estimate the fair value of performance stock units granted. Assumptions utilized
in the model are not substantially different from those used for stock options.
A summary of options outstanding under the plans as of June 30, 2026, and activity during the year then ended is presented
below:
Options Options
(in thousands)
Weighted
Average
Exercise Price
Weighted Average
Contractual Life
in Years
Aggregate
Intrinsic Value
OUTSTANDING AT JULY 1, 2025 96,621 $ 120.96
Granted 8,769 153.71
Exercised (10,188) 90.34
Forfeited/expired (657) 151.43
OUTSTANDING AT JUNE 30, 2026 94,544 $ 127.07 4.8 $ 2,143
Exercisable 69,692 $ 116.01 3.6 $ 2,134
The following table provides additional information on stock options:
Fiscal years ended June 30 2026 2025 2024
Weighted average grant-date fair value of options granted $ 33.17 $ 36.23 $ 34.25
Intrinsic value of options exercised 664 1,546 1,621
Grant-date fair value of options that vested 274 299 244
Cash received from options exercised 920 1,693 1,888
Actual tax benefit from options exercised 137 321 330
At June 30, 2026, $188 of compensation cost had not yet been recognized related to stock option grants. That cost is expected
to be recognized over a remaining weighted average period of 1.6 years.
The Procter & Gamble Company 53
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 65 of 92 --

A summary of non-vested RSUs and PSUs outstanding under the plans as of June 30, 2026, and activity during the year then
ended is presented below:
RSUs PSUs
RSU and PSU awards Units (in
thousands)
Weighted
Average Grant
Date Fair Value
Units (in
thousands)
Weighted
Average Grant
Date Fair Value
NON-VESTED AT JULY 1, 2025 3,361 $ 151.58 924 $ 166.15
Granted 1,704 152.91 585 161.53
Vested (1,556) 142.16 (506) 155.87
Forfeited (114) 156.01 (30) 163.05
NON-VESTED AT JUNE 30, 2026 3,396 $ 156.41 973 $ 168.83
At June 30, 2026, $250 of compensation cost had not yet been recognized related to RSUs and PSUs. That cost is expected to
be recognized over a remaining weighted average period of 1.6 years. The total grant date fair value of shares vested was $301,
$258 and $256 in 2026, 2025 and 2024, respectively.
The Company settles equity issuances with treasury shares. We have no specific policy to repurchase common shares to
mitigate the dilutive impact of options, RSUs and PSUs. However, we have historically made adequate discretionary purchases,
based on cash availability, market trends and other factors, to offset the impacts of such activity.
NOTE 8
POSTRETIREMENT BENEFITS AND EMPLOYEE STOCK OWNERSHIP PLAN
We offer various postretirement benefits to our employees.
Defined Contribution Retirement Plans
We have defined contribution plans, which cover the majority of our U.S. employees, as well as employees in certain other
countries. These plans are fully funded. We generally make contributions to participants' accounts based on individual base
salaries and years of service. Total global defined contribution expense was $534 in 2026 and 2025 and $425 in 2024,
respectively.
The primary U.S. defined contribution plan (the U.S. DC plan) comprises the majority of the expense for the Company's
defined contribution plans. For the U.S. DC plan, the contribution rate is predetermined and reflects years of service and plan
participation. Total contributions for this plan approximated 12% of total participants' annual wages and salaries in 2026 and
2025 and 13% in 2024.
We maintain The Procter & Gamble Profit Sharing Trust (Trust) and Employee Stock Ownership Plan (ESOP) to provide a
portion of the funding for U.S. other retiree benefits (described below), and historically, the U.S. DC plan. Operating details of
the ESOP are provided at the end of this Note.
Defined Benefit Retirement Plans and Other Retiree Benefits
We offer defined benefit retirement pension plans to certain employees. These benefits relate primarily to plans outside the U.S.
and, to a lesser extent, plans assumed in previous acquisitions covering U.S. employees.
We also provide certain other retiree benefits, primarily health care benefits for the majority of our U.S. employees who
become eligible for these benefits when they meet minimum age and service requirements. The plans require cost sharing with
retirees and the benefits are funded by ESOP Series B shares and certain other assets contributed by the Company.
54 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 66 of 92 --

Obligation and Funded Status. The following provides a reconciliation of benefit obligations, plan assets and funded status of
these defined benefit plans:
Pension Benefits (1) Other Retiree Benefits (2)
Fiscal years ended June 30 2026 2025 2026 2025
CHANGE IN BENEFIT OBLIGATION
Benefit obligation at beginning of year (3) $ 13,156 $ 12,355 $ 3,396 $ 2,687
Service cost 182 173 80 61
Interest cost 499 498 181 147
Participants' contributions 16 15 59 56
Amendments 18 12 — (4)
Net actuarial loss/(gain) (472) (263) 244 679
Special termination benefits 11 3 13 2
Currency translation and other (265) 980 17 17
Benefit payments (691) (617) (257) (250)
BENEFIT OBLIGATION AT END OF YEAR (3) $ 12,455 $ 13,156 $ 3,734 $ 3,396
CHANGE IN PLAN ASSETS
Fair value of plan assets at beginning of year $ 11,672 $ 10,857 $ 7,787 $ 8,043
Actual return on plan assets 1,253 326 (540) (168)
Employer contributions 220 189 40 42
Participants' contributions 16 15 59 56
Currency translation and other (312) 903 — —
ESOP debt impacts (4) — — 76 64
Benefit payments (691) (617) (257) (250)
FAIR VALUE OF PLAN ASSETS AT END OF YEAR $ 12,159 $ 11,672 $ 7,166 $ 7,787
FUNDED STATUS $ (296) $ (1,484) $ 3,432 $ 4,391
(1) Primarily non-U.S.-based defined benefit retirement plans.
(2) Primarily U.S.-based other postretirement benefit plans.
(3) For the pension benefit plans, the benefit obligation is the projected benefit obligation. For other retiree benefit plans, the benefit
obligation is the accumulated postretirement benefit obligation.
(4) Represents the net impact of ESOP debt service requirements, which is netted against plan assets for other retiree benefits.
The actuarial gain for pension plans in 2026 was primarily related to increases in discount rates. The actuarial loss for other
retiree benefits in 2026 was primarily related to updates in assumptions for medical claims costs. The actuarial gain for pension
plans in 2025 was primarily related to increases in discount rates and updates of various assumptions in the plan. The actuarial
loss for other retiree benefits in 2025 was primarily related to updates in assumptions for medical claims costs.
The underfunding of pension benefits is primarily a function of the different funding incentives that exist outside of the U.S. In
certain countries, there are no legal requirements or financial incentives provided to companies to pre-fund pension obligations
prior to their due date. In these instances, benefit payments are typically paid directly from the Company's cash as they become
due.
Pension Benefits Other Retiree Benefits
As of June 30 2026 2025 2026 2025
CLASSIFICATION OF NET AMOUNT RECOGNIZED
Noncurrent assets $ 1,992 $ 1,621 $ 4,213 $ 5,123
Current liabilities (85) (78) (45) (41)
Noncurrent liabilities (2,204) (3,026) (736) (691)
NET AMOUNT RECOGNIZED $ (296) $ (1,484) $ 3,432 $ 4,391
AMOUNTS RECOGNIZED IN ACCUMULATED OTHER COMPREHENSIVE (INCOME)/LOSS (AOCI)
Net actuarial loss/(gain) $ 197 $ 1,322 $ 1,743 $ 166
Prior service cost/(credit) 98 122 (458) (553)
NET AMOUNTS RECOGNIZED IN AOCI $ 295 $ 1,444 $ 1,285 $ (387)
The Procter & Gamble Company 55
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 67 of 92 --

The accumulated benefit obligation for all defined benefit pension plans, which differs from the projected obligation in that it
excludes the assumption of future salary increases, was $11.8 billion and $12.5 billion as of June 30, 2026 and 2025,
respectively. Information related to the funded status of selected pension and other retiree benefits at June 30 is as follows:
As of June 30 2026 2025
PENSION PLANS WITH A PROJECTED BENEFIT OBLIGATION IN EXCESS OF PLAN ASSETS
Projected benefit obligation $ 7,380 $ 8,175
Fair value of plan assets 5,091 5,070
PENSION PLANS WITH AN ACCUMULATED BENEFIT OBLIGATION IN EXCESS OF PLAN ASSETS
Accumulated benefit obligation $ 6,968 $ 7,653
Fair value of plan assets 5,070 5,018
OTHER RETIREE BENEFIT PLANS WITH AN ACCUMULATED BENEFIT OBLIGATION IN EXCESS OF
PLAN ASSETS
Accumulated benefit obligation $ 837 $ 802
Fair value of plan assets 55 70
Net Periodic Benefit Cost. Components of the net periodic benefit cost were as follows:
Pension Benefits Other Retiree Benefits
Fiscal years ended June 30 2026 2025 2024 2026 2025 2024
AMOUNTS RECOGNIZED IN NET PERIODIC BENEFIT COST/(CREDIT)
Service cost $ 182 $ 173 $ 164 $ 80 $ 61 $ 68
Interest cost 499 498 527 181 147 157
Expected return on plan assets (681) (657) (610) (787) (745) (687)
Amortization of net actuarial loss/(gain) 71 63 95 (4) (59) (38)
Amortization of prior service cost/(credit) 39 40 37 (90) (128) (127)
Amortization of net actuarial loss/(gain) due to settlements (6) 5 (13) — — —
Special termination benefits 11 3 4 13 2 3
NET PERIODIC BENEFIT COST/(CREDIT) $ 114 $ 126 $ 203 $ (607) $ (721) $ (623)
CHANGE IN PLAN ASSETS AND BENEFIT OBLIGATIONS RECOGNIZED IN AOCI
Net actuarial loss/(gain) - current year $ (1,044) $ 68 $ 1,571 $ 1,592
Prior service cost/(credit) - current year 18 12 — (4)
Amortization of net actuarial (loss)/gain (71) (63) 4 59
Amortization of prior service (cost)/credit (39) (40) 90 128
Amortization of net actuarial (loss)/gain due to settlements 6 (5) — —
Currency translation and other (20) 74 7 (14)
TOTAL CHANGE IN AOCI (1,149) 46 1,672 1,761
NET AMOUNTS RECOGNIZED IN PERIODIC
BENEFIT COST/(CREDIT) AND AOCI $ (1,035) $ 171 $ 1,065 $ 1,040
The service cost component of the net periodic benefit cost is included in the Consolidated Statements of Earnings in Cost of
products sold and SG&A. All other components are included in the Consolidated Statements of Earnings in Other non-
operating income/(expense), net, unless otherwise noted.
56 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 68 of 92 --

Assumptions. We determine our actuarial assumptions on an annual basis. These assumptions are weighted to reflect each
country that may have an impact on the cost of providing retirement benefits. The weighted average assumptions used to
determine benefit obligations recorded on the Consolidated Balance Sheets as of June 30, 2026 and 2025, were as follows: (1)
Pension Benefits Other Retiree Benefits
As of June 30 2026 2025 2026 2025
Discount rate 4.6 % 4.2 % 6.0 % 5.9 %
Rate of compensation increase 2.7 % 2.7 % N/A N/A
Interest crediting rate for cash balance plans 4.6 % 4.6 % N/A N/A
Health care cost trend rates assumed for next year N/A N/A 7.3 % 6.9 %
Rate to which the health care cost trend rate is assumed to
decline (ultimate trend rate) N/A N/A 5.6 % 5.4 %
Year that the rate reaches the ultimate trend rate N/A N/A 2031 2030
(1) Determined as of end of fiscal year.
The weighted average assumptions used to determine net benefit cost recorded on the Consolidated Statements of Earnings for
the fiscal years ended June 30 were as follows: (1)
Pension Benefits Other Retiree Benefits
Fiscal years ended June 30 2026 2025 2024 2026 2025 2024
Discount rate 4.2 % 4.2 % 4.2 % 5.9 % 5.8 % 5.6 %
Expected return on plan assets 6.0 % 6.0 % 6.0 % 8.5 % 8.5 % 8.5 %
Rate of compensation increase 2.7 % 2.8 % 2.9 % N/A N/A N/A
Interest crediting rate for cash balance plans 4.6 % 4.7 % 4.3 % N/A N/A N/A
(1) Determined as of beginning of fiscal year.
For plans that make up the majority of our obligation, the Company calculates the benefit obligation and the related impacts on
service and interest costs using specific spot rates along the corporate bond yield curve. For the remaining plans, the Company
determines these amounts utilizing a single weighted average discount rate derived from the corporate bond yield curve used to
measure the plan obligations.
Several factors are considered in developing the estimate for the long-term expected rate of return on plan assets. For the
defined benefit retirement plans, these factors include historical rates of return of broad equity and bond indices and projected
long-term rates of return obtained from pension investment consultants. The expected long-term rates of return for plan assets
are 8 - 9% for equities and 3 - 5% for bonds. For other retiree benefit plans, the expected long-term rate of return reflects that
the assets are comprised primarily of Company stock. The expected rate of return on Company stock is based on the long-term
projected return of 8.5% and reflects the historical pattern of returns.
Plan Assets. Our investment objective for defined benefit retirement plan assets is to meet the plans' benefit obligations and to
improve plan self-sufficiency for future benefit obligations. The investment strategies focus on asset class diversification,
liquidity to meet benefit payments and an appropriate balance of long-term investment return and risk. Target ranges for asset
allocations are determined by assessing different investment risks and matching the actuarial projections of the plans' future
liabilities and benefit payments with current as well as expected long-term rates of return on the assets, taking into account
investment return volatility and correlations across asset classes. Plan assets are diversified across several investment managers
and are generally invested in liquid funds that are selected to track broad market equity and bond indices. Investment risk is
carefully controlled with plan assets rebalanced to target allocations on a periodic basis and with continual monitoring of
investment managers' performance relative to the investment guidelines established with each investment manager.
Our target asset allocation for the fiscal year ended June 30, 2026, was as follows:
Target Asset Allocation (1)
Pension Benefits Other Retiree
Benefits	Asset Category
Cash 1 % 2 %
Debt securities 64 % 1 %
Equity securities 35 % 97 %
TOTAL 100 % 100 %
(1) Actual allocations approximated the targets.
The Procter & Gamble Company 57
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 69 of 92 --

The following table sets forth the fair value of the Company's plan assets as of June 30, 2026 and 2025, segregated by level
within the fair value hierarchy (see Note 9 for further discussion on the fair value hierarchy and fair value principles).
Investments valued using net asset value as a practical expedient are not valued using the fair value hierarchy, but rather valued
using the net asset value reported by the managers of the funds and as supported by the unit prices of actual purchase and sale
transactions.
Pension Benefits Other Retiree Benefits
As of June 30 Fair Value
Hierarchy Level 2026 2025 Fair Value
Hierarchy Level 2026 2025
ASSETS AT FAIR VALUE
Cash and cash equivalents 1 $ 74 $ 55 1 $ 180 $ 135
Company common stock — — 1 502 496
Company preferred stock (1) — — 2 6,433 7,087
Fixed income securities (2) 2 2,519 1,050 — —
Insurance contracts (3) 3 238 207 — —
TOTAL ASSETS IN THE FAIR
VALUE HIERARCHY 2,831 1,312 7,115 7,718
Investments valued at net asset value (4) 9,328 10,361 50 68
TOTAL ASSETS AT FAIR VALUE $ 12,159 $ 11,672 $ 7,166 $ 7,787
(1) Company preferred stock is valued based on the value of Company common stock and is presented net of ESOP debt discussed below.
(2) Fixed income securities are estimated by using pricing models or quoted prices of securities with similar characteristics.
(3) Fair values of insurance contracts are valued based on either their cash equivalent value or models that project future cash flows and
discount the future amounts to a present value using market-based observable inputs, including credit risk and interest rate curves. The
activity for Level 3 assets is not significant for all years presented.
(4) Investments valued using net asset value as a practical expedient are primarily equity and fixed income collective funds.
Cash Flows. Management's best estimate of cash requirements and discretionary contributions for the pension benefits and
other retiree benefit plans for the fiscal year ending June 30, 2027, is $200 and $59, respectively. Expected contributions are
dependent on many variables, including the variability of the market value of the plan assets as compared to the benefit
obligation and other market or regulatory conditions. In addition, we take into consideration our business investment
opportunities and resulting cash requirements. Accordingly, actual funding may differ significantly from current estimates.
Total benefit payments expected to be paid to participants, which include payments funded from the Company's assets and
payments from the plans are as follows:
Fiscal years ending June 30 Pension Benefits Other Retiree Benefits
EXPECTED BENEFIT PAYMENTS
2027 $ 712 $ 215
2028 735 218
2029 753 228
2030 797 236
2031 806 248
2032 - 2036 4,097 1,377
Employee Stock Ownership Plan
We maintain the ESOP to provide funding for certain employee benefits discussed in the preceding paragraphs.
The ESOP borrowed $1.0 billion in 1989, and the proceeds were used to purchase Series A ESOP Convertible Class A
Preferred Stock to fund a portion of the U.S. DC plan. Principal and interest requirements of the borrowing were paid by the
Trust from dividends on the preferred shares and from advances provided by the Company. The original borrowing of $1.0
billion has been repaid in full. No advances from the Company remain outstanding at June 30, 2026. Each share is convertible
at the option of the holder into one share of the Company's common stock. The dividend for the current year was equal to the
common stock dividend of $4.26 per share. The liquidation value is $6.82 per share.
In 1991, the ESOP borrowed an additional $1.0 billion. The proceeds were used to purchase Series B ESOP Convertible
Class A Preferred Stock to fund a portion of retiree health care benefits. These shares, net of the ESOP's debt, are considered
plan assets of the other retiree benefits plan discussed above. The original borrowings of $1.0 billion were repaid in 2021. Debt
service requirements were funded by preferred stock dividends, cash contributions and advances provided by the Company, of
58 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 70 of 92 --

which $596 are outstanding at June 30, 2026. Each share is convertible at the option of the holder into one share of the
Company's common stock. The dividend for the current year was equal to the common stock dividend of $4.26 per share. The
liquidation value is $12.96 per share.
Our ESOP accounting practices are consistent with current ESOP accounting guidance, including the permissible continuation
of certain provisions from prior accounting guidance. ESOP debt, which was guaranteed by the Company, was recorded as debt
with an offset to the Reserve for ESOP debt retirement, which is presented within Shareholders' equity. Advances to the ESOP
by the Company are recorded as an increase in the Reserve for ESOP debt retirement. Interest incurred on the ESOP debt was
recorded as Interest expense. Dividends on all preferred shares are charged to Retained earnings.
The Series A and B preferred shares of the ESOP are allocated to employees based on debt service requirements. The number
of Series A preferred shares outstanding of 18 million, 21 million and 23 million were all allocated as of June 30, 2026, 2025
and 2024, respectively. The number of Series B preferred shares outstanding at June 30 was as follows:
Shares in thousands 2026 2025 2024
Allocated 36,365 34,965 33,723
Unallocated 12,277 14,142 15,864
TOTAL SERIES B 48,642 49,107 49,587
For purposes of calculating diluted net earnings per common share, the preferred shares held by the ESOP are considered
converted from inception.
NOTE 9
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates,
currency exchange rates and commodity prices. We evaluate exposures on a centralized basis to take advantage of natural
exposure correlation and netting. To the extent we choose to manage volatility associated with the net exposures, we enter into
various financial transactions that we account for using the applicable accounting guidance for derivative instruments and
hedging activities. These financial transactions are governed by our policies covering acceptable counterparty exposure,
instrument types and other hedging practices.
If the Company elects to do so and if the instrument meets certain specified accounting criteria, management designates
derivative instruments as cash flow hedges, fair value hedges or net investment hedges. We record derivative instruments at fair
value and the accounting for changes in the fair value depends on the intended use of the derivative, the resulting designation
and the effectiveness of the instrument in offsetting the risk exposure it is designed to hedge. We generally have a high degree
of effectiveness between the exposure being hedged and the hedging instrument.
Credit Risk Management
We have counterparty credit guidelines and normally enter into transactions with investment grade financial institutions, to the
extent commercially viable. Counterparty exposures are monitored daily and downgrades in counterparty credit ratings are
reviewed on a timely basis. We have not incurred, and do not expect to incur, material credit losses on our risk management or
other financial instruments.
Certain of the Company's financial instruments used in hedging transactions are governed by industry standard netting and
collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the
agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair
value of the instruments covered by these contractual features that are in a net liability position was $260 and $1.1 billion as of
June 30, 2026 and 2025, respectively. The Company has not been required to post collateral as a result of these contractual
features.
Interest Rate Risk Management
Our policy is to manage interest cost using a mixture of fixed-rate and variable-rate debt. To manage this risk in a cost-efficient
manner, we enter into interest rate swaps whereby we agree to exchange with the counterparty, at specified intervals, the
difference between fixed and variable interest amounts calculated by reference to a notional amount.
We designate certain interest rate swaps on fixed-rate debt that meet specific accounting criteria as fair value hedges. For fair
value hedges, the changes in the fair value of the hedging instruments are immediately recognized in earnings, as well as the
adjustment to debt for the change in fair value attributable to the designated risk.
Foreign Currency Risk Management
We manufacture and sell our products and finance our operations in a number of countries throughout the world. As a result, we
are exposed to movements in foreign currency exchange rates. We leverage the Company’s diversified portfolio of exposures as
a natural hedge. In certain cases, we enter into non-qualifying foreign currency contracts to hedge certain balance sheet items
subject to revaluation. The change in fair value of these instruments and the underlying exposure are both immediately
recognized in earnings.
The Procter & Gamble Company 59
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 71 of 92 --

To manage exchange rate risk related to our intercompany financing, we primarily use forward contracts and currency swaps.
The change in fair value of these non-qualifying instruments is immediately recognized in earnings, substantially offsetting the
foreign currency mark-to-market impact of the related exposure.
Net Investment Hedging
We hedge certain net investment positions in foreign subsidiaries. To accomplish this, we either borrow directly in foreign
currencies and designate all or a portion of the foreign currency debt as a hedge of the applicable net investment position or we
enter into foreign currency swaps that are designated as hedges of net investments. The time value component of the net
investment hedge currency swaps is excluded from the assessment of hedge effectiveness. Changes in the fair value of the
swap, including changes in the fair value of the excluded time value component, are recognized in OCI and offset the value of
the net investment being hedged. The time value component is subsequently reported in income on a systematic basis.
Commodity Risk Management
Certain raw materials used in our products or production processes are subject to price volatility caused by weather, supply
conditions, political and economic variables and other unpredictable factors. As of and during the fiscal years ended June 30,
2026 and 2025, we did not have any financial commodity hedging activity.
Insurance
We self-insure for most insurable risks. However, we purchase insurance for Directors and Officers Liability and certain other
coverage where it is required by law or by contract.
Fair Value Hierarchy
Accounting guidance on fair value measurements for certain financial assets and liabilities requires that financial assets and
liabilities carried at fair value be classified and disclosed in one of the following categories:
• Level 1: Quoted market prices in active markets for identical assets or liabilities.
• Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
• Level 3: Unobservable inputs reflecting the reporting entity's own assumptions or external inputs from inactive markets.
The Company had no significant activity with Level 3 assets and liabilities during the periods presented. Except for the
impairment of the Gillette indefinite-lived intangible asset discussed in Note 4, there were no significant assets or liabilities that
were re-measured at fair value on a non-recurring basis for the periods presented. When applying fair value principles in the
valuation of assets and liabilities, we are required to maximize the use of quoted market prices and minimize the use of
unobservable inputs. The Company has not changed its valuation techniques used in measuring the fair value of any financial
assets or liabilities during the year.
When active market quotes are not available for financial assets and liabilities, we use industry standard valuation models.
Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based
observable inputs including credit risk, interest rate curves and forward and spot prices for currencies. In circumstances where
market-based observable inputs are not available, management judgment is used to develop assumptions to estimate fair value.
Assets and Liabilities Measured at Fair Value
Cash equivalents were $8.7 billion and $8.3 billion as of June 30, 2026 and 2025, respectively, and are classified as Level 1
within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the periods
presented.
The fair value of long-term debt was $28.3 billion and $29.5 billion as of June 30, 2026 and 2025, respectively. This includes
the current portion of long-term debt instruments ($6.5 billion as of June 30, 2026, and $5.3 billion as of June 30, 2025). All
long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. Long-term debt designated in
a fair value hedging relationship is adjusted for the change in fair value attributable to the designated hedged risk. We consider
our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical
or similar instruments.
60 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 72 of 92 --

Disclosures about Financial Instruments
The notional amounts and fair values of financial instruments used in hedging transactions as of June 30, 2026 and 2025, are as
follows:
Notional Amount Fair Value Asset Fair Value (Liability)
As of June 30 2026 2025 2026 2025 2026 2025
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts $ 5,241 $ 3,280 $ — $ — $ (221) $ (201)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts $ 13,587 $ 11,874 $ 170 $ — $ (173) $ (860)
TOTAL DERIVATIVES DESIGNATED AS
HEDGING INSTRUMENTS $ 18,828 $ 15,154 $ 170 $ — $ (394) $ (1,061)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts $ 4,146 $ 3,576 $ 6 $ 19 $ (7) $ —
TOTAL DERIVATIVES AT FAIR VALUE $ 22,975 $ 18,730 $ 176 $ 19 $ (401) $ (1,062)
The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging
adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt
obligation, which includes the unamortized discount or premium and the fair value adjustment, was $5.0 billion and $3.1 billion
as of June 30, 2026 and 2025, respectively. In addition to the foreign currency derivative contracts designated as net investment
hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying
value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency
transaction gain or loss on those instruments, was $12.0 billion and $11.2 billion as of June 30, 2026 and 2025, respectively.
The increase in the notional balance of interest rate contracts designated as fair value hedges is driven by debt portfolio
rebalancing to meet interest rate risk management objectives. The increase in the notional balance of derivative instruments
designated as net investment hedges was primarily driven by the Company's decision to leverage favorable interest rate spreads
in the foreign currency swap market.
Derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. Derivative liabilities are
presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedges are
recognized in the Foreign currency translation component of OCI. All of the Company's derivative assets and liabilities
measured at fair value are classified as Level 2 within the fair value hierarchy.
Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows:
Amount of Gain/(Loss)
Recognized in OCI on Derivatives
Fiscal years ended June 30 2026 2025
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign currency interest rate contracts $ 264 $ (1,040)
(1) For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was
recognized in Interest expense, was $242, $226 and $229 for the fiscal years ended June 30, 2026, 2025 and 2024, respectively.
(2) In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated
debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in AOCI for such instruments was $395
and $(1.1) billion, for the fiscal years ended June 30, 2026 and 2025, respectively.
Amount of Gain/(Loss) Recognized in Earnings
Fiscal years ended June 30 2026 2025 2024
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts $ (20) $ 124 $ 120
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts $ 48 $ 66 $ (91)
The gains/(losses) on the derivatives in fair value hedging relationships are fully offset by the mark-to-market impact of the
related exposure. These are both recognized in Interest expense. The gains/(losses) on derivatives not designated as hedging
instruments are substantially offset by the currency mark-to-market of the related exposure. These are both recognized in
SG&A.
The Procter & Gamble Company 61
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 73 of 92 --

NOTE 10
SHORT-TERM AND LONG-TERM DEBT
As of June 30 2026 2025
DEBT DUE WITHIN ONE YEAR
Current portion of long-term debt $ 6,457 $ 5,377
Commercial paper 4,837 4,108
Other 3 27
TOTAL $ 11,296 $ 9,513
Weighted average interest rate of debt due within one year (1) 3.3 % 3.0 %
(1) Weighted average interest rate of debt due within one year includes the effects of interest rate swaps discussed in Note 9.
62 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 74 of 92 --

As of June 30 2026 2025
LONG-TERM DEBT
0.55% USD note due October 2025 $ — $ 1,000
4.10% USD note due January 2026 — 650
2.70% USD note due February 2026 — 600
1.00% USD note due April 2026 — 1,000
3.25% EUR note due August 2026 741 762
2.45% USD note due November 2026 875 875
1.90% USD note due February 2027 1,000 1,000
2.80% USD note due March 2027 500 500
4.88% EUR note due May 2027 1,140 1,172
2.85% USD note due August 2027 750 750
3.95% USD note due January 2028 600 600
3.15% EUR note due April 2028 741 762
1.20% EUR note due October 2028 912 937
4.35% USD note due January 2029 600 600
4.15% USD note due October 2029 500 500
1.25% EUR note due October 2029 570 586
3.00% USD note due March 2030 1,500 1,500
4.05% USD note due May 2030 700 700
0.35% EUR note due May 2030 570 586
1.20% USD note due October 2030 1,250 1,250
1.95% USD note due April 2031 1,000 1,000
3.25% EUR note due August 2031 741 762
2.30% USD note due February 2032 850 850
4.10% USD note due November 2032 750 —
4.05% USD note due January 2033 850 850
2.90% EUR note due November 2033 570 —
4.55% USD note due January 2034 750 750
3.20% EUR note due April 2034 969 996
4.55% USD note due October 2034 500 500
4.60% USD note due May 2035 550 550
4.35% USD note due November 2035 500 —
5.55% USD note due March 2037 716 716
1.88% EUR note due October 2038 570 586
3.55% USD note due March 2040 516 516
0.90% EUR note due November 2041 684 703
3.65% EUR note due November 2045 570 —
All other long-term debt 5,265 5,263
Current portion of long-term debt (6,457) (5,377)
TOTAL $ 22,842 $ 24,995
Weighted average interest rate of long-term debt (1) 3.3% 3.3%
(1) Weighted average interest rate of long-term debt includes the effects of interest rate swaps discussed in Note 9.
Long-term debt maturities during the next five fiscal years are as follows:
Fiscal years ending June 30 2027 2028 2029 2030 2031
Debt maturities $ 6,457 $ 2,123 $ 1,993 $ 3,939 $ 2,275
The Procter & Gamble Company 63
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 75 of 92 --

Credit Facilities
We maintain bank credit facilities to support our ongoing commercial paper program. The current facility is an $8.0 billion
facility split between a $3.2 billion five-year facility and a $4.8 billion 364-day facility, which expire in October 2030 and
October 2026, respectively. Both facilities can be extended for certain periods of time as specified in the terms of the credit
agreement. These facilities are currently undrawn and we anticipate that they will remain undrawn. These credit facilities do not
have cross-default or ratings triggers, nor do they have material adverse event clauses, except at the time of signing.
NOTE 11
ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)
The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble
(AOCI), including the reclassifications out of AOCI by component:
Changes in Accumulated Other Comprehensive Income/(Loss) by Component
Investment
Securities
Post-
retirement
Benefit
Plans
Foreign
Currency
Translation Total AOCI
BALANCE AT JUNE 30, 2024, NET OF TAX $ 10 $ 613 $ (12,522) $ (11,900)
Other comprehensive income/(loss), before tax:
OCI before reclassifications (1) (1,717) (51) (1,769)
Amounts reclassified to the Consolidated Statement of Earnings — (81) 752 671
Total other comprehensive income/(loss), before tax (1) (1,798) 701 (1,098)
Tax effect 1 407 442 850
Total other comprehensive income/(loss), net of tax — (1,390) 1,143 (248)
Less: OCI attributable to non-controlling interests, net of tax — — (4) (4)
BALANCE AT JUNE 30, 2025, NET OF TAX 9 (777) (11,375) (12,143)
Other comprehensive income/(loss), before tax:
OCI before reclassifications 2 (533) 94 (437)
Amounts reclassified to the Consolidated Statement of Earnings — 12 131 143
Total other comprehensive income/(loss), before tax 2 (521) 226 (294)
Tax effect (1) 81 (129) (49)
Total other comprehensive income/(loss), net of tax 1 (440) 96 (343)
Less: OCI attributable to non-controlling interests, net of tax — (1) (20) (21)
BALANCE AT JUNE 30, 2026, NET OF TAX $ 10 $ (1,216) $ (11,259) $ (12,465)
Foreign currency translation includes financial statement translation and changes in fair value of net investment hedges (see
Note 9).
The below provides additional details on amounts reclassified from AOCI into the Consolidated Statement of Earnings:
• Postretirement benefit plan amounts are reclassified from AOCI into Other non-operating income/(expense), net and
included in the computation of net periodic postretirement costs/(credit) (see Note 8).
• Foreign currency translation amounts are reclassified from AOCI into Other non-operating income/(expense), net,
upon the substantial liquidation of foreign operations. These accumulated foreign currency translation losses include
non-cash charges due to the substantial liquidation of operations in certain Enterprise markets, including Pakistan in
2026 and Argentina in 2025 (see Note 3).
NOTE 12
LEASES
The Company determines whether a contract contains a lease at the inception of a contract by determining if the contract
conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration.
We lease certain real estate, machinery, equipment, vehicles and office equipment for varying periods. Many of these leases
include an option to either renew or terminate the lease. For purposes of calculating lease liabilities, these options are included
within the lease term when it has become reasonably certain that the Company will exercise such options. The incremental
borrowing rate utilized to calculate our lease liabilities is based on the information available at commencement date, as most of
the leases do not provide an implicit borrowing rate. Our operating lease agreements do not contain any material guarantees or
restrictive covenants. The Company does not have any material finance leases or sublease activities. Short-term leases, defined
64 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 76 of 92 --

as leases with initial terms of 12 months or less, are not reflected on the Consolidated Balance Sheets. Lease expense for such
short-term leases is not material. The most significant assets in our leasing portfolio relate to real estate and vehicles. For
purposes of calculating lease liabilities for such leases, we have combined lease and non-lease components.
The components of the Company’s total operating lease cost for the fiscal years ended June 30, 2026, 2025 and 2024, were as
follows:
Fiscal years ended June 30 2026 2025 2024
Operating lease cost $ 275 $ 276 $ 252
Variable lease cost (1) 85 81 91
Total lease cost $ 361 $ 357 $ 343
(1) Includes primarily costs for utilities, common area maintenance, property taxes and other operating costs associated with operating leases
that are not included in the lease liability and are recognized in the period in which they are incurred.
Supplemental balance sheet and other information related to leases is as follows:
As of June 30 2026 2025
Operating leases:
Right-of-use assets (Other noncurrent assets) $ 846 $ 925
Current lease liabilities (Accrued and other liabilities) 246 255
Noncurrent lease liabilities (Other noncurrent liabilities) 641 701
Total operating lease liabilities $ 887 $ 956
Weighted average remaining lease term:
Operating leases 6.0 years 6.0 years
Weighted average discount rate:
Operating leases 5.6 % 4.6 %
At June 30, 2026, future payments of operating lease liabilities were as follows:
June 30, 2026
1 year $ 246
2 years 205
3 years 171
4 years 126
5 years 82
Over 5 years 198
Total lease payments 1,028
Less: Interest (141)
Present value of lease liabilities $ 887
Total cash paid for amounts included in the measurement of lease liabilities was $273 and $280 for the fiscal years ended
June 30, 2026 and 2025, respectively.
The right-of-use assets obtained in exchange for lease liabilities were $168 and $261 for the fiscal years ended June 30, 2026
and 2025, respectively.
NOTE 13
COMMITMENTS AND CONTINGENCIES
Guarantees
In conjunction with certain transactions, primarily divestitures, we may provide routine indemnifications (e.g., indemnification
for representations and warranties and retention of previously existing environmental, tax and employee liabilities) for which
terms range in duration and, in some circumstances, are not explicitly defined. The maximum obligation under some
indemnifications is also not explicitly stated and, as a result, the overall amount of these obligations cannot be reasonably
The Procter & Gamble Company 65
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 77 of 92 --

estimated. We have not made significant payments for these indemnifications. We believe that if we were to incur a loss on any
of these matters, the loss would not have a material effect on our financial position, results of operations or cash flows.
In certain situations, we guarantee loans for suppliers and customers. The total amount of guarantees issued under such
arrangements is not material.
Off-Balance Sheet Arrangements
We do not have off-balance sheet financing arrangements, including variable interest entities, that have a material impact on our
financial statements.
Purchase Commitments
We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course
of business. Commitments made under take-or-pay obligations are as follows:
Fiscal years ending June 30 2027 2028 2029 2030 2031 Thereafter
Purchase obligations $ 1,155 $ 764 $ 602 $ 349 $ 287 $ 494
Such amounts represent minimum commitments under take-or-pay agreements with suppliers and are in line with expected
usage. These amounts include purchase commitments related to service contracts for information technology, human resources
management and facilities management activities that have been outsourced to third-party suppliers. Due to the proprietary
nature of many of our materials and processes, certain supply contracts contain penalty provisions for early termination. We do
not expect to incur penalty payments under these provisions that would materially affect our financial position, results of
operations or cash flows.
Litigation
We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range
of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark
matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our
counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of
operations or cash flows.
We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take
action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently
available information, we do not believe the ultimate resolution of environmental remediation will materially affect our
financial position, results of operations or cash flows.
NOTE 14
SUPPLIER FINANCE PROGRAMS
The Company has an ongoing program to negotiate extended payment terms with its suppliers consistent with market practices.
The Company also supports a Supply Chain Finance program (SCF) with several global financial institutions. Under SCF, the
Company maintains an accounts payable system to facilitate participating suppliers' ability to sell receivables from the
Company to a SCF bank. These participating suppliers negotiate their sales of receivables arrangements directly with the
respective SCF bank. The Company is not party to those agreements, but the SCF banks allow the suppliers to utilize the
Company’s creditworthiness in establishing credit spreads and associated costs. Under this model, this arrangement generally
provides the suppliers with more favorable terms than they would be able to secure on their own. The Company has no
economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier chooses to participate in SCF, the
supplier selects which individual Company invoices to sell to the SCF bank. The Company’s obligations to its suppliers,
including the amounts due and scheduled payment dates, are not impacted by the supplier’s decisions to finance amounts under
these arrangements. The Company does not provide any form of guarantee under these financing arrangements. Our payment
terms for suppliers under this program generally range from 60 to 180 days. All outstanding amounts related to suppliers
participating in SCF are recorded within Accounts payable in our Consolidated Balance Sheets, and the associated payments are
included in operating activities within our Consolidated Statements of Cash Flows.
The summary of the Company's outstanding obligation confirmed as valid under the SCF program is as follows:
Fiscal years ended June 30 2026 2025
CONFIRMED OBLIGATIONS OUTSTANDING - BEGINNING OF YEAR $ 5,790 $ 5,559
Invoices confirmed 18,110 17,132
Confirmed invoices paid (17,741) (16,999)
Translation and other 16 98
CONFIRMED OBLIGATIONS OUTSTANDING - END OF YEAR $ 6,176 $ 5,790
66 The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 78 of 92 --

NOTE 15
SUBSEQUENT EVENT
On August 4, 2026, the Company entered into an agreement to acquire Thorne, a premium wellness and supplement brand in
the vitamins, minerals and supplements category for $3.8 billion. We anticipate the transaction to close in the second quarter of
fiscal year 2027, with the timing subject to regulatory approval and customary closing conditions.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Not applicable.
Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures.
The Company’s Chairman of the Board, President and Chief Executive Officer, Shailesh Jejurikar, and the Company’s Chief
Financial Officer, Andre Schulten, performed an evaluation of the Company’s disclosure controls and procedures (as defined in
Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by
this report.
Messrs. Jejurikar and Schulten have concluded that the Company’s disclosure controls and procedures were effective to ensure
that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed,
summarized and reported within the time periods specified in SEC rules and forms, and (2) accumulated and communicated to
our management, including Messrs. Jejurikar and Schulten, to allow their timely decisions regarding required disclosure.
Reports on Internal Control over Financial Reporting.
The information required by this item is incorporated by reference to "Management's Report on Internal Control over Financial
Reporting" and "Report of Independent Registered Public Accounting Firm" included in Item 8 of this Form 10-K.
Changes in Internal Control over Financial Reporting.
There were no changes in our internal control over financial reporting that occurred during the Company's fourth fiscal quarter
that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial
reporting.
Item 9B. Other Information.
During the fiscal year ended June 30, 2026, none of our directors or officers adopted or terminated a "Rule 10b5-1 trading
arrangement" or "non-Rule 10b5-1 trading arrangement" as defined in Item 408 of Regulation S-K.
Insider Trading Arrangements and Policies
The Company has insider trading policies and procedures that govern the purchase, sale and other dispositions of its securities
by directors, officers and employees, as well as by the Company itself. We believe these policies and procedures are reasonably
designed to promote compliance with insider trading laws, rules and regulations and applicable listing standards.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not applicable.
PART III
Item 10. Directors, Executive Officers and Corporate Governance.
The Board of Directors has determined that the following members of the Audit Committee are independent and are Audit
Committee financial experts as defined by SEC rules: Mr. Brett Biggs and Ms. Christine McCarthy (Chair).
The information required by this item is incorporated by reference to the following sections of the 2026 Proxy Statement filed
pursuant to Regulation 14A, which will be filed no later than 120 days after June 30, 2026: the section entitled Election of
Directors; the subsections of the Corporate Governance section entitled Oversight of our Company - Code of Ethics and Board
Meetings and Committees of the Board; the subsection of the Beneficial Ownership section entitled Delinquent Section 16(a)
Reports and the subsection of the Other Matters section entitled Shareholder Recommendations or Nominations of Director
Candidates. Pursuant to the Instruction to Item 401 of Regulation S-K, Executive Officers of the Registrant are reported in Part
I of this report.
Item 11. Executive Compensation.
The information required by this item is incorporated by reference to the following sections of the 2026 Proxy Statement filed
pursuant to Regulation 14A, which will be filed no later than 120 days after June 30, 2026: the subsections of the Corporate
Governance section entitled Board Meetings and Committees of the Board, Compensation Committee Interlocks and Insider
Participation and Risk Oversight - Compensation-Related Risk; and the portion beginning with the section entitled Director
Compensation up to but not including the section entitled Pay Versus Performance.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The following table gives information about the Company's common stock that may be issued upon the exercise of options,
warrants and rights under all of the Company's equity compensation plans as of June 30, 2026. The table includes the following
The Procter & Gamble Company 67
Amounts in millions of dollars except per share amounts or as otherwise specified.

-- 79 of 92 --

plans: The Procter & Gamble 1992 Stock Plan; The Procter & Gamble 2001 Stock and Incentive Compensation Plan; The
Procter & Gamble 2003 Non-Employee Directors' Stock Plan; The Procter & Gamble 2009 Stock and Incentive Compensation
Plan; The Procter & Gamble 2014 Stock and Incentive Compensation Plan; The Procter & Gamble 2019 Stock and Incentive
Compensation Plan; and The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
Plan Category
(a)
Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
(b)
Weighted
average exercise
price of outstanding
options, warrants and
rights
(c)
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))
Equity compensation plans approved by
security holders
Stock Options/Stock Appreciation Rights 94,554,254 $127.0740 (1)
Restricted Stock Units (RSUs)/Performance
Stock Units (PSUs) 6,699,124 N/A (1)
TOTAL 101,253,378 $127.0740 (2)
(1) Of the plans listed above, only The Procter & Gamble 2025 Stock and Incentive Compensation Plan (the "2025 Plan") allows for future
grants of securities. The maximum number of shares that may be granted under this plan is 213 million shares (inclusive of unissued
shares that were carried over from the Procter & Gamble Company 2019 Stock and Incentive Compensation Plan), plus any shares of
Common Stock subject to outstanding awards under the 2019 Plan that are forfeited, cancelled or otherwise terminated without the
issuance of shares of Common Stock as set forth in the 2025 Plan. Stock options and stock appreciation rights are counted on a one-for-
one basis while full value awards (such as RSUs and PSUs) are counted as five shares for each share awarded. Total shares available for
future issuance under this plan is 213 million.
(2) Weighted average exercise price of outstanding options and stock appreciation rights only.
Additional information required by this item is incorporated by reference to the following section of the 2026 Proxy Statement
filed pursuant to Regulation 14A, which will be filed no later than 120 days after June 30, 2026: the subsection of the Beneficial
Ownership section entitled Security Ownership of Management and Certain Beneficial Owners.
Item 13. Certain Relationships and Related Transactions and Director Independence.
The information required by this item is incorporated by reference to the following sections of the 2026 Proxy Statement filed
pursuant to Regulation 14A, which will be filed no later than 120 days after June 30, 2026: the subsections of the Corporate
Governance section entitled Director Independence and Review and Approval of Transactions with Related Persons.
Item 14. Principal Accountant Fees and Services.
The information required by this item is incorporated by reference to the following section of the 2026 Proxy Statement filed
pursuant to Regulation 14A, which will be filed no later than 120 days after June 30, 2026: Report of the Audit Committee,
which ends with the subsection entitled Services Provided by Deloitte.
PART IV
Item 15. Exhibits and Financial Statement Schedules.
1. Financial Statements:
The following Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries, management's report
and the reports of the independent registered public accounting firm are incorporated by reference in Part II, Item 8 of this Form
10-K.
• Management's Report on Internal Control over Financial Reporting
• Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting (PCAOB Firm ID
is 34)
• Report of Independent Registered Public Accounting Firm on Consolidated Financial Statements
• Consolidated Statements of Earnings - for fiscal years ended June 30, 2026, 2025 and 2024
• Consolidated Statements of Comprehensive Income - for fiscal years ended June 30, 2026, 2025 and 2024
• Consolidated Balance Sheets - as of June 30, 2026 and 2025
• Consolidated Statements of Shareholders' Equity - for fiscal years ended June 30, 2026, 2025 and 2024
• Consolidated Statements of Cash Flows - for fiscal years ended June 30, 2026, 2025 and 2024
• Notes to Consolidated Financial Statements
2. Financial Statement Schedules:
These schedules are omitted because of the absence of the conditions under which they are required or because the information
is set forth in the Consolidated Financial Statements or Notes thereto.
68 The Procter & Gamble Company

-- 80 of 92 --

EXHIBITS
Exhibit (3-1) - Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011 and
consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's
Annual Report on Form 10-K for the year ended June 30, 2016).
(3-2) - Regulations (as approved by the Board of Directors on December 13, 2022, pursuant to authority granted by
shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company's
Current Report on Form 8-K filed December 13, 2022).
Exhibit (4-1) - Indenture, dated as of September 3, 2009, between the Company and Deutsche Bank Trust Company Americas, as
Trustee (Incorporated by reference to Exhibit (4-1) of the Company's Annual Report on Form 10-K for the year ended
June 30, 2015).
(4-2) - The Company agrees to furnish to the Securities and Exchange Commission, upon request, a copy of any other
instrument defining the rights of holders of the Company’s long-term debt.
(4-3) - Description of the Company’s Common Stock (Incorporated by reference to Exhibit (4-3) of the Company’s Annual
report on Form 10-K for the year ended June 30, 2019).
(4-4) - Description of the Company’s 1.200% Notes due 2028 and 1.875% Notes due 2038 (Incorporated by reference to
Exhibit (4-4) of the Company’s Annual report on Form 10-K for the year ended June 30, 2025).
(4-5) - Description of the Company’s 4.875% EUR notes due May 2027, 6.250% GBP notes due January 2030, and 5.250%
GBP notes due January 2033 (Incorporated by reference to Exhibit (4-5) of the Company’s Annual report on Form 10-
K for the year ended June 30, 2021).
(4-6) - Description of the Company’s 1.250% Notes due 2029 (Incorporated by reference to Exhibit (4-6) of the Company’s
Annual report on Form 10-K for the year ended June 30, 2025).
(4-7) - Description of the Company’s 1.800% Notes due 2029 (Incorporated by reference to Exhibit (4-7) of the Company’s
Annual report on Form 10-K for the year ended June 30, 2025).
(4-9) - Description of the Company's 0.350% EUR Notes due 2030 and 0.900% EUR Notes due 2041 (Incorporated by
reference to Exhibit (4-10) of the Company's Annual Report on Form 10-K for the year ended June 30, 2022).
(4-10) - Description of the Company's 0.110% Yen Notes due 2026 and 0.230% Yen Notes due 2031 (Incorporated by reference
to Exhibit (4-11) of the Company's Annual Report on Form 10-K for the year ended June 30, 2022).
(4-11) - Description of the Company's 3.250% Notes due 2026 and 3.250% Notes due 2031 (Incorporated by reference to
Exhibit (4-11) of the Company's Annual Report on Form 10-K for the year ended June 30, 2023).
(4-12) - Description of the Company's 3.150% Notes due 2028 and 3.200% Notes due 2034. (Incorporated by reference to
Exhibit (4-12) of the Company's Annual Report on Form 10-K for the year ended June 30, 2024).
(4-13) - Description of the Company’s 2.900% EUR Notes due 2033 and 3.650% EUR Notes due 2045.+
Exhibit (10-1) - The Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended), which was originally adopted by
shareholders at the annual meeting on October 9, 2001 (Incorporated by reference to Exhibit (10-1) of the Company’s
Annual Report on Form 10-K for the year ended June 30, 2018).*
(10-2) - The Procter & Gamble 2001 Stock and Incentive Compensation Plan related correspondence and terms and conditions
(Incorporated by reference to Exhibit (10-1) of the Company's Form 10-Q for the quarter ended December 31, 2013).*
(10-3) - The Procter & Gamble 1992 Stock Plan (as amended December 11, 2001), which was originally adopted by the
shareholders at the annual meeting on October 12, 1992 (Incorporated by reference to Exhibit (10-2) of the Company’s
Annual Report on Form 10-K for the year ended June 30, 2018).*
(10-4) - The Procter & Gamble Executive Group Life Insurance Policy (Incorporated by reference to Exhibit (10-3) of the
Company’s Annual Report on Form 10-K for the year ended June 30, 2018).*
(10-5) - The Procter & Gamble Company Executive Deferred Compensation Plan (Incorporated by reference to Exhibit (10-2)
of the Company's Form 10-Q for the quarter ended March 31, 2020).*
(10-6) - Company's Form of Separation Agreement & Release. (Incorporated by reference to Exhibit (10-1) in the Company's
Form 10-Q for the quarter ended March 31, 2025). *
(10-7) - Company's Form of Separation Letter and Release (Incorporated by reference to Exhibit (10-1) of the Company's Form
10-Q for the quarter ended March 31, 2023).*
(10-8) - Summary of personal benefits available to certain officers (Incorporated by reference to Exhibit (10-14) in the
Company's Form 10-K for the year ended June 30, 2025).*
(10-9) - The Gillette Company Deferred Compensation Plan (Incorporated by reference to Exhibit (10-18) of the Company’s
Annual Report on Form 10-K for the year ended June 30, 2017).*
The Procter & Gamble Company 69

-- 81 of 92 --

(10-10) - Senior Executive Officer Recoupment Policy. (Incorporated by reference to Exhibit (10-16) of the Company's Annual
Report on Form 10-K for the year ended June 30, 2024).*
(10-11) - The Gillette Company Deferred Compensation Plan (for salary deferrals prior to January 1, 2005) as amended through
August 21, 2006 (Incorporated by reference to Exhibit (10-20) of the Company's Annual Report on Form 10-K for the
year ended June 30, 2017).*
(10-12) - The Procter & Gamble 2009 Stock and Incentive Compensation Plan, which was originally adopted by shareholders at
the annual meeting on October 13, 2009 (Incorporated by reference to Exhibit (10-21) of the Company's Annual Report
on Form 10-K for the year ended June 30, 2017).*
(10-13) - Regulations of the Compensation and Leadership Development Committee for The Procter & Gamble 2009 Stock and
Incentive Compensation Plan, The Procter & Gamble 2001 Stock and Incentive Compensation Plan, The Procter &
Gamble 1992 Stock Plan, The Procter & Gamble 1992 Stock Plan (Belgium Version), The Gillette Company 2004
Long-Term Incentive Plan and the Gillette Company 1971 Stock Option Plan (Incorporated by reference to Exhibit
(10-21) of the Company’s Annual Report on Form 10-K for the year ended June 30, 2018).*
(10-14) - The Procter & Gamble 2009 Stock and Incentive Compensation Plan - Additional terms and conditions and related
correspondence (Incorporated by reference to Exhibit (10-2) of the Company Form 10-Q for the quarter ended
December 31, 2013).*
(10-15) - The Procter & Gamble 2013 Non-Employee Directors' Stock Plan (Incorporated by reference to Exhibit (10-3) of the
Company's Form 10-Q for the quarter ended December 31, 2013). *
(10-16) - The Procter & Gamble 2014 Stock and Incentive Compensation Plan, which was originally adopted by shareholders at
the annual meeting on October 14, 2014 (Incorporated by reference to Exhibit (10-25) of the Company's Annual Report
on Form 10-K for the year ended June 30, 2016).*
(10-17) - The Procter & Gamble 2014 Stock and Incentive Compensation Plan - Additional terms and conditions (Incorporated
by reference to Exhibit (10-26) of the Company's Annual Report on Form 10-K for the year ended June 30, 2017).*
(10-18) - The Procter & Gamble 2019 Stock and Incentive Compensation Plan, which was originally adopted by shareholders at
the annual meeting on October 8, 2019 (Incorporated by reference to Exhibit (10-1) of the Company’s Current Report
on Form 8-K filed October 11, 2019).*
(10-19) - The Procter & Gamble 2019 Stock and Incentive Compensation Plan - Additional terms and conditions. (Incorporated
by reference to Exhibit (10-28) of the Company's Annual Report on Form 10-K for the year ended June 30, 2024).*
(10-20) - The Procter & Gamble 2025 Stock and Incentive Compensation Plan - (Incorporated by reference to Exhibit (10-1) of
the Company's Form 10-Q for the quarter ended September 30, 2025). *
(10-21) - Regulations of the Compensation and Leadership Development Committee for The Procter & Gamble 2025 Stock and
Incentive Compensation Plan, 2019 Stock and Incentive Compensation Plan and The Procter & Gamble 2014 Stock and
Incentive Compensation Plan. *+
(10-22) - Retirement Plan Restoration Program Summary. *+
(10-23) - Short Term Achievement Reward Program. *+
(10-24) - Performance Stock Program Summary. *+
(10-25) - Long-Term Incentive Program Summary. *+
(10-26) - Form of STAR Stock Option Award Agreement. *+
(10-27) - Form of Director Annual RSU Award Agreement. *+
(10-28) - Form of Director Annual RSU Award Agreement (Deferred). *+
(10-29) - Form of Director RSU Award Agreement (Quarterly Fees). *+
(10-30) - Form of PSU Award Agreement. *+
(10-31) - Form of Deferred PSU Award Agreement. *+
(10-32) - Form of LTIP RSU Award Agreement. *+
(10-33) - Form of LTIP Stock Option Award Agreement. *+
(10-34) - Form of Special RSU Award Agreement. *+
(10-35) - Form of Retirement Restoration Plan RSU Award Agreement. *+
Exhibit (19-1) - P&G Global Insider Trading Policy. (Incorporated by reference to Exhibit (19-1) of the Company's Annual Report on
Form 10-K for the year ended June 30, 2024).
70 The Procter & Gamble Company

-- 82 of 92 --

(19-2) - P&G Share Repurchase Policy. (Incorporated by reference to Exhibit (19-2) of the Company's Annual Report on Form
10-K for the year ended June 30, 2024).
Exhibit (21) - Subsidiaries of the Registrant. +
Exhibit (23) - Consent of Independent Registered Public Accounting Firm. +
Exhibit (31) - Rule 13a-14(a)/15d-14(a) Certifications. +
Exhibit (32) - Section 1350 Certifications. +
Exhibit (97) - P&G Dodd-Frank Recoupment Policy. (Incorporated by reference to Exhibit (97) of the Company's Annual Report on
Form 10-K for the year ended June 30, 2024).
Exhibit (99-1) - Summary of Directors and Officers Insurance Program. +
101.INS (1) Inline XBRL Instance Document
101.SCH (1) Inline XBRL Taxonomy Extension Schema Document
101.CAL (1) Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF (1) Inline XBRL Taxonomy Definition Linkbase Document
101.LAB (1) Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE (1) Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
(1) Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration
statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities
Exchange Act of 1934 and otherwise are not subject to liability.
* Compensatory plan or arrangement.
+ Filed herewith.
Item 16. Form 10-K Summary.
Not applicable.
The Procter & Gamble Company 71

-- 83 of 92 --

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized in the city of Cincinnati, State of Ohio.
THE PROCTER & GAMBLE COMPANY
By /s/ SHAILESH JEJURIKAR
(Shailesh Jejurikar)
Chairman of the Board, President and Chief Executive Officer
August 4, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following
persons in the capacities and on the dates indicated.
Signature Title Date
/s/ SHAILESH JEJURIKAR
(Shailesh Jejurikar) Chairman of the Board, President and Chief
Executive Officer (Principal Executive Officer) August 4, 2026
/s/ ANDRE SCHULTEN
(Andre Schulten) Chief Financial Officer
(Principal Financial Officer) August 4, 2026
/s/ MATTHEW W. JANZARUK
(Matthew W. Janzaruk) Senior Vice President - Chief Accounting Officer
(Principal Accounting Officer) August 4, 2026
/s/ B. MARC ALLEN
(B. Marc Allen) Director August 4, 2026
/s/ CRAIG ARNOLD
(Craig Arnold) Director August 4, 2026
/s/ BRETT BIGGS
(Brett Biggs) Director August 4, 2026
/s/ SHEILA BONINI
(Sheila Bonini) Director August 4, 2026
/s/ AMY L. CHANG
(Amy L. Chang) Director August 4, 2026
/s/ JOSEPH JIMENEZ
(Joseph Jimenez) Director August 4, 2026
/s/ CHRISTOPHER J. KEMPCZINSKI
(Christopher J. Kempczinski) Director August 4, 2026
/s/ DEBRA L. LEE
(Debra L. Lee) Director August 4, 2026
/s/ CHRISTINE M. MCCARTHY
(Christine M. McCarthy) Director August 4, 2026
/s/ ASHLEY MCEVOY
(Ashley McEvoy) Director August 4, 2026
/s/ ROBERT J. PORTMAN
(Robert J. Portman) Director August 4, 2026
/s/ RAJESH SUBRAMANIAM
(Rajesh Subramaniam) Director August 4, 2026
72 The Procter & Gamble Company

-- 84 of 92 --

Company and Shareholder Information
P&G’s Purpose
We will provide branded products
and services of superior quality and
value that improve the lives of the
world’s consumers, now and for
generations to come. As a result,
consumers will reward us with
leadership sales, profit and value
creation, allowing our people, our
shareholders and the communities
in which we live and work to prosper.
To learn more, please visit us.pg.com.
Brands
P&G brands are trusted to provide
products of the highest quality
and superior performance and
value for the daily-use cleaning,
health and hygiene needs of
consumers around the world.
For information on our portfolio
of brands and our latest innovations
please visit us.pg.com/brands.
Citizenship
We are committed to doing
what’s right and being a good
corporate citizen. Our Citizenship
efforts are focused on Community
Impact, Equality & Inclusion and
Environmental Sustainability, with
a foundation of Ethics & Corporate
Responsibility guiding everything
we do.
P&G Online
• us.pg.com
• pginvestor.com
• us.pg.com/newsroom
• linkedin.com/company/
procter-and-gamble
• youtube.com/proctergamble
• instagram.com/proctergamble
Shareowner Services
EQ Shareowner Services serves as
the transfer and dividend paying
agent for P&G Common Stock
and Administrator of the Procter
& Gamble Direct Stock Purchase
Plan. Registered shareholders and
Plan participants needing account
assistance with share transfers,
plan purchases/sales, lost stock
certificates, etc., should contact
EQ Shareowner Services at:
Website shareowneronline.com
Email shareowneronline.com
Click Email under the Contact Us
section.
Phone Mon–Fri, 7 a.m.–7 p.m., CST
1-800-742-6253 or 1-651-450-4064
P&G Direct Stock
Purchase Plan
The Procter & Gamble Direct Stock
Purchase Plan (DSPP) is a direct
stock purchase and dividend
reinvestment plan. The DSPP is open
to current P&G shareholders as well
as new investors and is designed to
encourage long-term investment
in P&G by providing a convenient
and economical way to purchase
P&G stock and reinvest dividends.
Highlights of the plan include:
• Minimum initial investment — $250
• Twice-weekly purchases
• 24/7 online account access
• Optional cash investment —
minimum $50
• Administered by EQ
Shareowner Services
For complete information on
the DSPP, please read the Plan
Prospectus. The Prospectus and
online Plan Application are available
at shareowneronline.com or by
contacting EQ Shareowner Services.
P&G shares can also be purchased
through any financial institution
that offers stock purchase services
for shares traded on the New York
Stock Exchange.
Stock Symbol
PG
Transfer Agent
EQ Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100
Registrar
EQ Shareowner Services
P.O. Box 64874
St. Paul, MN 55164-0874
Exchange Listings
New York Stock Exchange
Corporate Headquarters
The Procter & Gamble Company
1 P&G Plaza
Cincinnati, OH 45202-3315
Annual Meeting
The next annual meeting of
shareholders will be held on Tuesday,
October 13, 2026. A full transcript of
the meeting will be available from
P&G’s Assistant Secretary, who can
be reached at 1 P&G Plaza, Cincinnati,
OH 45202-3315.
Form 10-K
Shareholders may obtain a copy of
P&G’s 2026 report to the Securities
and Exchange Commission on Form
10-K at no charge at pginvestor.com.
The most recent certifications
by our Chief Executive and Chief
Financial Officers pursuant to Section
302 of the Sarbanes-Oxley Act of
2002 are filed as exhibits to our Form
10-K for the fiscal year ended June 30,
2026. We have also filed with the
New York Stock Exchange the most
recent Annual CEO certification as
required by Section 303A.12(a) of the
New York Stock Exchange Listed
Company Manual.
The Procter & Gamble Company • 73

-- 85 of 92 --

Measures Not Defined by U.S. GAAP
The following provides definitions of the non-GAAP measures used in Procter & Gamble’s 2026 Annual
Report and the reconciliation to the most closely related GAAP measure. We believe that these measures
provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual
items) and results and provide a supplemental measure of year-on-year results.
The non-GAAP measures described below are used by management in making operating decisions,
allocating financial resources and for business strategy purposes. These measures may be useful to
investors, as they provide supplemental information about business performance and provide investors
a view of our business results through the eyes of management. These measures are also used to evaluate
senior management and are a factor in determining their at-risk compensation.
These non-GAAP measures are not intended to be considered by the user in place of the related GAAP
measure, but rather as supplemental information to our business results. These non-GAAP measures may
not be the same as similar measures used by other companies due to possible differences in method and
in the items or events being adjusted. Note that certain columns and rows may not add due to rounding.
Organic sales growth. Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions
and divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with
a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure
is used in assessing the achievement of management goals for at-risk compensation.
The following tables provide a numerical reconciliation of organic sales growth to reported net sales growth:
Type 	Net Sales Growth 	Foreign Exchange Impact 	Acquisition & Divestiture
Impact/Other 1 	Organic Sales Growth
FY 2026 	3% 	(2)% 	–% 	1%
Grooming 	4% 	(3)% 	–% 	1%
(1) Acquisitions & Divestitures Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile
net sales to organic sales.
Adjusted free cash flow. Adjusted free cash flow is defined as operating cash flow less capital spending and excluding
payments for the transitional tax resulting from the 2017 U.S. Tax Act. Adjusted free cash flow represents the cash that the
Company is able to generate after taking into account planned maintenance and asset expansion. We view adjusted free
cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends,
share repurchases, acquisitions and other discretionary investments.
The following table provides a numerical reconciliation of adjusted free cash flow:
($ millions) 	Operating Cash Flow 	Capital Spending 	2017 U.S. Tax Act
Payments 	Adjusted Free Cash Flow
FY 2026 	$19,556 	$(4,409) 	$688 	$15,835
Adjusted free cash flow productivity. Adjusted free cash flow productivity is defined as the ratio of adjusted free cash
flow to net earnings excluding the gain from the dissolution of the Glad joint venture business. We view adjusted free
cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. Adjusted free cash
flow productivity is used by management in making operating decisions, in allocating financial resources and for budget
planning purposes. This measure is used in assessing the achievement of management goals for at-risk compensation.
74 • The Procter & Gamble Company

-- 86 of 92 --

The following table provides a numerical reconciliation of adjusted free cash flow productivity:
($ millions) 	Adjusted Free
Cash Flow 	Net Earnings 	Adjustments to
Net Earnings 1
Net Earnings
as Adjusted
Adjusted Free Cash
Flow Productivity
FY 2026 	$15,835 	$16,144 	$(261) 	$15,883 	100%
(1) Adjustments to Net Earnings relate to the gain from the dissolution of the Glad joint venture business.
Core EPS and currency-neutral Core EPS. Core net earnings per share, or Core EPS, is a measure of the Company’s
diluted net earnings per common share (diluted EPS) excluding items that are not judged by management to be part
of the Company’s sustainable results or trends. Currency-neutral Core EPS is a measure of the Company’s Core EPS
excluding the incremental current year impact of foreign exchange. Management views these non-GAAP measures
as useful supplemental measures of Company performance over time.
The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures
adjusted as applicable for the following items:
Incremental Restructuring: The Company has historically had an ongoing level of restructuring activities of approximately
$250 to $500 million before tax. During fiscal 2025, the Company completed its limited market portfolio restructuring
with the substantial liquidation of its operations in Argentina. In June 2025, the Company announced a portfolio
and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness.
The Company incurred over half of the costs under this plan in fiscal 2026, with the remainder expected to be incurred
in fiscal 2027. The adjustments to Core earnings include the restructuring charges that exceed the normal, recurring
level of restructuring charges.
Glad joint venture agreement: In January 2026, the Glad joint venture agreement between the Company and Clorox
expired. Under the terms of the agreement, Clorox purchased the Company’s minority interest in the venture at fair
market value for $476 million. This transaction was accounted for as a dissolution of the Glad joint venture business
and the Company recorded an after-tax gain of $261 million.
Intangible asset impairment: During fiscal 2024, the Company recognized a non-cash, after-tax impairment charge
of $1.0 billion ($1.3 billion before tax) to adjust the carrying value of the Gillette indefinite-lived intangible asset acquired
as part of the Company’s 2005 acquisition of The Gillette Company.
We do not view these items to be part of our sustainable results and their exclusion from Core earnings per share
provides a more comparable measure of year-on-year results.
Years ended June 30 	2026 	2025 	2024 	2023 	2022
Diluted Net Earnings Per Common Share from
Continuing Operations, attributable to P&G 	$6.62 	$6.51 	$6.02 	$5.90 	$5.81
Incremental restructuring 	$0.37 	$0.33 	$0.15 	– 	–
Glad joint venture agreement 	$(0.11) 	– 	– 	– 	–
Intangible asset impairment 	– 	– 	$0.42 	– 	–
Core EPS 	$6.89 	$6.83 	$6.59 	$5.90 	$5.81
Core EPS growth vs. prior year 	1% 	– 	– 	– 	–
Currency Impact to Earnings 	$(0.09) 	– 	– 	– 	–
Currency-neutral Core EPS 	$6.80 	– 	– 	– 	–
Currency neutral Core EPS growth 	–% 	– 	– 	– 	–
The Procter & Gamble Company • 75

-- 87 of 92 --

Board of Directors
B. Marc Allen
Chief Executive Officer of Electra.aero, Inc. (aircraft
designer and manufacturer). Former President, Boeing
International and Chief Strategy Officer of The Boeing
Company (aerospace). P&G Director since 2021. Age 53.
Craig Arnold
Former Chairman and Chief Executive Officer of
Eaton Corporation (intelligent power management).
P&G Director since 2025. Also a director of KKR & Co.,
independent chairman of Honeywell Aerospace Inc.
and lead director of Medtronic plc. Age 66.
Brett Biggs
Former Executive Vice President and Chief Financial
Officer of Walmart, Inc. (global retailer). P&G Director
since 2023. Also a director of J.B. Hunt Transport
Services, Inc. and YUM! Brands, Inc. Age 58.
Sheila Bonini
Senior Vice President of Private Sector Engagement at
the World Wildlife Fund (nonprofit wildlife conservation
organization). P&G Director since 2023. Age 62.
Amy L. Chang
Former Executive Vice President of Cisco Systems,
Inc. (networking technology). Founder and former
Chief Executive Officer of Accompany, Inc. (relationship
intelligence AI). P&G Director since 2017. Also a director
of The Walt Disney Company and Salesforce, Inc. Age 49.
Shailesh Jejurikar
Chairman of the Board, President and Chief Executive
Officer of the Company. P&G Director since 2025. Age 59.
Joseph Jimenez
Co-Founder and Managing Director at Aditum Bio
(a biotech venture fund). Former Chief Executive Officer
of Novartis AG (global healthcare). P&G Director since 2018;
Independent Lead Director since 2021. Also a director of
Quantinuum Inc. and General Motors Company. Age 66.
Christopher Kempczinski
Chairman, President and Chief Executive Officer at
McDonald’s Corporation (restaurant operator and
franchisor). P&G Director since 2021. Also a director
of McDonald’s. Age 57.
Debra L. Lee
Chair of Leading Women Defined Foundation (nonprofit
education and advocacy organization). Former Chairman
and Chief Executive Officer of BET Networks (media and
entertainment). P&G Director since 2020. Also a director
of Marriott International, Inc. and Warner Bros. Discovery.
Age 72.
Christine M. McCarthy
Former Senior Executive Vice President and Chief
Financial Officer of The Walt Disney Company (global
entertainment). P&G Director since 2019. Also a director
of CoStar Group, Inc. and Flutter Entertainment. Age 71.
Ashley McEvoy
President and Chief Executive Officer of Insulet
Corporation (healthcare). P&G Director since 2023.
Also a director of Insulet. Age 55.
Robert J. Portman
Former United States Senator, Director of the U.S.
Office of Management and Budget, and United States
Trade Representative. P&G Director since 2023. Age 70.
Rajesh Subramaniam
President and Chief Executive Officer at FedEx Corporation
(transportation and business services). P&G Director since
2022. Also a director of FedEx. Age 60.
The Board of Directors Has Four Committees:
• Audit
• Compensation & Leadership Development
• Governance & Public Responsibility
• Innovation & Technology
76 • The Procter & Gamble Company

-- 88 of 92 --

Victor Aguilar
Chief Research, Development
and Innovation Officer
Benjamin Binot
President – Oral Care
Eric Breissinger
President – Family Care
April Cielica
President – Global Business Services
Seth Cohen
Chief Information Officer
Kristine Decker
Chief Equality and Inclusion
Officer and Senior Vice President –
Brand Building Transformation
Philip J. Duncan
Chief Design Officer
Franco Giannicchi
President – Latin America
Damon Jones
Chief Communications Officer
Sue Kyung Lee
President – Skin Care and Asia Focus
Market Beauty Eco-Systems
Artur (Litar) Litarowicz
President – Personal Care
and North America Beauty
Eco-Systems
Marchoe Northern
President – Fabric Care,
North America
Oya Ongor
President – India, Middle East,
Turkey, Africa (IMETA)
Guy Persaud
President – Habitat Care
Marc S. Pritchard
Chief Brand Officer
Bala Purushothaman
Chief Human Resources Officer
Luc Reynaert
Chief Product Supply Officer
Ranya Shamoon
President – Feminine Care
Mindy Sherwood
President – North America
and Chief Sales Officer
Kirti Singh
Chief Analytics and Insights Officer
Eddie Sukkari
President – Home Care
Loïc Tassel
President – Europe
Stanislav (Standa) Vecera
President – Asia Pacific
Susan Street Whaley
Chief Legal Officer and Secretary
Jasmine Xu
President – Greater China
Company Leadership
Shailesh G. Jejurikar
Chairman of the Board, President and Chief Executive Officer
Hesham Tohamy Abd El Hak
Chief Executive Officer –
Baby and Feminine Care
Juliana Azevedo
Chief Executive Officer –
Grooming
Freddy Bharucha
Chief Executive Officer –
Beauty
Paul Gama
Chief Executive Officer –
Health Care
Sundar G. Raman
Chief Executive Officer – Fabric and
Home Care, and Executive Sponsor
for Corporate Sustainability
Andre Schulten
Chief Financial Officer
Visit us at us.pg.com/leadership-team to learn more about P&G’s global leaders.	As of August 4, 2026
The Procter & Gamble Company • 77

-- 89 of 92 --

TIME awards: © 2025 TIME USA LLC. All rights reserved. Used under license.
Fortune awards: © 2026 Fortune Media IP Limited. All rights reserved. Used under license. Fortune is a registered trademark and Fortune World’s Most Admired
Companies ™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not
endorse the products or services of, P&G.
All logos are property of their respective owners; used with permission.
Recognitions and Awards
We’re proud to be consistently recognized as a leading global company, earning a variety
of awards and recognition in several key areas.
Design: Madison
The paper utilized in the printing of this annual report is certified to the FSC ® Standards, which promotes
environmentally appropriate, socially beneficial and economically viable management of the world’s forests.
Brands
& Innovation
Community
Impact
Ethics & Corporate
Responsibility
Equality
& Inclusion
Environmental
Sustainability
2025 Circana New Product Pacesetters:
7 of the Top 10 Non-Food Product Launches in 2025
78 • The Procter & Gamble Company

-- 90 of 92 --

HEALTH CARE • Oral Care | Personal Health Care
BABY, FEMININE AND FAMILY CARE
P&G’s Focused Portfolio
GROOMING
BEAUTY • Hair Care | Skin & Personal Care
FABRIC AND HOME CARE

-- 91 of 92 --

Explore the digital version of the P&G 2026
Annual Report at us.pg.com/annualreport2026 © 2026 Procter & Gamble
00387142

-- 92 of 92 --